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ABSTRACT 
Preventing falls in older people 
Simon Conroy 
 
Falls are a major cause of injury fear of falling and death affecting 24% of 
older people annually. Falls have a major impact on hospital services, and 
are an important cause of carer strain and admission to long term care. 
Multifactorial interventions delivered to fallers are effective in reducing falls 
rates by 25%. However, no UK studies have evaluated the role of 
screening older people living in the primary care setting and offering those 
at high risk a falls prevention programme. This work describes two studies 
– the evaluation of a postal falls risk screening tool, and a randomised 
controlled trial assessing the benefits of offering a falls prevention 
programme to those identified as being at high risk. 
335 older people were recruited into the screening study, using a modified 
version of the Falls Risk Assessment Tool. The sensitivity was 79%, 
specificity 58%, positive predictive value 50% and the negative predictive 
value 83%. 
In the RCT, 364 community5dwelling older people at high risk of falls were 
randomised into a pragmatic, multicentre trial evaluating falls prevention 
programmes. 181 were allocated to the control group and 183 to the 
intervention. 
The primary outcome was the rate of falls; the adjusted IRR was 0.73 
(0.5151.03), p=0.071. There were no significant differences between the 
groups in terms of the proportion of fallers, recurrent fallers, medically 
verified falls, injurious falls, time to first fall or time to second fall. Nor 
were there significant differences in terms of institutionalisation, mortality, 
basic or extended activities of daily living, or fear of falling. 
Further work on the acceptability and implementation of falls prevention 
interventions is required, but subject to these conditions being met and a 
supportive cost5effectiveness analysis, the totality of the evidence suggests 
that screening and intervening for individuals at high risk of fall may be 
effective.
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Falls are one of the ‘geriatric giants’1. They are a common and potentially 
serious problem for older people; falls may result in injury, fear of falling, 
social isolation and death2. There is an important relationship between 
frailty, falls and fractures3 4, with the three sharing risk factors. Falls are a 
commonly cited factor leading to a care home admission and give rise to a 
major financial demand on the National Health Service and Social 
Services5.  
Several systematic reviews have collated published work on falls6511 and 
show that interventions can reduce falls by up to one5third. Such 
interventions typically consist of a medical review, home hazards 
assessment, and strength and balance training. Individual components or 
combinations of these components have been shown to be effective in 
hospital, primary care and care home settings, and in many different 
countries12 13. 
This work will focus on falls prevention in community dwelling older people. 
 .(-!/(&%&01	
Most studies on falls quote the seminal paper by Mary Tinetti 5  ‘one third 
of those aged over 65 years fall annually, rising to one half of those aged 
85’14, data from 1988 based on a well conducted cohort study of 336 
individuals in the United States. Other groups reproduced Tinetti’s results 
at around the same time15 16, which led to a focus on falls as a research 
topic and the recognition of the importance of falls in health planning and 
policy, not least the highlighting of falls in the United Kingdom (UK) 
National Service Framework for Older People2. However, there have been 
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relatively few well conducted studies on the incidence and/or prevalence of 
falls in the UK in recent years. 
Table 1.1 shows a compilation of recent studies (199652008) on falls 
prevalence and incidence in various settings. There is marked 
heterogeneity in the studies in terms of study design, size, setting and 
reporting methods, but nevertheless all point towards the high frequency of 
falls in older people. The UK and European studies indicate an annual falls 
prevalence of around 24% for older people (70 years old or greater) living 
in the community17 18, which is broadly similar to rates in Australia19 and 
the United States20522. A recent survey of older people in England reported 
falls prevalence of 23% for men and 29% for women23. One Dutch study 
reported falls prevalence of 51% over 10 months24, with reasonable 
reporting methods and a community dwelling older population similar to 
those studies cited above, which is inconsistent with the bulk of the 
literature. However, of those originally randomly invited to participate in 
the study, only 31% responded, so selection bias is likely. 
Worthy of mention is that studies with tighter ascertainment of falls 
(weekly as opposed to monthly or less frequent diaries), seem to report 
higher falls prevalence. For example, Snijder25 used weekly diaries in a 
Dutch cohort study of community dwelling older people and found rates of 
33% over one year, which is closer to Tinetti’s original study, which used 
bimonthly phone calls to ascertain falls14. This finding was reproduced by 
Cummings 26 who followed up 325 community dwelling older people 
over one year using weekly falls diaries; however at one year, 13% of 
participants were unable to recall incident falls and a further 7% recalled 
falls that were not otherwise corroborated by the diaries (see 3.6.4.1). 
Falls prevalence in very old (>85 years) community dwelling adults 
appears to be much higher, nearer the 50% originally reported by Tinetti. 
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For example, the Longitudinal Study on Ageing Amsterdam (LASA) cohort 
of 85+ year olds found a 12 month fall prevalence of 44%27. 
Few prospective cohort studies have reported falls incidence rates in 
community dwelling older people, which is in the region of 1.151.8 falls per 
person5year28 29, although many intervention trials use incidence as an 
outcome measure9 30536. Unpublished work using the THIN database general 
practises in England has found reported falls rates of 3.6 per 100 person5
years (0.04 per person5year) in people aged 60 or more, though 
underreporting is likely. 
Rates for recurrent falls (i.e. more than one fall per annum) are more 
consistent, at around 10512% per annum25 37539 though one Australian 
study found rates for recurrent falls as high as 22%19, but this was a 
randomised controlled study, and there is likely to be a degree of selection 
bias. 
By comparison, fall rates in high risk populations, such as those in care 
homes or geriatric care settings, are consistently higher – 10% over one 
week40, 12% over three months41, 20550% over six months42545 and 355
60% over one year46549. 
Fall prevalence appears to be slightly lower in oriental countries, for 
example rates in Singapore are around 15% over one year, although this 
study did include a substantial proportion of younger participants (<70 
years)50. Assantachai  reported rates of 20% in community dwelling 
Thai seniors (65+)51, albeit using two monthly diaries to ascertain self 
reported falls. One study of community dwelling older people from India 
reported 12 months falls prevalence of 48%, though the recruitment 
methods (word of mouth) make selection bias highly likely52. Falls rates in 
Turkish older people attending a geriatric outpatient setting are consistent 
with figures from Western societies (29%)53. 
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However, there are few studies comparing like with like which further 
explore varying falls rates by country. One study compared fall rates 
between white and African5American women54, but did not find any major 
difference between the two different ethnic groups.
14 
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Study Study design Falls 
reporting 
method/ 
period 
Ascertainment Setting Population Sample size Incidence Prevalence Injurious 
falls 
Clough5Gorr 
200817 
Cohort study Prospective 
12 months 
Self5reported London, UK; 
Hamburg, 
Germany; 
Solothurn, 
Switzerland 
Community 
dwelling older 
adults 
1644  24% over 12 
months 
 
Sayer 200618 Cohort study Prospective 
12 months 
Self5reported United 
Kingdom 
Community 
dwelling older 
people 
2148  124/866 
(14%) men; 
289/1282 
(23%) 
women 
 
Tinetti 200855 Cohort study Prospective 
3 years 
Routine hospital 
systems data 
Unites States Older people 
attending 
hospitals with a 
serious injurious 
fall 
>200,000   31532 per 
1000 
person5
years 
Lamoreux 
200850 
Cohort study Retrospective 
12 months 
Self reported 
falls over 12 
months 
Singapore Community5
dwelling adults 
40 to 80 years  
3266  480/3266 
(15%) over 
previous 12 
months 
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Tiedemann 
200819 
RCT (control 
arm rates 
reported) 
Prospective 
12 months 
Self5reported, 
monthly falls 
calendar 
Australia Community 
dwelling older 
people 
362  99/362 
(27%); 
80/362 
(22%) had 
recurrent 
falls 
 
Wijlhuizen 
200724 
Pre5post 
(control arm 
rates 
reported) 
Prospective 
10 months 
Self5reported Netherlands Community 
dwelling older 
people 
1752 159 per 
1000 
person5
years 
51% over 10 
months 
 
Chan 200720 Cohort study Retrospective 
4.5 years 
Self5reported, 4 
monthly recall 
of falls 
United States Community5
living older men 
5867  1489/5867 
(25%) 
 
Ganz 200721 Meta5analysis Estimated pre 
test5
probability of 
falling  
12 months 
  Community 
dwelling older 
people 
  27% (19%5
36%) over 
one year 
 
Shumway5
Cook 200728 
Cohort study Prospective 
12 months 
Self5reported 
falls 
United States Community5
living older 
adults 
453 1.8 
falls/person
5year 
  
Snijder 
200625 
Cohort study Prospective 
12 months 
Self5reported  
falls weekly on a 
fall calendar 
Netherlands Community 
dwelling older 
people 
1231  405/1231 
(33%) had at 
least one fall; 
142/1231 
(12%) had 
more than 
one fall 
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Stone 200638 Cohort study Retrospective 
12 months 
Self reported, 4 
monthly diary 
United States Ambulatory, 
community5
dwelling women 
aged 65 and 
older 
8101  10518% for 
recurrent 
falls over 12 
months 
 
Campbell 
200529 
RCT (control 
arm rates 
reported) 
Prospective 
12 months 
Self5reported  
monthly 
postcard 
calendars with 
cross check 
Australia Community 
dwelling older 
people 
361 1.1 falls per 
person5
year 
95/196 
(48%) 
0.6 per 
person5year 
van Bemmel 
200527 
Cohort study Retrospective 
12 months 
Self5reported 
recall of falls 
Netherlands Observational 
population5
based study 
599  212/599 
(44%) over 
12 months 
 
Volpato 
200539 
Cohort study Retrospective 
3 years 
Self5reported 
recall of falls 
every six 
months 
US Community 
dwelling older 
people 
878  65% over 
three years 
30% had 
recurrent 
falls 
 
Li 200622 Cohort study Retrospective 
12 months 
Self5reported 
falls over one 
year 
United States Community 
dwelling older 
people 
2193  512/2193 
(23%) 
 
Tinetti 198814 Cohort study Retrospective 
12 months 
Bimonthly 
telephone calls 
US Community 
dwelling older 
people 
336  108/336 
(32%) 
 
Birks 200456 RCT (control 
arm rates 
reported) 
Retrospective 
Median 28 
months 
Self reported UK Community 
dwelling older 
women at risk 
of fracture 
4169  43% over 
previous 12 
months 
 
Assantachai 
200257 
RCT (control 
arm rates 
reported) 
Mixed 
12 months 
Diary completed 
in retrospect 
every 2 months 
Thailand Community 
dwelling older 
people 
1043  20% over 12 
months 
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Steinberg 
200058 
Cohort study Prospective 
12 months 
Self reported, 
daily calendar 
Australia Community 
dwelling older 
people 
250  6.357.0 falls 
per 100 
person 
months 
 
Bouwen 
200842 
Cluster RCT 
(control arm 
rates 
reported) 
Prospective 
6 months 
Recorded by 
health care 
professional 
Belgium Nursing home, 
dependant 
210 N/A 44/210 
(21%) over 6 
months 
 
Kerse 200446 Cluster RCT 
(control arm 
rates 
reported) 
Prospective 
12 months 
Staff reported New Zealand Older people in 
residential care, 
dependant 
238 2.3 per 
person5
year 
103/238 
(43%) 
42/238 
(18%) 
injurious 
falls 
1.0 per 
person5year 
102 
MMSE >19 
2.9 per 
person5
year 
38554% over 
six months 
0.9 per 
person5year 
Jensen 200347 Cluster RCT 
(control arm 
rates 
reported) 
Prospective 
34 weeks 
Staff reported Sweden Residential care 
facilities 
79 
MMSE ≤19 
3.3 per 
person5
year 
46561% over 
six months 
0.9 per 
person5year 
Izumi 200259 Cohort study Unclear Unclear Japan Rehabilitation 
wards, long5
term care 
facilities, and 
nursing homes 
746  13% over 
three months 
 
Kallin 200540 Cohort study Retrospective 
One week 
Staff reported Sweden Cognitively 
impaired 
residents of 
geriatric care 
settings 
2008  189 (9%) in 
previous 
week 
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Hill 200860 Cohort study Retrospective 
6 months 
Self5reported – 
recall over six 
months 
Australia Falls clinic 254  78% over 
previous 6 
months 
123/254 
(51%) 
injurious 
falls 
8510% 
fractures 
over 6 
months 
Nowalk 
200148 
RCT (control 
arm rates 
reported) 
Retrospective 
24 months 
Self reported 
every six 
months 
US Long5term care 
facilities with 
services ranging 
from 
independent 
living to skilled 
nursing 
  67/110 
(61%) 
 
Psychogeriatric 
clinic 
  171 (1465
196) per 
10,000 
patient days 
Geriatric 
rehabilitation 
clinic 
  92 (725112) 
per 10,000 
patient days 
Nyberg 
199761 
Cohort study Prospective 
Unclear 
Staff reported Sweden 
Nursing home   31 (22541) 
per 10,000 
patient days 
38% 
injurious 
Rosendahl 
200843 
RCT (control 
arm rates 
reported) 
Prospective 
6 months 
? Sweden Residential care 
facilities, 
dependant in 
ADLs 
191 4.6 falls per 
person5
year 
51% over 6 
months 
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Sakamoto 
200645 
RCT (control 
arm rates 
reported) 
Prospective 
6 months 
Staff reported Japan Mixed 
community/resi
dential setting – 
‘high risk’ 
  51/212 
(24%) over 
six months 
 
Sjösten 
200762 
RCT (control 
arm rates 
reported) 
Retrospective 
12 months 
Self5reported Finland People who had 
fallen 
  2.3 (aged 655
74) & 
3.1 (aged 
75+) 
falls per 
person in 
previous 12 
months 
 
6.7 per 100 
person5
years 
(ambulatory
) 
Thapa 199649 Cohort study Prospective 
Mean 11 
months 
Minimum data 
set (individual 
and staff 
reported) 
United States Nursing homes, 
dependant 
1228  35% over 1 
year 
17.0 per 
100 person5
years (non5
ambulatory)
Ray 200544 Cluster RCT 
(control arm 
rates 
reported) 
Retrospective 
12 months 
Minimum data 
set (individual 
and staff 
reported) 
United States Nursing home 
residents 
10 558 99.5 fall 
related 
injuries per 
1000 
person5
years 
36% in 
previous 180 
days 
70.1 per 
1000 
person5
years of 
follow up. 
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Falls in older people are undignified, a reminder of vulnerability – in 
contrast to younger, typically more active individuals in whom falls may be 
expected and innocuous. For some older people, they are also potentially 
very serious in terms of health outcomes. Falls are strongly associated with 
future falls, and recurrent falling can lead to a downwards spiral, leading to 
fear of falling, reduced activity, deconditioning, more falls, social isolation 
and depression. 
 	

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Fear of falling is a well recognised consequence of falling – the ‘post5fall 
syndrome’, but also can be anticipatory 5 ‘ptophobia’, a phobic reaction to 
standing or walking10. One widely accepted definition of fear of falling is 
‘	


	
	
63 64 5 see Figure 1.1. 
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Person Behaviour Outcome
Efficacy 
Expectation
Outcome 
Expectation
:!	&-!%	&+	!%+7++(;$;1	5$"-4#$=	6  9



: “conviction that one can successfully execute behaviour required 
to produce the outcome”. Sources: Mastery experience, vicarious experience, social 
persuasion and emotional arousal.  However most influential: Mastery experience and 
emotional arousal.



: “person’s estimate that a given behaviour will lead to certain 
outcome”.  
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Applied to falls, Bandura’s theory predicts that low self efficacy leads to 
negative outcome expectations (‘I will fall’), or more simply, falls beget 
falls. 
Fear of falling was recently reviewed in the National Institute of Clinical 
Excellence (NICE) guidelines on the assessment of falls in older people10, 
and this section builds on their findings; see 1.1.1 for search methods. 
The main findings from the NICE guidance were that there is considerable 
overlap between fear of falling and falls in terms of risk factors and 
associated outcomes. NICE recommended that falls assessments should 
include a measure of fear of falling, and favoured the Falls Efficacy Scale63. 
Risk factors for fear of falling include: age >80 years (relative risk 1.5), a 
sedentary lifestyle (relative risk 2.0), a lack of emotional support (relative 
risk 2.6) and visual impairment (relative risk 1.4)65 66. Further falls are 
associated with fear of falling (relative risk 1.7)65, especially after hip 
fracture associated with a fall67. 
Other investigators have found an association between increased fear of 
falling and balance performance68, whilst Hellstrom 69 found that falls 
efficacy was a better predictor of daily function in people recovering from 
stroke than more objective measures of balance. The association between 
fear of falling and functional impairment and quality of life has been shown 
in other studies70 71. 
Fear of falling is also associated with serious adverse outcomes such as 
institutionalisation and death in individuals recovering from hips fracture72 
73 74. 
The striking overlap in underlying risk factors and outcomes between falling 
and fear of falling make falls prevention programmes an obvious 
intervention to reduce not only falls but fear of falling65. Some investigators 
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have found that any reduction in fear of falling is more likely related to 
improvements in health and functional ability – irrespective of specific 
nature of the interventions75 76. However, conventional exercise classes 
have not been able to demonstrate a reduction in fear of falling77, though it 
appears that Tai Chi based exercise regimes may be effective. In a 
randomised controlled trial, Wolf  showed no fear of falling in 47% of 
people undergoing intensive Tai Chi classes, compared to 33% for those 
receiving computerised balance training and 41% for those receiving 
educational classes at between 7520 months of follow up, though this was 
not significant (p=0.55)78. 
 	
(See 4.1.4 for search methods) 
Falls and depression are associated79585 and share common risk factors86. 
There is also an association between depression and fracture, which may 
be in part mediated through increased falls87. Furthermore, depression is 
independently associated with functional decline after a fall88. 
There is an association between fear of falling and depression: in a cross5
sectional study of 540 community dwelling Dutch people aged 70+, 28% 
and 26% with severe fear of falling had feelings of anxiety and symptoms 
of depression respectively, and the severity of fear of falling was correlated 
with symptoms of depression and anxiety89. The association between fear 
of falling and depression is also seen in Chinese communities (cross5
sectional study of 100 care home residents)90. People with depression and 
fear of falling appear to be most likely to restrict their activity ( 
study – cross5sectional study of 926 Italians aged 65+)91. 
Although several trials have suggested that falls prevention programmes 
may reduce depression in fallers92594, and exercise is considered effective 
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treatment for depression95 a recent systematic review96 and a large, well 
conducted randomised controlled trial97 failed to find any robust evidence 
that a multifactorial falls prevention programme can reduce depressive 
symptoms in fallers. 
The story gets more complicated; treatment with antidepressants 
approximately doubles the risk of falling985100 and is associated with a two5
fold increase in fragility fractures1015103. There is some weaker evidence 
(cross5sectional study of 301 adults living in long term care settings having 
fallen in the previous week) that newer anti5depressants (serotonin and 
noradrenalin reuptake inhibitors (SNRIs)) are not associated with falls104. 
In summary, depression may cause falls, and may be caused by falls, 
especially in those fallers with fear of falling or functional decline. Falls 
prevention interventions are not effective treatments of depression in 
people who fall, and anti5depressants may increase falls risk, as well as the 
risk of fracture. 
The optimal management of depression in people who fall is unclear, 
though careful attention to other modifiable falls risk factors is advisable 
when starting anti5depressants in people at risk of falling105 106. 
 
Approximately 30 to 50 percent of falls result in minor soft tissue injuries 
that do not require medical attention107, although falls are a major cause of 
trauma in older people108. Although falls in older people usually result in 
relatively low impact energies, typically consisting of a fall from the stairs 
or the standing position109 110, the effects of the fall can still be serious 
because of other factors such as osteoporosis and diminished protective 
reflexes. In community dwelling older people, an estimated 1% of falls 
result in hip fractures; 355% result in other types of fractures, and an 
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additional 5% produce serious soft tissue injuries14 111. Rates of fracture 
resulting from a fall are as high as 10% in high risk populations (e.g. those 
attending a falls service), with overall injurious falls being as high as 
51%60. Injurious falls are also high (38%) amongst vulnerable populations 
such as those living in care homes and other geriatric care settings44 49 61. 
 	
(See 4.1.5 for search methods) 
Falls are the leading cause of mortality due to injury in people aged over 
75 in the United Kingdom5 112 113. In Finnish community dwelling older 
people, death rates from falls were 51/100,000 in 1995114 and increased to 
55/100000 in 2002115. However, it should be noted that falls related 
mortality in Finland is one of the highest in Europe. Amongst European 
Union (EU) countries, the UK has one of the lowest rates of fall related 
deaths (standardised mortality ratio 33)116. 
Although people over 60 years of age make up 19% of the EU population, 
they account for 28% of injury5related deaths116. The injury mortality rate 
(age5standardised) in EU515 is about 39 deaths per 100,000 people, while 
in EU525 it is about 45 deaths per 100,000 people116. 
In the United States, death from falls overtook deaths from road traffic 
accidents between 199051998, accounting for 9,604 deaths per 100,000 
aged 65+ in 1998117; for the oldest old (>85 years) the rate was 109 per 
100,000 in 1998118. 
In Australia in 1998, there were 1,114 deaths from falls5related incidents 
for people aged more than 65 years119. 
 	

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In 1999 there were over 647,721 fall related A&E attendances in the UK for 
people aged >60 years5. This is a rate of nearly 40/1000 people attending 
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emergency departments per year because of a fall. International rates of 
	 falls (Table 1.1) range from 0.5551.00 per person5year29 46 47, with 
serious injurious falls rates in the region of 32 per 1000 person5years55. 
The rate of injurious falls appears to be increasing (adjusted OR 1.08 (95% 
CI 1.03–1.12)), according to a Finnish study of routine health service data 
from 199151999120. This makes falls an issue for secondary care services 
as well as primary care. Indeed, falling in hospital in5patients is also 
common and serious1215123, but is out with the remit of this work. 
The impact of falls on hospital services is difficult to estimate, as Hospital 
Episode Statistics (HES) data do not specifically code falls (which is 
appropriate given that a fall is usually a non5specific presentation of some 
other disease process). But by way of example, HES data for the year 
ending 2005/6 showing some common conditions and also falls5related 
conditions are shown in Table 1.2. 
These data illustrate that falls related hospital admissions have a similar 
impact on hospital resource use to conditions such as stroke, and probably 
a greater impact than traditionally high profile conditions such as acute 
myocardial infarction. 
Costs relating to hospital and nursing home care are greater in people who 
fall, increasing annual hospital related costs by $11,042 (United States, 
1996) compared to matched non5fallers; this relationship was stronger for 
those with recurrent or injurious falls124. 
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HRG code  Mean 
Age 
Finished 
consultant 
episodes* 
Mean 
Length 
of 
Stay  
Median 
Spell 
Duration  
Bed days† 
E31 Syncope or Collapse >69 79 74842 5.7 2 293,914 
H82 Extra5capsular Neck of 
Femur Fracture with Fixation 
81 2983 20.6 16 54,807 
H84 Intra5capsular Neck of 
Femur Fracture with Fixation 
79 4134 19.7 14 71,837 
H36 Closed Pelvis or Lower 
Limb Fractures >69 
77 30137 19.5 11 445,992 
A22 Non5Transient Stroke or 
Cerebrovascular Accident >69 
78 79922 25.7 13 1,126,041 
E11 Acute Myocardial Infarction 77 28643 13.3 8 216,613 
 
 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
(See 4.1.5 for search methods) 
The previous sections have illustrated the impact of falls on individuals in 
terms of morbidity, functional decline and depression. Many carers of older 
people are themselves old, and likely to be at risk of falls and functional 
decline. However, there are only a small number of papers which describe 
the impact of falling on carers, all of which point to the increased carer 
burden in those looking after people who fall. 
Japanese carers of people who fall scored higher than those caring for non5
fallers on the Zarit Burden Interview126. In patients with Parkinson’s 
disease, falls are associated with greater carer burden127 128. Falls are often 
                                          
 
* A count of the number of HES records, submitted on behalf of English 
NHS hospital providers that relate to episodes of admitted patient care that 
ended during the financial year (1 April to 31 March). 
† The sum of all the days that patients in the group occupied hospital beds 
during the financial year (1 April to 31 March). 
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cited as a key driver of admission to long term care, presumably a 
reflection of the increased carer burden. 
 			
(See 4.1.2 for search methods) 
People who fall have greater need of health and social care resources than 
matched controls who have not fallen (1.4 relative risk for hospitalisation, 
2.7 relative risk for nursing home admission), and often have some form of 
limitation in basic (relative risk 1.4) or extended (relative risk 1.3) 
activities of daily living129. However, the association is just that and it is not 
correct to infer that falls 
 increase health resource use, but are a 
marker of an underlying ill5health, with the fall being a non5specific 
manifestation of the underlying co5morbidities. 
Rates of institutionalisation in long term care are 255 times greater after a 
single fall compared to those who have not fallen82 130, and 2520 times 
greater for people with recurrent falls1315133. Falls rates are 255 times higher 
in those people admitted to long term care compared to age and gender 
matched controls not admitted to long term care134 and those that fall in 
long term care are at increased risk of death compared to those who do not 
fall135. Much of this will be related to selection bias, though one might 
argue that the care home environment might play a role, for example, the 
type of flooring (wooden carpeted versus other types) influence the risk of 
fracture from a fall (OR 1.8 (95% CI 1.352.4)), highlighting the importance 
of the physical environment136.
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(See 4.1.7 for search methods) 
There are many risk factors for falls. Fall risks factors were reviewed in the 
NICE guidelines on falls prevention, and this section provides an update on 
that work. 
Table 1.3 summarises falls risk factors at the population level as identified 
in prospective cohort studies, the gold standard method for identifying risk 
factors137. Some systematic reviews which refer to older cohort studies are 
also included. The use of falls risk assessment tools for individual patients 
is considered separately (see section 1.3.9.5). 
The major risk factors for falls include, in approximate descending order of 
risk, balance deficits, reduced mobility, home hazards, muscle weakness, 
history of falls, Parkinson’s disease, fear of falling, use of an assistive 
device, frailty, cognitive impairment, arthritis, impaired ADL, depression, 
vitamin D deficiency, testosterone deficiency, anaemia, diabetes, 
medication, neuropathy, female gender and visual deficits (Table 1.3). 
There are many other important but less well studied risk factors for falls, 
such as disturbed sleep (odds ratio 1.3)38 and renal impairment (odds ratio 
3.7). Preliminary studies indicate a possible role for genetic factors138 139. 
The number of risk factors appears to be additive, with the risk of falling 
increased linearly with the number of risk factors14. 
Other studies have focussed on risk factors for falls in specific populations, 
though there is considerable overlap. For example, in stroke patients, 
depressive symptoms, disability, previous falls, and older age are 
associated with falls, whereas higher cognitive and physical function were 
protective140. Lee 141 examined falls risk factors in individuals in a 
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rehabilitation setting and found poor cognitive and physical function to be 
associated with in5patient falls. 
1.3.8.1 Cognitive impairment and falls 
Several studies have found that there is a significant association between 
cognitive impairment and falls142. The odds ratio of falling when there is 
cognitive impairment (≤26/30 on the mini5mental state examination 
[MMSE]) has been reported as 5.0 (95% CI 1.8513.7)14 and 2.2 (95% CI 
1.553.2)143. The likely mechanisms behind falls in older people with 
cognitive impairment include judgemental errors, cerebrovascular disease 
and psychotropic medication or a combination of factors. However, the only 
published randomised control trial examining a multifactorial intervention 
(compared to usual care) to reduce fall in individuals with cognitive 
impairment (MMSE ≤ 26) found no benefit – relative risk 0.92 (95% CI 
0.81 to 1.05)144. 
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Risk Factor Source (SR=systematic review, R=review, C=cohort study, MA=meta5
analysis) 
Approximate measure of effect 
Balance deficit Piirtola 2006145 R, Pluijm 2006146 C, Delbaere 2006147 C, Stalenhoef 
2002148 C, Clark 2005 149 C 
Odds ratio ~ 4 
Reduced mobility Morris 2007150 C, Tiedemann 200819 C Odds ratio 3.7 
Home hazards Lord 2006151 R, Fletcher 2002152 C, Pluijm 2006146 C 
Van Bemmel 2005 27 C 
Relative risk 3.6 
Muscle weakness Otaka 2008 SR153, Moreland 2004 SR, Pluijm 2006146 C, Stalenhoef 
2002148 C 
Odds ratio~3 
History of falls Capon 2007154 C, Morris 2007150 C, Pluijm 2006146 C,  
Papaioannou 2004155 C, Stalenhoef 2002 148 C 
Odds ratio ~ 3 
Parkinson’s disease Fink 2006156 C, Fletcher 2002 152 C Odds ratio 3 
Fear of falling Scheffer 200875 C, Delbaere 2004157 C, Pluijm 2006146 C, Delbaere 
2006147 C, Delbaere 2004157 C, Murphy 200365 C 
Odds ratio 3 
Use of an assistive 
device 
Nandy 2004158 R Relative risk 2.6 
Frailty Ensrud 2008 159 C 
(Two of: weight loss, the subject’s inability to rise from a chair 5 times 
without using her arms, and reduced energy level) 
Odds ratio 2.4 (recurrent falls, 
frail vs. non5frail) 
Cognitive 
impairment 
Assantachai 200351 C, Shaw 2002160 R, Fletcher 2002152 C, 
Papaioannou 2004155 C, Van Doorn 2003161 C, Van Schoor 2002 162 SR 
Odds ratio ~254 
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Risk Factor Source (SR=systematic review, R=review, C=cohort study, MA=meta5
analysis) 
Approximate measure of effect 
Arthritis Reyes5Ortiz 2004163 C, Assantachai 200351 C Relative risk 2 
Impaired ADL Capon 2007154 C, Reyes5Ortiz 2004163 C, Assantachai 200351 C, 
Perracini 2002164 C, Pluijm 2006146 C, Shumway5Cook 2005165 C 
Odds ratio 2 
Depression Reyes5Ortiz 2004163 C, Stalenhoef 2002 148 C Odds ratio 2 
Vitamin D 
deficiency 
Fosnight 2008166 SR, Faulkner 2006167C, Bischoff5Ferrari 2004168 MA, 
Latham 2003169 SR, Snijder 200625 C 
Odds ratio 1.8 
Testosterone 
deficiency 
Orwoll 2006170 C, Szulc 2003171 C Relative risk 1.8 
Anaemia Duh, 2008172 C, Penninx 2005173 C Relative risk 1.7 
Diabetes Reyes5Ortiz 2004163 C, Schwartz 2002174 C Odds ratio 1.7 
Medication Allain 2005175 R, Hartikainen 2007176 SR, Landi 2005177 C Odds ratio 1.5 (mainly 
benzodiazepines 
antidepressants, 
antipsychotics) 
Neuropathy Schwartz 2008178 C Odds ratio 1.5 (diabetics) 
Female gender Reyes5Ortiz 2004163 C, Assantachai 200351 C, Fletcher 2002 152 C Odds ratio 1.5 
Visual deficit Schwartz 2008178 C, Coleman 2007179 C, Lord 2006180 R, Assantachai 
200351 C, Perracini 2002164 C, Lord 2002181 C, Szabo 2008182 C, 
McCarty 2002183 C 
Odds ratio 1.4 (diabetics) 
1.553.0 other populations 
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Having highlighted that there are multiple risk factors for falls in multiple domains 
(physical, psychological, environmental etc). The logical progression is to combine these 
risk factors into a single tool capable of predicting falls in the future. 
Many falls risk screening tools have been published for use in a variety of settings. A 
major limitation in several of the published screening tools is that they rely upon 
retrospective recall of falls, which has been shown to be unreliable, underestimating the 
true prevalence of falls26. Individuals who are truly at high risk of falling are likely to be 
at high risk of injurious falls (because of multiple risk factors and recurrent falls); this 
population are likely to report falls because of associated injury. This differential recall 
leads to bias, in this case underestimating non5injurious falls. 
The search used to identify published falls screening tools is listed in 4.1.8; only 
multidimensional tools, evaluated prospectively and reporting sensitivity, specificity, 
likelihood ratios and/or the area under the curve were reviewed. 
1.3.9.1 Hospital based falls risk screening tools 
Though not of immediate relevance to this study (focussing on community dwelling older 
people), much of the original work on falls screening tools emerged from hospital 
settings, and a brief review of such tools is appropriate. 
Oliver 184 developed a falls risk screening tool for use in the hospital setting (stroke 
unit, acute and rehabilitation wards). They identified five risk factors which were 
associated with a future in5patient fall: 
• Patient presented (to hospital) with a fall or had fallen in hospital 
• Agitation 
• Visual impairment affecting daily function 
• Requiring help with toileting 
• Transfer and mobility score of 3 or 4 (derived from the Barthel index185) 
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The tool was prospectively validated in a separate in5patient setting. The sensitivity of 
the tool for predicting a fall in the week after assessment was 92%, the specificity 68%. 
The authors noted different sensitivity and specificity in two different settings where the 
tool was validated. In general terms, tools developed for one setting should not be 
assumed to perform equally well in a different setting, with a different population. Wijnia 
 tested the STRATIFY tool in a Dutch nursing home and found that it underperformed 
(sensitivity 50%, specificity 76 %) compared to the results seen for STRATIFY in the 
hospital setting186. 
Though STRATIFY fulfilled a useful function in highlighting the importance of in5patient 
falls, there has been a move to more simple approaches since its inception. For example, 
in 2008 Salameh187 found previous fall and ‘acute impairing medical’ illness to be 
predictive of a future in5patient fall and the combination of the two had a sensitivity of 
64%, specificity 68%. Also in 2008, Vassallo188 found that clinical judgment based on 
observed wandering had better predictive accuracy indicated by the number of patients 
correctly classified (157/200, 79%) than either the STRATIFY (93/200, 47%) or the 
Downton*189 falls risk assessment tool (100/200, 50%) in a geriatric rehabilitation 
setting. The general consensus appears to be that falls are so common in hospital that 
screening is not useful190, and that falls reduction strategies should be applied at the 
level of the population, rather than on screened and selected individuals. This approach 
has been tested in a well conducted cluster RCT of a multifactorial falls intervention in 
Australia, though the results were negative191. However, this may be due to the relative 
ineffectiveness of the intervention rather than the global approach 	; in particular 
                                          
 
* The Downton falls screening tool has not been formally evaluated but consists of a 
history of falls, medications (tranquillisers/sedatives, diuretics, anti5hypertensives 
excluding diuretics, anti5Parkinsonian drugs, and antidepressants), sensory deficits 
(visual impairment, hearing impairment), limb abnormalities (such as hemiparesis), 
confusion and an unsafe gait (with or without aids). Each one of these factors scores a 
point, and scores of three or above identified patients at risk. 
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strength and balance training was only delivered over a short period, whereas any 
improvements from such an approach take weeks to manifest. 
Other investigators have used the STRATIFY tool in an attempt to predict falls in patients 
being discharged from hospital. This is a plausible approach, as the items in STRATIFY 
seem equally likely to predict falls in the primary care setting as in hospital. Smith192 
tested the STRATIFY tool on people with stroke being discharged but found it performed 
poorly (sensitivity 11% and specificity 90%) and suggested a disease specific tool. 
Subsequently, Ashburn193 found that fall or near fall in hospital and upper limb 
dysfunction were the strongest predictors of future fall in people with stroke being 
discharged from hospital (specificity 70% and sensitivity 60%). Similarly, Mackintosh194 
found that in people with stroke being discharged from hospital, a history of inpatient 
falls and poor balance predicted future fall (sensitivity and specificity >80%). 
Hyndman195 found that people with stroke living in the primary care setting who ‘stop 
walking when talking’ (a test of the ability to perform dual tasks) had a sensitivity of 
53% and specificity of 70% for future fall. The dual tasking phenomenon has also been 
identified as a useful predictor of falls in patients with cognitive impairment196. 
The PROFET study was one of the seminal falls prevention studies, in which older people 
attending an emergency department with a primary ‘diagnosis’ of fall were offered a 
multidisciplinary assessment197. Eligibility was on the basis of a fall, rather than a 
screening process. In a further analysis of the risk factors predictive of future falls, three 
of the six risk factors included a fall in the previous year, falling indoors and the inability 
to rise following a fall198, the remaining items were negative predictors 5 moderate 
alcohol consumption, a reduced abbreviated mental test score and admission to hospital 
as a result of the fall. Again, the most powerful predictor of future fall was a history of a 
previous fall. 
1.3.9.2 Falls screening tools in residential settings 
The Mobility Interaction Fall (MIF) Chart has been developed for use by a trained 
assessor in residential community settings199. The MIF chart includes an observation of 
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the ability to walk and simultaneously interact with a person or an object, a vision test, 
and a concentration rating. Additionally, staff rated each resident's risk as high or low 
and reported the resident's history of falls during the past six months. Detailed results 
are not available, but the investigators reported that the combination of two high risk 
scores (MIF chart, staff judgment, falls history) was better than any one individual 
predictor. 
Chen 200 derived a falls risk score to differentiate people at extremely high risk of 
falling from those at moderate risk of falling, in an institutionalised population with an 
overall prevalence of 50% of falls in one year and 30% prevalence for recurrent falls in 
one year. Combining balance, cognition, illness severity, age and continence they derived 
a risk score which at the extremes differentiated patients with an annual falls rate of 3.2 
per person, six times greater than those at the lower end of the scale (0.5 falls person5
year). The assessments do require a trained assessor, but are relatively straightforward, 
and should be readily applicable in a residential care setting, or other similar setting such 
as intermediate care. However, the usefulness of identifying the very high risk versus 
moderate risk individuals is questionable. 
1.3.9.3 Falls screening tools in the primary care setting 
A screening tool using prospective falls data has been developed by Tromp 201 in a 
nested cohort study within the Longitudinal Aging Study Amsterdam (LASA). They 
recorded falls prospectively using a weekly diary in 1,285 people living in the community, 
aged over 65. Previous fall, visual impairment (can you recognise someone’s face at four 
metres?), urinary incontinence and use of benzodiazepines were the strongest predictors 
identified in the risk profile model for any falls (area under curve (AUC)=0.65), whereas 
previous falls, visual impairment, urinary incontinence and functional limitations proved 
to be the strongest predictors in the model for recurrent falls (AUC=0.71). The model 
developed found that a previous fall (OR 2.5) was more strongly associated with future 
falls than the other three risk factors (OR 1.6 for each of visual impairment, urinary 
incontinence and functional limitation). The final model developed was a better predictor 
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of recurrent falls (AUC 0.71) than a single fall (AUC 0.65). This was a well5conducted 
study and there appears to be little reason to think that the findings are not externally 
generalisable. 
Stalenhoef 202 developed a risk model for predicting recurrent falls based on 
retrospective self reported data. They identified six statistically significant associations 
with self reported falls (age ≥80, female gender, musculoskeletal symptoms, balance 
disturbance, chronic neurological disorder and the use of anti5depressants). These factors 
were used to construct a predictive model, which gave a positive predictive value of 42% 
and negative predictive value of 85%. The usefulness of this model is questionable, in 
particular as the response rate was 60%; they acknowledged that the very old (≥ 80) 
were under5represented in their sample. The use of retrospective monitoring of falls is 
likely to have led to an underestimate of falls prevalence26, and so an underestimate of 
the positive predictive value. 
Stel 203, again using data from LASA, devised a tree5structured survival analysis to 
predict falling. Building on the paper by Tromp, discussed above, they focussed on 
recurrent falls (two falls within six months), with careful follow up over three years 
(weekly falls calendar posted to the research centre at the end of every three months, 
with telephone contact if they were unable to complete the fall calendar, if the fall 
calendar was not returned even after a reminder, or if it was completed incorrectly). The 
model that they developed identified the importance of a combination of risk factors in 
identifying future fallers (grip strength, functional limitation and recurrent falls). The 
baseline screening data was collected through a face to face interview, though the falls 
diaries were self completed. 
Pluijm 146, building on previous work in LASA identified nine variables which 
combined gave modest predictive ability to identify recurrent fallers (a score of five or 
more had 59% sensitivity and 71% specificity, AUC 0.71). The items included two or 
more previous falls, dizziness, functional limitation, weak grip strength, low body weight, 
fear of falling, the presence of dogs/cats in the household, a high educational level, 
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drinking 18 or more alcoholic consumptions per week and two interaction terms (high 
education x 18 or more alcohol consumptions per week and two or more previous falls x 
fear of falling). Though comprehensive, this dataset offer limited advantages compared 
to the more simple tools. 
The Falls Risk Assessment Tool (FRAT)158, was developed in the United Kingdom and can 
be administered by a non5health care professional. Using the presence of three risk 
factors as a cut off point, it had good specificity, identifying 92% of people who did not 
have a fall (14% reported falls in the previous six months), but poor sensitivity, 
identifying only 42% of individuals who did have a fall; the positive predictive value was 
57%. The methodology used in monitoring falls is questionable, as fall rates were based 
upon retrospective recall at six months. Retrospective recall of falls has been shown to be 
of limited accuracy; Cummings 26 carried out a study on falls reported by individuals 
using prospective, weekly follow up and contrasting with retrospective recall by the same 
individuals at three, six or twelve months of participants. At three months, 32% of falls 
were forgotten, 26% at six months and 13% at one year; Hale et al204 found similar 
results using comparable methodology. For the FRAT, recall bias may have resulted in an 
under5estimate of falls prevalence, thus reducing the positive predictive value. It is 
possible that a higher positive predictive value may be seen in practice. 
Ensrud159 showed that a frailty score (consisting of weight loss, inability to rise from a 
chair five times without using arms, and reduced energy level) predicted recurrent falls 
over one year (AUC 0.61), fractures (AUC 0.64) as well as other frailty related outcomes 
(death, institutionalisation). 
The key characteristics of falls screening tools for use in the primary care are 
summarised in Table 1.4.
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Study Uses previous 
fall in tool? 
Sensitivity Specificity AUC 
Stalenhoef 202 No 64% 71% 0.73 
Tromp 201 
Recurrent falls 
Yes   0.71 
Pluijm et al146 Yes   0.71 
FRAT158 Yes 42% 92% Youden’s 
index* 0.39; 
AUC~0.70205 
Tromp 201 
Any fall 
Yes 54% 79% 0.65 
Stel 203 Yes 5 5 5 
Ensrud159 
Recurrent falls 
No   0.61 
 
With the exception of the Stalenhoef tool, which was specifically developed to able to 
identify people at high risk of falls from routinely available primary care data, the 
screening tools with the best predictive proprieties include previous fall as a ‘risk factor’. 
It can be argued that identifying people who have fallen is more case5finding than 
screening 	, though from a practical perspective, the distinction is not as important 
as having a tool which is easy to use and has robust predictive properties. 
1.3.9.4 Physical assessment scales 
A variety of physical assessments have been tested for their ability to predict future falls 
5 the Tinetti balance and gait scale206, Physiological Profile Assessment (PPA)147 207, Timed 
Get Up and Go Test (TUGT)208, Global Rating of Fall Risk (GLORF)209, the Modified Gait 
Abnormality Rating Scale (MGARS), Physical Performance Test (PPT)210, Berg balance, 
                                          
 
* For a two disease, two outcome measure (diagnostic testing) scenario, the area under 
the curve is equivalent to (Youden’s index+1)/2, where Youden’s index equals sensitivity 
+ specificity 
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ABC and reaction time211, and a variety of functional mobility assessments19, as detailed 
in Table 1.5. 
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Item Study Sensitivity Specificity 
Area 
under 
the 
curve 
History of falls Nordin209 58% 76% 0.66 
GLORF Nordin209 56% 80% 0.68 
GUGm (high risk) Nordin209 7% 92% 0.62 
TUGT 15 seconds Nordin209 96% 32% 0.69 
TUGT 30 seconds 
Women with vertebral 
fracture 
Morris 2007150 33% 85% 0.60 
PPA Laessoe 2007212 50% 43%  
Two positives from 
MGARS, history of fall 
and PPT 
VanSwearingen 
1998210 
90% 87%  
Sit5to5stand once ≥ 1s Tiedemann19 49%   
Sit5to5stand five times ≥ 
12s 
Tiedemann19 66% 55%  
Alternate5step test ≥ 10s Tiedemann19 69% 56%  
Six5metre walk ≥ 6s Tiedemann19 50% 68%  
Stair descent ≥ 5s Tiedemann19 63% 55%  
Reaction time, total Berg 
score and total ABC score 
Lajoie,2004211 89% 96%  
 
Aside from the necessity for a trained assessor to undertake these tests, the other main 
limitation is that they are little better in predicting future fall than a history of previous 
fall150. 
1.3.9.5 Falls risk assessment tools 
Once individuals have been identified as being at risk of falling on the basis of risk factors 
or previous falls, there is a need then to identify the specific modifiable factors in that 
individual that are amenable to intervention. This process of individualised assessment, 
as opposed to risk stratification, lends itself to a structured assessment scale. Such 
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scales are designed for use in individuals, rather than in populations, which can be a 
source of confusion. 
As individual practitioners and units will have their own approach to addressing falls 
management with their individual clients, depending on local expertise and facilities, 
there are an enormous number of assessment tools in the published literature. Rather 
than complete an exhaustive search of these tools, the following section summarises the 
findings from the 2004 NICE guidelines10. 
The NICE guidelines state that in community dwelling older people and in extended care 
settings (intermediate care, residential care, rehabilitation units), the important 
assessment tools include: 
• an assessment of balance and gait (for example, Timed Up and Go Test, Berg 
Balance Scale) 
• a multifactorial assessment addressing home hazards and individual risk factors 
for falls 
• in home care and residential settings, a Minimum Data Set (for example, that 
developed by Inter !213) should be used to guide management. 
Such tools are not considered further here. 
1.3.9.6 Summary – screening tools 
Despite the proliferation of screening tools which have been developed over the last 15 
years, many of which are valid, few are better at identifying future falls than a history of 
a previous fall. This phenomenon is seen in other frailty related conditions, such as 
fracture214, in which the best predictor of future event is to have had the event already. 
This highlights the difficulty of screening for frailty related outcomes (i.e. identifying 
individuals at high risk before they have had the event). 
The FRAT tool is the only published screening tool based on a UK population, albeit that 
the evaluation was carried using self5reported recall of falls. 
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Lord’s Physiological Profile Assessment215 provides an excellent understanding as to why 
an individual might fall. As detailed in Figure 1.2, the upright posture is dependant upon 
five key physiological mechanisms – vision, vestibular system, proprioception, central 
control and muscle strength. Accumulative defects in these systems, for example 
because of a disease process such as diabetes, leads to increased falls risk. 
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In addition to these intrinsic factors, extrinsic factors play an important part such as 
environmental hazards and medication. The relative contribution of intrinsic and extrinsic 
factors will vary from individual to individual, but it is likely that in most people, there will 
be more than one cause for a fall (see 1.3.8). Figure 1.3 succinctly encapsulates the 
potential contribution of intrinsic an extrinsic risk factors. 
Central processing – integrate 
sensory inputs and coordinate 
effectors mechanisms  
Proprioception  
Effector 
mechanisms – 
muscle strength 
Vision 
Vestibular 
system 
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Key: 
A = Patient with an accidental fall and no intrinsic or extrinsic risk factors 
B = Patient with acute illness 
C = Patient with moderate illness, loss of mobility and some prescription medications 
who falls because of an extrinsic factor 
D = Severely ill patient with many medications who falls even without extrinsic factors 
E = Elderly patient with numerous age5related changes who falls because of an extrinsic 
factor 
From Steinweg KK. The changing approach to falls in the elderly. Am Fam Physician 
1997;56:1815522,1823. 
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Interventions to reduce falls in older people have been reviewed extensively in recent 
years; a summary of the most recent reviews is presented here. One of the main reviews 
influencing the 2004 NICE guidelines10 is the Cochrane systematic review on 
interventions to reduce falls in older people9, due to be updated very soon216. 
The 2003 Cochrane review assessed 62 randomised trials involving 21,668 people. The 
main outcomes were the number of fallers, or falls. The main findings were that 
43 
 
multidisciplinary, multifactorial, health/environmental risk factor screening/intervention 
programmes in primary care both for an unselected population of older people (4 trials, 
1,651 participants, pooled RR 0.73, 95%CI 0.63 to 0.85), and for older people with a 
history of falling or selected because of known risk factors (5 trials, 1,176 participants, 
pooled RR 0.86, 95%CI 0.76 to 0.98), were likely to be effective. This reflects the 
multifactorial causes of falls discussed in previous sections. However, unifactorial 
interventions can to be of benefit, namely: 
• muscle strengthening and balance retraining, individually prescribed at home by a 
trained health professional (3 trials, 566 participants, pooled relative risk 0.80, 
95% CI 0.66 to 0.98) 
• home hazard assessment and modification that is professionally prescribed for 
older people with a history of falling (3 trials, 374 participants, RR 0.66, 95% CI 
0.54 to 0.81) 
• withdrawal of psychotropic medication (1 trial, 93 participants, relative hazard 
ratio 0.34, 95% CI 0.16 to 0.74) 
• cardiac pacing for fallers with cardioinhibitory carotid sinus hypersensitivity (1 
trial, 175 participants, weighted mean difference 55.20, 95% CI 59.40 to 51.00) 
• a 15 week Tai Chi group exercise intervention (1 trial, 200 participants, risk ratio 
0.51, 95% CI 0.36 to 0.73). 
They concluded ‘interventions to prevent falls that are likely to be effective are now 
available; less is known about their effectiveness in preventing fall5related injuries…’ 
The Cochrane review was integrated into the NICE guidance10, which stated that ‘all older 
people with recurrent falls or assessed as being at increased risk of falling, should be 
considered for an individualised multifactorial intervention.’ NICE stipulated that such 
programmes should consist of ‘strength and balance training, a home hazards 
assessment and interventions, visual assessment and referral and a medication review 
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with modifications.’ This guidance is consistent with recent Canadian evidence based 
guidelines217. 
The NICE guideline group went on to pool data from studies looking at unselected 
community dwelling older people, recruited on the basis of age and domestic 
circumstances, but not specifically falls risk factors. The pooled estimates showed that 
multifactorial interventions are effective in reducing the proportion of fallers in the 
intervention group (pooled relative risk reduction 0.73, 95% CI 0.6350.85). 
In a targeted population identified on the basis of falls status or known risk factors, the 
pooled data showed a significant reduction in the proportion of fallers in the intervention 
groups (RR 0.86, 95% CI 0.7650.98). 
Outside the remit of this PhD, but of interest, the NICE guidance did not find sufficient 
evidence to be able to recommend multifactorial interventions specifically in extended 
care settings or for people with cognitive impairment, but instead emphasised the need 
to provide multifactorial interventions to targeted, high risk populations (irrespective of 
domicile or cognition). 
 #	
A key issue with interventions for frail older people is compliance – or better still, 
concordance. An intervention which is highly efficient (it works when taken/complied 
with), but not acceptable to the population for which it is intended, may not be effective 
in clinical practice. 
The NICE guidelines examined this issue in some detail and showed that drop out rates 
from falls interventions are significant (Table 1.6), with typical rates of around 20%. 
Some of the drop outs will be unavoidable – mortality, change of residence etc, but some 
will be related to the acceptability (or not) of the intervention.
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Type of intervention Drop out rates Follow up period 
Tai Chi 20% 7520 months 
Home hazards intervention 2528% 12518 months 
Psychotropic medication 
withdrawal 
68% 24 months 
Cardiac pacing 9% 12 months 
Untargeted multidisciplinary 
interventions 
6528% 12536 months 
Targeted multidisciplinary 
interventions 
3526% 3518 months 
  
Other investigators have highlighted the importance of the language used in encouraging 
older people to attend such interventions218, suggesting a more positive approach, 
emphasising healthy ageing rather than falls prevention. Programmes using more user 
friendly strategies may see better adherence. Key enabling factors include ‘social 
support, low intensity exercise, greater education, involvement in decision5making, and a 
perception of the programmes as relevant and life5enhancing’, whilst barriers include 
‘fatalism, denial and under5estimation of the risk of falling, poor self5efficacy, no previous 
history of exercise, fear of falling, poor health and functional ability, low health 
expectations and the stigma associated with programmes that targeted older people’219. 
Herein lies the paradox – those most in need are least likely or able to access the service 
that may confer benefit (‘differential challenge’). We know fall interventions work, but the 
key issue is getting people at high risk of falls to attend. 
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The search strategy for this part of the literature review is detailed in 4.1.9. 
1.5.2.1 Tai Chi 
There has been a growing interest in Tai Chi as a potential strategy for falls prevention. 
Initial trials failed to show any significant difference compared to ‘wellness education’ 
(placebo)78, though the confidence intervals for falls reduction were consistent with a 
marked beneficial effect over 48 weeks (RR=0.75, 95% CI 0.5251.08, p=0.10). A smaller 
study was unable to show benefit from thrice weekly Tai Chi220. Li 2004221 showed a 
reduction in falls following on from a programme of Tai Chi, but only in those patients in 
whom an improvement in functional balance could be demonstrated. 
In 2005 Li222 showed a reduction in falls (7% vs. 18%; p=0.03) compared with the 
‘stretching5only’ control group. After adjusting for baseline covariates, the risk for 
multiple falls in the Tai Chi group was 55% lower than that of the stretching control 
group (risk ratio 0.45; 95% confidence interval, 0.30 to 0.70). Compared with the 
stretching control participants, the Tai Chi participants showed significant improvements 
following intensive Tai Chi (three times per week). Voukelatos223 also showed benefit 
from once per week Tai Chi classes, the proportion of fallers after 24 weeks was 0.67 
(95% CI=0.4950.93, p=0.02). 
These studies suggest that Tai Chi is a useful intervention to reduce both falls and 
recurrent falls in community dwelling older people. 
1.5.2.2 Interventions in specific populations 
Increasingly, investigators have focussed interventions on specific populations. 
Clemson224 showed a reduction in falls following a multifaceted community5based 
program, for community dwelling older people who had already fallen in the previous 
year: relative risk 0.69, 95% CI 0.5050.96, p=0.025. Shumway5Cook28 was unable to 
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show a reduction in falls following a community5based multifactorial intervention in a 
community dwelling population (Incidence Rate Ratio (IRR) 0.75, 95% CI 0.5251.09).  
Weatherall225 carried out a meta5analysis and reinforced the prevailing view that 
multifactorial interventions (OR 0.64, 95% CI 0.4750.88) are superior to unifactorial 
interventions in falls prevention (OR 0.81, 95% CI 0.5851.14). But Gates  226 sparked 
controversy with their meta5analysis of 19 multifactorial fall prevention programmes in 
primary care, community, or emergency care settings, which showed no overall benefit 
(risk ratio for the number of fallers 0.91, 95% CI 0.8251.02). However, this paper was 
roundly criticised for its methods – mainly inappropriate trial selection (namely including 
trials in which the intervention was suboptimal or consisted of advice only), which at 
present the authors do not appear to have rebutted. 
More recent trials have focussed on pragmatic (effectiveness) trials as opposed to 
explanatory (efficacy) trials. Pragmatic/effectiveness trials concern established clinical 
services, and evaluate interventions delivered in routine clinical practice. 
Explanatory/efficacy trials evaluate clearly defined, protocol driven interventions under 
highly controlled conditions227 228. Using the analogy of drug trials, in an efficacy trial of 
Aspirin, double blinding and careful control of all other conditions are used to ensure the 
only difference between groups is the drug. In contrast an effectiveness trial will address 
how Aspirin works in practice, and will be subject to real5life conditions, such as whether 
trial participants actually take the drug, or abandon it because of side5effects etc. 
A recent pragmatic RCT of a multifactorial falls prevention programme in New Zealand 
also failed to show any evidence of benefit (n=312, mean age 81, IRR 0.96 95% CI 0.705
1.34), which the authors tentatively ascribe to inadequate follow through of referrals to 
the relevant professionals229. Similarly negative findings over 12 months were found in a 
pragmatic RCT of a multifactorial falls prevention programme delivered to older people 
attending the emergency department following a fall carried out in the Netherlands 
(n=333, OR 0.86, 95% CI 0.50–1.49)230. These two trials raise concerns about the 
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application of the evidence base in clinical practice – the difference between efficacy and 
effectiveness. 
Lord231 assessed a group exercise programme in frail older people living in intermediate 
or sheltered care settings, and showed a reduction in falls rates (IRR=0.69, 95% 
CI=0.4850.99). Suzuki232 showed a reduction in fallers from 13.6% in the intervention 
group, compared to 54.5% (p = 0.0097) at 20 months in Japanese elders attending a 
comprehensive geriatric assessment and receiving an exercise intervention, though the 
numbers were small (52 in total). Weerdesteyn233 showed a reduction in falls in people 
attending a falls service (IRR 0.54, 95% CI 0.3450.86). 
Morgan234 suggested that a low intensity exercise programme may be of benefit in the 
convalescent setting, but only in those with limited baseline function. Nikolaus235 
reinforced the importance of addressing home hazards in a high risk populations 
(recently admitted to hospital with functional decline) in reducing falls (IRR 0.69, 95% CI 
0.5150.97). Though in a similar Australian population, Latham 236 failed to show any 
benefit from 10 weeks of high5intensity home5based quadriceps resistance exercise or 
vitamin D (calciferol 300,000 International Units). 
Shaw237 evaluated a multifactorial programme in patents with dementia presenting to an 
emergency department with a falls and showed no reduction in the proportion of fallers 
(relative risk ratio 0.92, 95% CI 0.81 to 1.05). Similar results were seen in cognitively 
intact older people with 	
		 (RR for the total number of falls 0.64, 95% CI 
0.4650.90) – but no change in the proportion of fallers. 
Ashburn238 showed a non5significant trend towards a reduction in falls in patients with 
Parkinson’s disease with a history of falling using a personalised exercise strategy. 
Campbell239 showed that a home safety programme was superior to an exercise 
programme in reducing falls in people with visual impairment (≤6/24). Harwood240 
showed a reduction in falls rates in patients undergoing expedited cataract surgery (IRR 
0.66, 95% CI 0.4550.96, p=0.03), though the study was unable to show a significant 
result for second eye surgery241. A larger study (n=616) showed an 
	 in falls in 
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older people attending a geriatric service referred for visual correction (IRR 1.57, 95% CI 
1.2052.05, p=0.001)242. The authors posited a variety of explanations for this finding, the 
most plausible of which were differential reporting bias (those in the control group may 
have been less motivated to report falls), increased activity or a period of increased risk 
during a period of adjustment in the visual aid group. 
Additional work has looked at refining falls interventions. For example, Barnett77 looked 
at group exercise (including Tai Chi) over one year against falls education and showed a 
reduction in falls rate (IRR=0.60, 95% CI 0.3650.99). Other investigators reported 
benefits such as increased confidence and mobility from enhanced balance training over 
six weeks, but did not record falls as an end5point243. 
Other unifactorial interventions however, have not been able to demonstrate a reduction 
in falls, including 15 weeks of physiotherapy244, 12 weeks of physiotherapy245 (small 
trials); Lord 2005 246 and Liu5Ambrose 2004 247 showed a reduction in falls risk 
(measured using Lord’s Physiological Profile Assessment), but not falls. Means248 was 
able to show a reduction in falls following six weeks of exercise, which included an 
obstacle course. Sakamoto45 failed to showed a reduction in falls burden from unipedal 
standing. But 36 weeks of specific falls prevention directed physiotherapy, including 
balance training reduced falls (IRR 0.66, 95% CI 0.49–0.90), as did a fitness intervention 
in apparently low risk individuals recruited from a health insurance company database, 
RR = 0.77, 95% CI 0.6050.97)249. 
Campbell12 has suggested that well conducted unifactorial intervention might be effective 
for primary care based prevention. This was based on a meta5analysis of trials meeting 
the following relatively stringent criteria: 
• participants were randomly allocated to intervention and control groups 
• all participants were aged 65 years or older 
• the majority lived independently in the community 
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• fall events were recorded prospectively using a diary or calendar during the entire 
trial and monitored at least monthly 
• follow up was for 12 months or longer 
• at least 70% of participants completed the trial 
• all falls during the trial for at least 50 participants were included in the analysis 
• a relative rate ratio with 95% CI comparing the number of falls in the intervention 
and control groups was reported. 
This meta5analysis identified 14/90 falls prevention trials including 5,968 individuals 
meeting the above criteria. The meta5regression showed that single interventions were 
as effective in reducing falls as interventions with multiple components (pooled rate 
ratios 0.77, 95% CI 0.67–0.89 and 0.78, 0.68–0.89 respectively). A sensitivity analysis, 
using less stringent selection criteria identified 27 interventions involving 8,380 
individuals, but this also failed to shown any trend toward multifactorial programmes 
being more effective. 
1.5.2.3 Vitamin D 
There is a growing body of evidence suggesting a role for vitamin D in reducing falls2505
254, including in patients with renal impairment2555257. A systematic review suggested that 
vitamin D supplementation is effective in reducing falls by up to 20%258. 
1.5.2.4 Medication reviews 
Haumschild259 and colleagues used a pre5post design to look at a fall5focused 
pharmaceutical intervention and showed a 47% reduction in falls in the intervention 
group. Huang260 showed a home hazards assessment combined with a focus on 
medication safety reduced falls, though this was a small, quasi5randomised study. 
Zermansky261 showed a reduction in the number of falls per person following a 
pharmacist medication review in a large RCT of care home residents (n=661, 0.8 vs. 1.3 
falls per patient, p< 0.0001) Pit262 showed a reduction in the proportion of falls through 
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the implementation of a broad based educational programme given to GPs in an 
Australian cluster RCT (n=849, adjusted OR 0.61, 95% CI 0.4150.91). Another 
educational intervention aimed at primary care, using a review of electronic prescribing 
records and advice to the prescriber, failed to show any reduction in falls263. 
1.5.2.5 Injurious falls 
NICE and the Cochrane reviewers concluded that there is uncertainty around the 
effectiveness of multifactorial falls prevention programmes in reducing injurious falls. 
This is important, as the morbidity and mortality resulting from falls is attributable to 
injurious falls, rather than fall 	. An intervention which for some reason reduced 
falls, but had little or no impact upon injurious falls, may not achieve the desired 
outcome of improving well being and reducing morbidity or mortality. 
McClure and colleagues carried out a Cochrane systematic review aimed at identifying 
population5based intervention effective in reducing falls5related injuries amongst older 
people264. The methodology was robust, though on this occasion study heterogeneity 
precluded a meta5analysis. Perhaps unsurprisingly, the reviewers did not find any 
randomised studies addressing this issue at the population level – as opposed to targeted 
populations described in the previous section. Such large scale randomised trials are 
extremely unusual, given the practical difficulties and costs of carrying out such studies 
(see 3.2.3.1.2). 
The reviewers did identify six controlled studies addressing injury reduction, including 
multifactorial educational interventions aimed at health care professionals and 
individuals265 as well as provision of safer environments2665270 and in one study, 
widespread promotion of Tai Chi271. All six studies reported benefits in the intervention 
groups, ranging from 6533% relative risk reduction. The reviewers concluded that though 
evidence was far from certain, given the methodological limitations of these large scale 
trials (internal validity, external generalisability, limited comparator groups, uncertain 
ascertainment and positive publication bias, regression to mean and confounding by 
secular trends), the studies support the preliminary claim that a population5based 
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approach to the prevention of fall5related injury is effective264. The most recent study 
from Tinetti 55 which was a pragmatic, non5randomised evaluation of falls prevention 
services in the US, showed a 9% reduction in serious fall5related injuries. Day "#" 
have predicted similar outcome in Australia. 
There is a large body of studies addressing fracture reduction specifically, often using 
pharmacological treatments, but not usually including interventions to reduce falls and 
fractures combined273. These studies have not been addressed in this work. 
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Most falls prevention studies in community dwelling older people have delivered the 
intervention in the primary care setting, in which the interventions are delivered by staff 
working in the community, and with general practitioners providing the medical 
intervention28 29 224 231 249 2745277. The advantage of this model is that treatments are 
delivered in the context of an established relationship between patients and their carers, 
rather than the intervention being delivered by secondary care specialists, who may have 
no long term relationship with the patients. No trials have evaluated a falls prevention 
programme delivered in a secondary care setting against one in a primary care setting. 
The consensus appears to be that the components of a successful falls prevention 
intervention are strength and balance training, home hazards assessment and 
medical/medication review; the setting in which these components are delivered is of 
less importance, as long as it is acceptable to the intended participants. 
One systematic review has looked at the benefit of day hospital for older people against 
other forms of comprehensive care. Including papers up until 1999, Forster et al278 found 
that day hospitals are effective in terms of death or poor outcome, disability, and use of 
resources compared to no comprehensive care, but hold no advantage over other 
settings. A search on Medline and EMBASE using a similar search strategy did not reveal 
any additional studies of relevance to falls prevention. 
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There is no particular reasons to suspect that a falls programme delivered in a day 
hospital would have any advantage over a primary care delivered intervention – indeed 
the opposite is more likely to be true, as care closer to home is likely to see better 
compliance. 
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Falls are a common problem for older people, with 24% of people aged over 65 years 
falling at least once every year. The method of falls reporting has a critical influence on 
rates, with more frequent follow up resulting in a greater number of falls being 
ascertained. Falls incidence is around 1.7 falls per person per annum using such 
methods. 
Fear of falling is an important consequence of falls and has a set of risk factors in 
common with falls. Interventions to reduce falls are likely to reduce fear of falling as long 
as there is an improvement in overall function. The management of depression in fallers 
is more complex, and though there are similarities with fear of falling in the shared risk 
factors and interventions, pharmacological treatment of depression may increase the risk 
of falls. 
Falls are the leading cause of trauma in older people and a prime cause of fracture; they 
are also a major cause of mortality in older people. Falls have as similar impact on 
hospital services to other major conditions such as stroke and myocardial infarction. Falls 
are a cause of carer strain, though this is poorly studied, and are a leading cause of 
admission to long term care. 
Screening for falls is confounded by the fact that the best predictor of future fall is a 
previous fall, so most falls screening tools serve a case finding function as much as 
perform a true screening function. Nevertheless, multifactorial interventions delivered to 
previous fallers and others at high risk have been effective in reducing falls rates by 
around 15%. The best evidence is for multifactorial interventions, though targeted 
unifactorial interventions (including Tai Chi, medication reviews and vitamin D) can be 
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equally beneficial. More recent studies have cast doubt on the 
 of 
multifactorial falls prevention programmes (as opposed to the efficacy as demonstrated 
in clinical trials). 
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The literature review has highlighted that screening for community dwelling older people 
at high risk of falling can be done, but there is no prospectively evaluated tool that has 
been tested in the United Kingdom. The first research question then was ‘can a falls risk 
screening tool identify community dwelling older people at high risk of falls and can it 
identify those at low risk of falling?’ 
The second research question identified in the literature review concerns the 
effectiveness, as opposed to the efficacy, of a falls prevention programme – ‘does a 
multifactorial falls prevention programme, delivered in a day hospital, reduce the rate of 
falls in community dwelling older people identified by a screening process as being a high 
risk of future falls?’ 
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This thesis describes two main studies: an evaluation of a falls screening tool (referred to 
as the cohort study) and a randomised controlled trial (Figure 1.4). Both the cohort study 
and the RCT share similar methodology regarding ascertaining outcomes. 
All participants in the cohort study were asked to complete a screening questionnaire. 
Those at high risk were first invited to participate in the RCT. If they declined, they were 
invited to participate in the cohort study, along with those individual as low risk of falls. 
Prospective data collected from the cohort was used to validate the screening 
questionnaire (chapter 2). Those screened as being at high risk and entered into the RCT 
were allocated to a multifactorial day hospital intervention or control (usual care). The 
primary outcome measure was the rate of falls (chapter 3). These form the two main 
components of this work 5 developing a screening tool and evaluating a falls prevention 
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programme. A concomitant economic analysis has been undertaken but is not discussed 
in this thesis. 
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Several different definitions of screening exist, but the essence is to 
identify a population at an early stage in a disease process, and to then 
provide an intervention which prevents more serious consequences of the 
disease manifesting at a later stage. 
Screening has been defined as ‘applying a test to a defined group of 
persons in order to identify an early stage, a preliminary stage, a risk 
factor or a combination of risk factors of a disease. The object of screening 
as a service is to identify a certain disease or risk factor for a disease 
before the affected person spontaneously seeks treatment, in order to cure 
the disease or prevent or delay its progression or onset by (early) 
intervention’ (Council of Europe)279. 
An alternative definition of screening is ‘a public health service in which 
members of a defined population, who do not necessarily perceive they are 
at risk of, or are already affected by, a disease or its complications, are 
asked a question or offered a test to identify those individuals who are 
more likely to be helped than harmed by further tests or treatment to 
reduce the risk of disease or its complications’ (UK National Screening 
Committee)280. 
Screening is but one method of disease management, which can be 
considered as having four possible levels of intervention. Primordial 
prevention is concerned with establishing conditions that minimise the 
hazards to health by preventing the development of risk factors or 
underlying conditions leading to causation; these are typically 
environmental factors (economic, social or behavioural)281. An example 
relating to falls might include reducing socio5economic deprivation, which 
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has been linked with an increase in hospital admission rates related to 
falls282. For primordial prevention, interventions are made at the population 
level. 
Primary prevention is directed at specific causal factors, usually at the 
population level, such as increasing levels of physical activity in the 
population as a whole. More targeted primary prevention might define a 
population in whom specific risk factors are known to be prevalent, and 
provide an intervention. An example related to falls might include giving 
calcium and vitamin D supplements to prevent falls in care home 
residents168, irrespective of a given individual’s vitamin D status. 
When the risk factor for a disease process is continuous measure, such as 
vitamin D levels and the risk of falling, there are two possible approaches. 
Firstly, to introduce population level changes which shift the distribution of 
the risk factor to the left. This might include supplementing the 
population’s diet with vitamin D – by way of example, margarine has added 
vitamin D.  This achieves a greater reduction in the population attributable 
risk (see 2.4.2). Secondly, prevention could focus on those at highest risk 
alone (such as individuals with severe vitamin D deficiency). Individuals 
with very low levels of serum vitamin D will be at the highest risk of 
developing myopathy or muscle weakness and so have a higher risk of 
falling, but the greatest population effect is seen by increasing the vitamin 
D levels of those at intermediate or even low risk. Screening is not required 
with a population level approach, but the consequence is that low risk 
individuals are included that may not benefit from the intervention. If an 
intervention has the potential to cause harm (such as vitamin D induced 
hypercalcaemia), then the absolute benefit obtained may be reduced. 
Secondary prevention is directed at slowing the progression of a disease 
identified at an early stage and preventing more serious consequences, 
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such as injury related to falls. A example of secondary prevention might be 
the use of hip protectors in someone who falls frequently283. 
Tertiary prevention is used at a late stage in a disease processes and is 
mainly restorative or adaptive284. An example might include rehabilitation 
following a hip fracture resulting from a fall, either by improving balance 
and gait (restorative) and/or by improving stability by providing a walking 
frame (adaptive). 
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The most commonly cited criteria against which the suitability of a 
proposed screening programme may be assessed are those conceived by 
Wilson & Jungner in 1968285: 
• the condition should be an important public health problem 
• there should be an accepted treatment 
• facilities for diagnosis and treatment should be available 
• there should be a recognisable latent or early asymptomatic stage 
• there should be a suitable test 
• the test should be acceptable to the population 
• the natural history of the condition should be understood 
• there should be an agreed policy on whom to treat as patients 
• the cost of case5finding should be economically balanced in relation 
to the possible expenditure as a whole 
• case5finding should be a continuing process. 
It is useful to consider the case for screening for falls on a point by point 
basis. 
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Key determinants of the importance of a public health problem include the 
frequency of the problem, the impact on individuals and the impact upon 
society, in terms of costs and resource use. For example, synringomyelia 
(a progressive neurological condition) can have a major impact upon 
individuals and their carers, but is relatively rare and so not a major public 
health problem (which is not to say that it is not important). By contrast, 
falls in older people are common (24% of people aged 65 plus fall each 
year), may have serious consequences, including fracture286 and are a 
major determinant of health and social costs in the United Kingdom287, thus 
making falls a major public health issue. 
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Several studies or reviews have highlighted the efficacy of a multifactorial 
assessment and intervention falls prevention programme, which can reduce 
falls in a variety of settings, typically by around 25%10 12 288. 
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Most previous studies rely on self reporting of falls, as indeed does clinical 
practice. There is no ‘gold standard’ test for falls, other than a good 
collateral history. Medically verified falls are used to add some degree of 
validity to self5reporting, but using this technique alone will inevitably lead 
to under reporting (minor falls may not be reported to the general 
practitioner). So ‘diagnosing’ a fall is difficult 5 indeed from the clinical 
perspective, falls are not a diagnosis but a symptom of other underlying 
problems which require a diagnosis. 
A variety of facilities or services are available for the identification and 
management of people who fall. These can be divided into primary care 
services (falls prevention schemes, general practitioner, intermediate care 
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services) or secondary care services (geriatric day hospitals, falls clinics). 
Often a combination of resources is used in the management of any one 
individual and as such there is not one single discrete locus for diagnosis 
and care. 
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Many cohort studies and case5control studies have identified risk factors for 
falling14 15 34 143 168 201 207 2895296. Randomised control trials have 
demonstrated that intervening on the reversible risk factors can reduce 
subsequent falls8 9 31 33 36 2975299. Interventions provided to the high risk 
individuals have been successful in reducing falls. It is generally accepted 
that there is a latent stage during which an individual is at risk, for 
example because of reduced balance and mobility, but has not yet fallen 
(see 1.4). 
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The natural history of falls is reasonably well understood, namely an 
accumulation of intrinsic risk factors, combined with extrinsic risk factors, 
triggering a fall (see 1.4). In essence, there is a threshold at which we are 
all at risk of falling. Extrinsic factors (accidents) can overwhelm this 
threshold and give rise to a fall. Additionally, cumulative intrinsic factors 
lower the threshold for falling (muscle weakness, reduced balance). Many 
of these factors are potentially reversible, as is the risk of falling. Different 
risk factors are associated with different magnitudes of risk. 
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This point usually refers to a biological test for a condition, which does not 
apply to falls. The joint British Geriatrics Society/American Geriatrics 
Society guidelines advocate the use of the ‘get up and go test’ to indicate 
the risk of an individual falling300. Screening tools are reasonably good at 
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differentiating people at high versus low risk of future fall, typically with a 
sensitivity of 50560% and specificity of 80%202 (see 1.3.9.6). 
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There is general guidance on who should be considered for falls reduction 
strategies (National Service Framework for Older People2 and guidance 
from the National Institute of Clinical Excellence10) but as people who fall 
represent such a heterogeneous population, it is not possible to be precise 
as to who should and who should not be treated. In general terms, an 
individual with an isolated fall and no other risk factors for falling, such as a 
gait disturbance, would not be considered for a falls prevention 
programme10 300. Current practice is mainly opportunistic, whereas this 
thesis will examine the role of a more systematic approach. 
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Screening and a concomitant cost analysis in the primary care setting for 
individuals thought to be at risk of falling has not taken place in the United 
Kingdom. 
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Current recommendations state that all people over 70 should be asked 
about falling on an annual basis10 300, and assessments offered to those 
thought to be at high risk. 
' ,
It appears that there is a theoretical role for screening for people at risk of 
falling and offering an intervention, but some of the key questions needed 
to justify a large scale screening programme have yet to be answered. 
These include having a robust screening tool, and determining the costs of 
a screening programme and the associated intervention. 
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In the United Kingdom, screening programmes have centred on non5
communicable diseases with a pre5symptomatic phase, where interventions 
during the pre5symptomatic phase can prevent progression to overt 
disease. Examples include cervical cancer, breast cancer and 
cardiovascular disease. Potential advantages of screening are the 
prevention of disease, improvement in quality of life (through avoiding ill5
health), reduction in mortality and cost savings. Screening has potential 
disadvantages as well as advantages, such as: 
• delay in diagnosing false negatives 
• the effects, side effects and psychological distress relating to 
potentially invasive clinical diagnosis of false positives 
• psychological distress where there is no cure for the disease or 
where the treatment and/or intervention is unacceptable to the 
individual concerned 
• individuals who are positively screened might experience difficulties 
such as access to insurance, employment or social stigmatisation 
• unfavourable cost5benefit relationship of a screening programme 
Relating to falls, screening may increase fear of falling by alerting people to 
previously unrecognised risk, for example. The costs of a systematic falls 
screening programme are not known, so it is possible that the cost may 
outweigh the benefits. 
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The prevalence of a disease is the number of cases in a defined population 
at a specified point in time whereas the incidence of a disease reflects the 
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number of new cases arising in a population in a given period301. The two 
measures provide different and complimentary information. For a chronic 
condition such as multiple sclerosis, the incidence may be low but the 
prevalence high. This is because there are relatively few new cases of 
multiple sclerosis each year, but once contracted it is (usually) permanent, 
so increasing the prevalence. This is in contrast to short5lived conditions 
such as the common cold, in which the incidence in one year may be high 
(we all get colds) and the prevalence low, as at any one time only a 
relatively few people will be affected. 
Point prevalence refers to the prevalence at any given point in time; an 
alternative measure is period prevalence, which is the number of people 
affected by a disease in a specified period. Prevalence is influenced by the 
severity and duration of the illness as well as the incidence and diagnostic 
accuracy. 
Incidence is the number of newly identified cases occurring over a period of 
time. The incidence rate is given as the number of new cases detected 
during a defined period of time, divided by the sum of the length of time at 
which each person is at risk. Incidence rates are often measured in events 
per person5year. 
An alternative measure of incidence is cumulative incidence, which 
measures the number of new cases divided by the number of disease5free 
individuals at the beginning of the period (and is a proportion). This 
measure is useful for comparing risk of disease in different populations. 
The third possible measure of incidence is the odds of disease, a measure 
of the number of new cases in a given period divided by the number of 
‘disease5free’ individuals at the end of the study period. Odds can also be 
calculated for prevalent cases. 
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The population attributable risk (PAR) is the amount of risk that can be 
reduced if the risk for the exposed group was reduced to that of the risk of 
the unexposed. The PAR is derived from measures of relative risk. To 
calculate the relative risk, we need to know the rate (incidence 5 2.4.1) or 
the risk in the exposed (r1 5 in this case individuals at high risk of falling) 
and the unexposed (r0 5 low risk); the rate ratio is r1/ r0. 
An alternative measure of effect is the risk difference, which reflects the 
excess risk in the exposed population: risk difference = r1 5 r0. It is 
important to recognise that risk difference assumes causality, which is an 
over5simplification, as in practice, few diseases have a single causative 
factor. Risk difference further assumes that removal of the risk factor will 
reduce risk in the exposed group to the level of risk in the unexposed 
group, again an over5simplification. 
Given the assumptions made in estimating risk differences, a more useful 
measure of effect is the risk difference percent (also the ‘attributable 
fraction’) – the proportion of cases that could have been prevented in the 
exposed group if they had not been exposed. 
Risk difference percent (RD%) = (r15 r0) / r1 
Measures of effect tell us little about the impact upon a population; the 
impact measures the amount of disease in a population that could be 
prevented if the exposed became unexposed (assuming causality). The 
impact of an exposure on a population depends upon the prevalence of the 
exposure and is called the population attributable risk (PAR): R – r0, where 
R is the rate in the whole population and is given by the weighted sum of r0 
and r1, weighted by the prevalence (p) of the risk factor in the population: 
R = pr1 + (15p)ro. By rearranging the equation PAR = p(r15 r0). 
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As with risk difference, this is more usefully expressed as a percentage – 
the proportion of all cases in the whole population that may be attributable 
to the exposure: population attributable fraction (PAF) = p(r15 r0)/R. The 
PAF can also be estimated from risk ratios (or odds ratios in a case5control 
study): p(RR51) / [p(RR51)+1]. 
Or, more simply, the PAR equals the attributable risk multiplied by the 
proportion of the population exposed. 
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Sensitivity refers to how good a test is at identifying people who have a 
disease; specificity reflects how good a test is at identifying those who do 
not have the disease302. These are crucial to determining the effectiveness 
of a screening programme. Taking the screening questionnaire to be used 
in this study, the aim is to identify those that are at high risk of falling. 
Ideally, it should be sensitive (correctly identifying all of those that fall) 
and specific (excluding those that do not fall); this is best represented in a 
two by two table (Figure 2.1). 
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Sensitivity is a/(a + c) and specificity is d/(b + d), both expressed as a 
percentage. There will inevitably be a trade off between sensitivity and 
specificity; for example, a test which is always positive will have 100% 
66 
 
sensitivity but the specificity would be 0% and so the test would be 
clinically useless. Assuming that the intervention is relatively harm5free, 
the ideal properties of the screening tool would be high sensitivity with less 
emphasis on specificity. But a reduced emphasis on specificity may result 
in individuals being assessed that are not going to benefit. A good 
screening test will have high sensitivity and specificity (above 95%), but 
the optimal values for a particular screening test (using a continuous 
measure) will be determined by a receiver5operator characteristic curve 
(ROC curve). The ROC curve plots sensitivity against (15specificity); the 
area under the curve (AUC) can be calculated, and the higher this value, 
the more discriminatory the test. 
Perhaps more clinically useful in the context of a screening questionnaire 
are the positive predictive value (PPV) and the negative predictive value 
(NPV). The crude PPV give the probability of having a falls when the 
screening tool identifies the individual as being at high risk: a/(a + b). The 
crude negative predictive value gives the probability of the individual not 
falling when they are screened as being at low risk: d/(c + d). 
As the prevalence of a condition changes, the predictive value of the test 
will change, even though the sensitivity and specificity remain constant. 
This is important, as a test with a high PPV in one context will may have a 
lower PPV in another context where prevalence is lower; it means that 
screening tests from one setting cannot always be reliably adopted in 
another where prevalence is different. 
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The screening tool is a health measurement scale and if it is to be of use in 
future falls screening programmes, it needs to be valid (it needs to do what 
it sets out to do) and reliable. The screening tool used in this study is a 
67 
 
postal questionnaire, designed to select out older people living in the 
primary care setting who are at high risk of falls over the following year. 
 .			
The first step for developing a health outcome measure is to develop an 
item pool. These items should be known to be associated with the outcome 
of interest. Where an outcome has been well studied, such items might be 
drawn from a review of the literature. Where an outcome has been less 
well studied, the items will need to be generated , typically by 
using qualitative methods such as key informant interviews, to generate 
the domains relevant to the outcome. 
 /
There are three forms of validity – face validity, content validity and 
construct validity. 
2.5.2.1 Face validity  
Face validity ‘indicates whether, on the face if it, the instrument appears to 
be assessing the desired qualities’303. This is usually measured subjectively, 
typically by a panel of experts; the Delphi technique304 can be useful in this 
process. The Delphi process is a structured approach to establishing face 
validity of items under consideration for an outcome measure. Once the 
item pool has been generated, the items are collated and sent out to a 
group of experts in the field. These experts usually include content experts 
(clinicians), both researchers in the field and practitioners, and should be 
interdisciplinary. The interdisciplinarity of the group is crucial to ensure 
that the items selected are valid, relevant and reasonable305. The Delphi 
group should ideally include representatives from various sectors, such as 
primary and secondary health care306 and may include patients or patient 
representative bodies. Delphi groups are usually quite large, numbering 
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many tens or even hundreds of participants. The panel should vote on each 
item, indicating how valid they felt it was, the results would then be 
collated and items selected on the basis of their overall ranking. 
An alternative to the Delphi technique is the Nominal Group technique, 
more typically used in constructing guidelines, though equally useful for 
assessing face validity. The principles are similar to the Delphi technique, 
in that the group should be interdisciplinary, but the group size is smaller, 
and should assemble for a face to face meeting307. At the meeting, each 
item would be discussed and then voted on in a structured manner, with 
each participant being given the opportunity to comment. A disadvantage 
of the nominal group technique is that more verbose members may 
dominate proceedings and some stakeholder may not contribute as fully. 
Once the items have been selected on the basis of their face validity, it is 
reasonable to then check the items with patients to check face validity from 
the patient perspective, although patients should be represented on the 
panel in any case. 
2.5.2.2 Content validity 
Content validity assesses ‘the extent to which the measurement 
incorporates the domain of the phenomenon under study’281. To have 
acceptable content validity, a tool should include items reflecting the range 
of concepts relating to the question. For example, if asking about functional 
health status, the tool should include items not only relating to physical 
health, but cognition, activities of daily living, social aspects and so on. It is 
possible to assess the properties of a tool against a gold standard if one 
exists, comparing the result obtained with the new tool against similar 
items in the gold standard, known as criterion validity. 
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2.5.2.3 Construct validity 
Construct validity reflects whether the measurement of the construct 
adequately represents what is intended by theoretical account of the 
construct being measured, by using various forms of validity checks. For 
example, do the observed results from a screening questionnaire confirm 
the expected results? It would be expected that those that screen as high 
risk, do in reality fall more often than those screened at low risk. 
Other important areas include convergent validity and sensitivity to 
change. 
2.5.2.4 Convergent validity 
Convergent validity for an outcome measure is used when the items are 
being generated , and involve comparing patient’s self5reported 
data for the measure against either spouse or peer5reports for the patient. 
This data helps establish confidence in the accuracy of the self5reported 
measure. 
Convergent validity can also be examined by looking at the scale’s 
relationship with other outcome measures included in a study. By exploring 
these relationships further validity for the scale can be established by 
showing expected relationships with other measures relevant to falls (e.g. 
fear of faling). 
2.5.2.5 Sensitivity to change 
For health measurement scales, sensitivity to change is very important – 
does the outcome measure score change as the patient’s condition changes 
or once an intervention has been applied. However, for a screening tool, 
this property is not so relevant. 
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Reliability examines the concept of reproducibility – the tool should 
produce similar results for questions asked of the same individual at 
different times or by different interviewers. Reliability is usually measured 
as a ratio (score 051) of the variability between individuals compared to the 
overall variability; there are various possible measures of reliability 
described below. 
2.5.3.1 Internal consistency 
For large questionnaires, several items may correlate with each other. 
Using the example of a functional health questionnaire, it is likely that 
there will be several items assessing physical function. These can be 
correlated, for example using Cronbach’s alpha308. Correlations amongst 
items measuring similar attributes should be in the range of 0.750.9309. 
2.5.3.2 Stability 
The stability of responses to a tool can be assessed between observers 
(inter5observer reliability) or ‘within’ observer (the same observer 
obtaining the same result on different occasions (intra5observer reliability). 
It can also be assessed by checking to see of the same respondent 
provides the same answers at different times (test5retest reliability); this 
however assumes that the item being tested should provide a consistent 
response over time (not the case with falls for example). There are no 
clearly defined gold standards by which to measure reliability, but it is 
generally accepted that measures of reliability should be above 0.7302. 
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It can be seen from the above sections that the development of a valid and 
reliable screening tool represents a large body of work, including a 
literature review, convening an interdisciplinary panel and a series of 
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validity and reliability checks, which would require studying a large cohort 
of participants. Fortunately, previous work in the United Kingdom had 
already identified a set of items (Table 2.1) suitable for inclusion in a fall 
screening tool (FRAT158), which was modified for use in this study. We 
considered if the existing items were useful and further considered 
additional possible items. 
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History of falling in the previous year, 
Taking four or more prescribed medications, 
History of stroke  
History of Parkinson’s disease 
Reported problems with balance 
Loss of proximal muscle strength 
 
The aim of the screening tool was to gather information from community 
dwelling older people using a postal questionnaire. The information 
gathered should differentiate between individuals who go on to fall and 
those that do not. The questionnaire should be brief, easy to understand 
and reliable. 
2.5.4.1 Selection of items for inclusion in the screening tool 
Questions about cognitive impairment (see 3.4.3.1.1) were deemed 
inappropriate on a postal questionnaire, because of the practical difficulties 
in obtaining an accurate cognitive assessment by post. 
It was felt insensitive to ask a question about depression without additional 
support, although the geriatric depression scale has been validated for use 
as a postal questionnaire in older people. However, this comprises a 
minimum of four items, and is even then only a screening tool rather than 
a diagnostic tool310. We were seeking questions relevant to falls, which 
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were concise and valid, and felt that introducing a section screening for 
depression would not be helpful. 
Items asking about a diagnosis risk the introduction of reporting bias. 
However, self5reporting of many diagnoses has been shown to be valid 
when compared to medical records311; these include diabetes312, and other 
chronic diseases. Important exclusions to this caveat are osteoarthritis and 
peripheral vascular disease313. Stroke reported by older people agrees 
moderately well with GP records (kappa 0.56) in Holland313, though other 
studies have found that it is underreported by patients314 315. Diabetes is 
valid as a self5reported diagnosis, and an increasingly recognised risk 
factor for falling316, but is not as powerful a risk factor as the items 
selected, and therefore was not included. Stroke and Parkinson’s disease 
were included as self5reported items in the screening tool because of their 
major impact on falls risk. 
Visual acuity is a modest predictor of falls (RR 1.4) but was not included as 
it is difficult to measure using a postal questionnaire – though it has been 
successfully used in the LASA study201. Furthermore, there is the obvious 
difficulty that those with impaired vision may not be able to read the 
questionnaire. 
Fear of falling is a strong predictor of falls, but was not included as 
published tools are lengthy and so not easily incorporated into the planned 
screening questionnaire317. 
For the purposes of this study, it was decided to use modify the Falls Risk 
Assessment Tool, being the only published screening tool used in a UK 
population; the FRAT contains previous fall, so serves a function of case 
identification, but also other robust predictors of future fall. However, it has 
only been validated in a retrospective cohort, it was decided to undertake a 
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series of checks to determine the validity, reliability and prospective 
predictive properties of the tool. 
Three extra items were introduced into the FRAT, self5reported mobility 
limitation as a composite item reflecting balance and muscle strength, 
rather than self reported problems with balance originally used (see Table 
2.2), use of a mobility aid as a further marker of mobility limitation and 
poor balance and symptoms of dizziness on standing as a marker of 
postural hypotension. Self5reported mobility was formulated as a Likert 
scale rating of mobility: not at all/with assistance/around one level of the 
house/up & down stairs/to the local shops/unlimited), and for analysis was 
dichotomised to housebound/not housebound). This item is a composite 
measure of several well established risk factors predicting future falls 
(reduced mobility, lower limb disability, activity limitation, gait deficit). Use 
of a mobility aid was a simple question about whether the individual used a 
stick or walking frame. 
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 Item 
1 Fall in the previous twelve months 
2 Taking more than four prescribed medications 
3 Previous stroke 
4 Parkinson’s disease 
5 Inability to stand from a chair without using arms to push up 
6 Symptoms of dizziness on standing 
7 Use of a mobility aid 
8 Housebound (mobility impairment) 
 
2.5.4.2 Format of the screening questionnaire 
The finalised version of the screening questionnaire was designed to be 
easy for older people to read (font size 14, sans serif, double spaced, one 
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double sided sheet with clear instructions to complete both sides) (see 
appendix 4.2). 
The answers to the questions were in the form of a simple yes/no 
response, except for item 8, which was on a six point Likert scale. A simple 
closed response was selected because such questions are easy to 
complete, define the domain of interest and are easy to standardise, code 
and analyse318. The disadvantage of selecting this style of question is that 
some participants may just guess, tick any response at random or make 
errors. 
The screening questionnaire had a clear title and instructions and was 
accompanied by a letter of introduction from the potential participants’ 
general practitioner. A patient information leaflet explaining the study was 
included. The reverse of the screening questionnaire contained sections for 
recording demographic data and for the potential participants to indicate 
their willingness to be contacted. A stamped, addressed envelope was 
included for return of the questionnaire. 
2.5.4.3 Determining risk 
Whilst individual risk factors for falls may be more or less powerful in 
predicting future risk, the combination of risk factors is the key predictor of 
recurrent falls14 203 295. 
Of the risk factors included in this study, falls in the previous year was felt 
to be robust and reliable (90% of individuals falling in the previous year 
report this correctly26 204), as well as being a strong predictor (relative risk 
from previous studies 1.952.4). In the predictive model developed by 
Stel203, a fall in the previous year was the strongest risk factor for future 
falls203. Furthermore, further assessment of people who have already fallen 
is mandatory following on from the NICE guidance10. Given these facts, it 
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was felt appropriate to use a previous fall or a combination of any two of 
the other risk factors as the entry criterion to the study (i.e. defining high 
risk). 
2.5.4.4 Validity of screening tool 
Most risk factors for falls have ‘face validity’319, and the bulk of the items 
selected had been assessed by a panel of experts in developing the FRAT. 
The face validity of the modified FRAT was ascertained through informal 
consensus by a panel of experts in the field of falls research (Prof Tahir 
Masud, geriatrician/Prof John Gladman, geriatrician/Prof Denise Kendrick, 
GP and expertise in injuries/Dr Rob Morris, geriatrician/Dr Avril Drummond, 
occupational therapist/Prof Rowan Harwood, geriatrician/Dr Carol 
Coupland, statistician with an interest in injures). The panel felt that the 
screening questions were sensible, relevant, reasonable and clear. 
Validity was further assessed amongst primary healthcare workers (DK), 
physiotherapists (day hospital staff), occupational therapists (AD, day 
hospital staff) and day hospital patients. All participants in the pilot were 
asked to comment on the tool screening questionnaire. Further comments 
were obtained after the screening questionnaire had been used in practice. 
It was not possible to assess the criterion validity of the modified FRAT, as 
there is no gold standard tool for predicting future falls in community 
dwelling older people. 
Construct validity is discussed in the main results section, and assessed by 
determining if those assessed as being at high risk went on to fall more 
than those at low risk (see section 2.7.5.1). 
Convergent and discriminant validity of the tool are best examined by 
evaluating the tool’s relationship with other baseline measures included in 
the study. By exploring these relationships it should be possible establish 
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further validity for the scale by showing expected relationships with other 
measures. For example, the item asking about mobility could be assessed 
by comparing response against a standardised measure of mobility, such 
as a timed walk. However, given the potential burden to participants and 
added cost, this was not possible. 
2.5.4.5 Test5retest reliability 
The test5retest reliability properties of the screening questionnaire were 
determined during the recruitment phase. Twenty high risk and 20 low risk 
study participants returning the questionnaire were sent a second 
questionnaire a week later, with a request that it be completed within one 
week and returned. No attempt was made to follow up any participants 
who did not send back either the second questionnaire and if the second 
questionnaire was sent back after two weeks or longer it was discarded. 
Sixteen high risk and 12 low risk participants completed the second 
questionnaire. Reliability was examined using kappa scores for each of the 
eight items in the screening questionnaire. Mobility was collapsed into two 
categories for the purpose of analysis (Table 2.3). 
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Mobility response (How far can you 
walk, with or without the help of a 
stick or frame?) 
Recoded as 
Not at all 
With assistance 
Around one level of the house 
Housebound 
Up & down stairs 
To the local shops 
Unlimited 
Not housebound 
 
The kappa scores for each item on the screening questionnaire are shown 
in Table 2.4.
77 
$2%!		!,37#!3!,3	#!%($2(%(31	,;&#!,	+&#	,;#!!"("0	A4!,3(&""$(#!	
Item Observed 
agreement 
Expected 
agreement 
Kappa AgreementB 
Fall in last year 85.2% 58.3% 0.64 Good 
≥ 4 medications 89.3% 60.7% 0.73 Good 
Previous stroke 92.9% 62.5% 0.81 Very good 
History of Parkinson’s 
disease 
100%  1.0 Perfect (no 
discordant 
cases) 
Able to stand unaided 82.1% 50% 0.64 Good 
Dizzy on standing 82.1% 57.7% 0.58 Moderate 
Requires mobility aid 89.3% 53.1% 0.77 Very good 
Housebound 92.0% 78.6% 0.63 Good 
 
2.5.4.6 Summary 5 development of the screening tool 
The initial development of the screening tool indicates that it is valid and 
reliable; further evaluation of the predictive properties is detailed in the 
next section. 
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The cohort study examining the screening tool was carried out in parallel to 
the randomised controlled trial, and many of the methodological aspects 
are common to both studies. The methods for the cohort study are 
presented here, but the methodological considerations are mainly 
highlighted in chapter 3. 
 ,
We carried out a cohort study to determine the predictive properties of the 
screening tool over the course of one year. The study started in 2004 and 
the last follow up was in 2007. 
                                          
 
* Agreement according to Altman, 1997 
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The purpose of the screening tool was to identify older people in the 
community; accordingly participants were recruited from a primary care 
setting; this first necessitated recruiting general practices willing to allow 
access to their patients. 
2.6.2.1 Recruitment of general practices 
General practices that were registered with the Trent Focus for Primary 
Care Research, Collaborative Research Network (CRN), were approached 
by the researchers (DK, SC). The CRN has a Research Practices Board 
which assesses studies on behalf of the member practices. This study was 
submitted to the board and approved in June 2004. The CRN then 
advertised the project to member practices, who then indicated their 
interest in taking part in the study. The CRN Practices expressing an 
interest were visited by the study nurse to explain the study, to ensure 
that they would be able to identify the potential participants and to answer 
any queries about the study protocol.  
Only one CRN practice was registered in the Derby area and declined to 
participate in this trial. In order to overcome this barrier, the principal 
investigator at Derby (Dr J Youde), wrote to all practices within the Central 
Derby PCT, inviting them to participate. Two practices were enrolled 
following this invitation and were included in the trial in the same way as 
the CRN practices.
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The individual participant inclusion criteria were kept as broad as possible 
to try and maximise external generalisability. The criteria were that the 
individual should be: 
• aged 70 or over 
• registered on the practice list of one of the participating general 
practices 
• scored two or more on the screening questionnaire (previous fall or 
two or more other risk factors). 
2.6.3.1 Exclusion criteria 
The exclusion criteria were kept to the minimum possible however, in order 
to reduce contamination and in the interests of research governance, some 
exclusion criteria were necessary. The general practices were asked to 
exclude individuals if they were: 
• residents in nursing or residential homes (the interventions required 
to reduce falls in care home residents are different from those living 
in their own homes 
or 
• patients with terminal illnesses (would not be ethical) 
The study nurse excluded potential participants if they met the following 
criteria: 
• individuals already attending one of the day hospitals (it would not 
be ethical to randomise them to usual care if they had already been 
referred to the day hospital for a non5falls indication. if attending for 
falls prevention, these individuals are already receiving an 
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intervention and so by definition are not part of the screening 
population that this study targeted) 
• patients under follow up with an existing primary care based falls 
prevention scheme (these individuals are already receiving an 
intervention and so by definition are not part of the screening 
population that this study targeted) 
• those unwilling or unable to travel to the day hospital, using 
transport as provided (not eligible for the intervention arm) 
• patients unwilling or unable to provide fully informed consent 
(would not be ethical). 
Individuals who preferred not to participate in the randomised trial were 
offered the possibility of completing monthly diaries only as part of the 
screening cohort (section 2.5). 
2.6.3.2 Recruitment interviews 
Recruitment of individuals was carried out by three researchers (SC, RT, 
JE). The general practices were provided with recruitment packs, 
containing a letter of introduction (signed by one of the general 
practitioners at each practice), a screening questionnaire, a patient 
information leaflet and a reply5paid envelope. Each pack was in a sealed 
envelope and the addresses of potential participants were affixed by the 
practice staff, who then arranged for the invitation to be posted. 
On receipt of a completed questionnaire indicating that the individual was 
willing to participate further in the study, one of the three researchers 
responsible for recruitment made telephone contact with the potential 
participant. The telephone conversations followed a standardised format. If 
the individual was willing to participate, verbal consent was obtained over 
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the telephone. On a few occasions, a home visit was required to recruit 
individuals (for example, where hearing or vision was an issue). 
Day hospital and primary care falls prevention service records were 
checked to ensure that the potential participant was not currently attending 
the service or under active follow up (exclusion criteria). Active follow up in 
this context was defined as regular visits with either of the services, or on5
going telephone contact between the service and the participant. 
A consent form was then mailed to the individual, who was asked to sign 
and return the form. 
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2.6.4.1 Baseline characteristics 
Participants were described in terms of their age at entry into the study, 
their gender and their responses to the screening questionnaire (fall in the 
previous twelve months, taking more than four prescribed medications, 
previous stroke, Parkinson’s disease, inability to stand from a chair without 
using arms to push up, symptoms of dizziness on standing, use of a 
mobility aid, housebound/not housebound 5 see 2.5.4.1). Respondents 
were categorised as high risk of fall based on the presence of a previous 
fall or two or more of the other risk factors. 
2.6.4.2 Primary outcomes 
The primary outcomes were the predictive properties of the falls screening 
tool, described in terms of prevalence, sensitivity, specificity, positive and 
negative predictive values and their 95% confidence intervals (CIs). 
2.6.4.3 Secondary outcomes 
We asked for self reports of whether the fall was injurious or not but no 
secondary outcomes were pre5specified in the study protocol for the cohort 
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study. However, we subsequently decided to collect 12 month data on 
quality of life, basic and extended activities of daily living and fear of falling 
as additional descriptors of the population, and to help with assessing 
convergent validity. 
2.6.4.4 Ascertainment 
Prospective monthly falls diaries were used to collect falls outcomes over 
12 months, with participants being sent a diary at the beginning of each 
month, and being prompted to return the diary by inclusion of a stamped 
addressed envelope sent with the next month’s diary. A more detailed 
discussion on the merits of diary follow up is found in section 3.6.4. 
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The initial sample size was based on recruiting approximately 340 
individuals, as this has been shown to have sufficient power to determine 
sensitivity with a confidence interval of 20% in previous studies158. A 
further power calculation was carried out based on the first six month’s 
data (Table 2.5). 
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 Fall  
Risk Yes No Totals 
High 14 (27%) 38 (73%) 52 
Low 4 (11%) 33 (89%) 37 
Totals 18 71 89 
 
The odds ratio for at least one fall over the six months was 3.0 (95% CI 
0.8513.8), Fisher’s exact (25sided) p=0.106. The sensitivity was 
14/(14+4)=78%, the specificity was 33/(38+33)= 46%; the positive 
predictive value (PPV) was 14/(14+38)=27%, the negative predictive value 
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(NPV) was 33/(4+33)=89%, with a falls prevalence over the first six 
months of 18/89=20%. 
nQuery was used to calculate the sample size; 17 individuals with falls 
would be needed to be able to demonstrate a sensitivity of 78% (95% CI 
58598%), using a two5sided test with α at 0.05. Assuming the falls 
prevalence remained constant at 20%, we will need to recruit 
(17/20%=85) individuals. Using more narrow confidence intervals (705
90%), we would have needed 66 individuals who fell, or a sample size of 
(66/20%=330). We initially planned to recruit 330 individuals into the 
cohort study. 
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All analyses were carried out in Stata version 9. 
The baseline and fall data were described in terms of proportions, and age 
using medians and the interquartile range because of the skewed nature of 
the data. The predictive properties were described using sensitivity, 
specificity, positive and negative predictive values with their 95% 
confidence intervals. The choice of the optimal cut off point for determining 
high and low risk of falls was examined by calculating the sensitivity and 
specificity for differing cut off points and by plotting a receiver operating 
curve. Falls rates were calculated using Poisson regression and 
comparisons between groups were calculated as incident rate ratios. 
Quality of life, activities of daily living and fear of falling were compared 
between those at high and low risk and between fallers and non5fallers. 
The functional outcomes were continuous data but not normally 
distributed. Various transformations were tried, but none were suitable. 
Accordingly, scores were dichotomised on the basis of the median value, 
and comparisons made using chi square tests and logistic regression.
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2.6.6.1 Handling missing data 
Postal questionnaires were used to gather outcome measures. The 
advantages of postal questionnaires include: 
• no interviewer bias309 320 (particularly important in any therapy 
interventions) 
• standardised measurement across a large number of participants 
• participants are more likely to answer sensitive questions 
honestly321 
• postal questionnaire are relatively cheap322. 
The disadvantages of postal questionnaires include missing or unclear data, 
and low response rates, which may introduce bias if responders are 
different to non5responders323. Missing data reduces the effective sample 
size as regression models require that all cases have complete data. 
During the course of the study it became apparent that some of the 
monthly falls diaries had not been sent to some participants because of 
clerical error. Stata handles missing data by a process of ‘listwise deletion’ 
or ‘complete cases only’, that is to say only using complete datasets for 
regression commands. However, this is inappropriate for the falls and 
functional outcomes as it risks introducing bias. The conventional response 
to missing data for the Barthel and Nottingham Extended activities of Daily 
Living (NEADL) scales is to code missing as ‘never’ or ‘not at all’ i.e. worst 
possible outcome324. Alternatively, for hierarchical scales such as the 
NEADL it is reasonable to assume that if an individual fails an easy item 
they would have failed a more difficult item. An alternative is to replace 
missing items with the mean for a given subscale, providing there are not 
too many missing items. Multiple responses to single choice items are 
treated in the same way as missing items. 
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In view of the missing data, we carried out a series of analyses: 
• restricting analysis to those participants completing all 12 monthly 
diaries 
• restricting analysis to those participants who had a fall or had 
complete diaries 
• imputing missing data. 
A sensitivity analysis was undertaken where missing data on whether a fall 
occurred or not over the 12 month follow up period was imputed using the 
multiple imputation procedure in Stata. Variables used in the equation for 
predicting a missing value for falls were age, gender, (plus a term for the 
interaction between age and gender where there was evidence of a 
significant interaction), falls risk (low or high), all eight risk factor 
variables, the number of returned diaries, plus the Barthel, NEADL, FES 
and EuroQoL scores. Ten imputed datasets were created. Sensitivity, 
specificity and predictive value were estimated on each of the 10 imputed 
datasets and the mean and 95% confidence intervals of the values for 
sensitivity, specificity and predictive value were estimated using Rubin’s 
rules. 
A second sensitivity analysis was undertaken comparing secondary 
outcomes by falls risk and by whether a fall occurred or not using the 
micombine command with the linear regression option. If scores were not 
normally distributed and no suitable transformation could be found, scores 
were dichotomised at the median and analysed using logistic regression. 
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Recruitment into the cohort study took place in parallel to recruitment in to 
the RCT. Overall, 2846/5312 (54%) of people completed at least some 
parts of the screening questionnaire. Overall study recruitment is shown in 
Figure 2.2; 335 individuals agreed to participate in the evaluation of the 
screening tool. 
Five individuals replied but supplied insufficient information to allow their 
risk to be calculated, and did not give additional contact details. Reasons 
for exclusion included residence in a care home (2) or recent attendance at 
a falls programme (10). We recruited 335 participants into the cohort 
study, but due to clerical error, some of the participants did not receive 
study diaries and have incomplete data. 
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The baseline characteristics for at the key recruitment stages of the trial for 
the 2841 with data are shown in Table 2.7. 
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Characteristic 
All eligible 
n=2841 
(some had 
incomplete data) 
Declined 
N=2130* 
Excluded 
N=12* 
Screening 
cohort 
N=335 
Randomised 
Controlled 
Trial 
N=364 
Age (mean, SD) 72 (24.7), n=2840 78.0 (5.9) 80.5 (5.7) 77.5 (5.6) 78.7, 5.6 
Female gender 1539 (56%) 1319/1994 (57%) 10 (50%) 165 (50%) 218 (60%) 
At least one fall in 
previous 12 
months 
724/2776 (26%) 414/2050 (20%) 18/20 (90%) 76 (23%) 210 (58%) 
Taking more than 
4 medications 
834/2835 (29%) 544/2110 (26%) 10/20 (50%) 79 (24%) 192 (53%) 
History of CVA 249/2832 (9%) 171/2107 (8%) 4/20 (20%) 20 (6%) 53 (15%) 
Parkinson’s 
disease 
43/2838 (1.5%) 32/2113 (1.5%) 4/20 (20%) 1 (0.3%) 6 (2%) 
Inability to stand 
from a chair 
without using 
arms to push up 
1191/2825 (42%) 804/2099 (38%) 13/20 (65%) 124 (38%) 240 (66%) 
Symptoms of 
dizziness on 
standing 
936/2821 (33%) 594/2093 (28%) 12/20 (60%) 107 (33%) 218 (60%) 
Use of a mobility 
aid 
822/2828 (29%) 530/2100 (25%) 17/20 (85%) 87 (26%) 182 (50%) 
Housebound/not 
housebound 
(mobility 
impairment) 
448/2823 (16%) 306/2099 (15%) 11/20 (55%) 46 (14%) 83 (23%) 
High risk of falls 1481/2841 (52%) 928/2121 (44%) 18/20 (90%) 167 (50%) 
364 
(100%) 
 
These data show that those that declined to participate were less likely to 
have fallen and so at overall reduced risk compared to the all those with 
baseline data, and that the screening cohort lay between the two being at 
slightly higher risk overall than those declining (50% vs 44% high risk), 
but slightly lower risk overall than all those with baseline data (50% vs 
52% high risk). 
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Table 2.7 shows the baseline characteristics of the screening population 
spilt into risk group compared to the RCT population. These data 
demonstrate that the high risk group in the screening population was 
characterised by fewer fallers, fewer individuals taking more than four 
medications and fewer individuals with postural dizziness compared to the 
RCT population, suggesting a degree of selection bias, inflating the overall 
risk profile in the RCT population compared to the screening population. 
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Screening cohort 
N=335 
Characteristic 
Low risk 
n=168 
High risk 
n=167 
Randomised 
Controlled 
Trial 
N=364 
Age (mean, SD) 75.6 (4.0) 79.5 (6.4) 78.7, 5.6 
Female gender 76 (45%) 93 (55%) 218 (60%) 
At least one fall in previous 12 
months 
0 (0%) 80 (48%) 210 (58%) 
Taking more than 4 medications 19 (11%) 66 (40%) 192 (53%) 
History of CVA 1 (1%) 20 (12%) 53 (15%) 
Parkinson’s disease 0 (0%) 1 (1%) 6 (2%) 
Inability to stand from a chair 
without using arms to push up 
21 (13%) 110 (66%) 240 (66%) 
Symptoms of dizziness on standing 28 (17%) 81 (49%) 218 (60%) 
Use of a mobility aid 4 (2%) 87 (52%) 182 (50%) 
Housebound/not housebound 
(mobility impairment) 
0 (0%) 47 (28%) 83 (23%) 
High risk of falls 167 (50%) 
364 
(100%) 
*Some individuals provided incomplete data 
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The data collected in the cohort study consisted of monthly diaries. 
108/335 diaries were double5entered and the data entry error rate was 
34/5184 (0.66%). For fall/no fall the error rate was 16/1296 (1.2%), for 
the number of falls the error rate was 3/1296 (0.2%), for injurious falls 
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15/1296 (1.2%) and for the functional outcomes 31/4982 (0.62%). All 
errors were corrected in the original Access database. 
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A total of 3072 diaries were returned. The median number of returned 
diaries was 10 (IQR 8, 12). 134 participants (41.2%) returned all diaries, 
10 participants died during the 12 month follow up period and were 
excluded from the final analysis, a further three participants provided 
baseline data, but no falls diaries (Figure 2.3). 
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The baseline characteristics for those recruited in to the cohort study are 
shown in Table 2.8, separated by diary return status (complete or 
incomplete). These data show some significant differences between those 
with complete compared to incomplete diary returns, with ‘incomplete 
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returners’ being less likely to have had a previous fall (20% vs. 28%), 
previous stroke (4% vs. 10%) and less likely to have postural dizziness 
(28% vs. 40%). The proportion of people at high risk was greater in the 
population returning all diaries compared to those with incomplete diaries 
(55% vs. 45%), which is a potential source of bias. 
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Characteristic 
Complete 
diaries n=134 
Incomplete 
diaries n=191 
Significance 
test 
Age (mean, SD) 77.5 77.5 P=0.913 
Female gender 75 (56%) 90 (47%) p=0.116 
At least one fall in previous 
12 months 
37 (28%) 39 (20%) p=0.013 
Taking more than four 
medications 
39 (29%) 40 (21%) p=0.091 
History of stroke 13 (10%) 7 (4%) p=0.026 
Parkinson’s disease 0 (0%) 1 (1%) p=0.402 
Inability to stand from a 
chair without using arms to 
push up 
56 (42%) 68 (36%) p=0.258 
Symptoms of dizziness on 
standing 
53 (40%) 54 (28%) p=0.029 
Use of a mobility aid 37 (28%) 50 (26%) p=0.774 
Housebound/not 
housebound 
(mobility impairment) 
18 (13%) 28 (15%) p=0.755 
High risk of falls 74 (55%) 86 (45%) p=0.070 
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A total of 191 falls were recorded in 3072 returned diaries. The annual falls 
rate was 746/1000 person5years (0.75 per person5year). Table 2.9 shows 
the number of falls and type of fall by the different diary return groups 
(those with complete follow up vs. all participants). 
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  Returned all diaries 
[n=134] 
All participants 
[n=322] 
Number at high risk (%) 74 (55%) 158 (49%) 
At least one fall in follow up 
period (%) 
47 (35%) 96 (30%) 
Rate of falls per person5year 
(Poisson, 95% CI) 
0.35 
(95% CI 0.2650.47) 
0.39 
(95% CI 0.3150.47) 
Had more than 1 fall in 
follow up period (%) 
24 (18%) 43 (13%) 
Had injurious fall in follow up 
period (%) 
26 (19%) 56 (17%) 
 
The data in Table 2.9 demonstrate the effect of including those participants 
with incomplete diary returns, who were at lower risk of falls as shown in 
Table 2.8, namely an attenuation of adverse falls related outcomes. 
2.7.5.1 Falls by risk group 
Considering those who returned all 12 diaries (n=134), 37/74 (50%) of 
those at high risk fell at least once, compared to 10/60 (17%) at low risk; 
odds ratio 5.0 (95% CI 2.1512.6, Fisher’s exact (25sided) p=0.0001. 
For all participants surviving at 12 months (n=322), 66/158 (42%) high 
risk versus 30/164 (18%) low risk participants reported at least one fall, 
odds ratio 3.2 (95% CI 1.955.5), Fisher’s exact (25sided) p<0.0001. This is 
likely to be a biased estimate, as many of those alive at 12 months did not 
complete all 12 diaries and are at lower risk than those that did complete 
all twelve diaries. 
The rate of falls in the high risk group (using data from all diaries returned) 
was 1.2 (95% CI 1.051.4) compared to 0.3 (95% CI 0.2550.46) falls per 
person5year in the low risk group, incidence rate ratio 3.4 (95% CI 2.55
4.6), p<0.0001. 
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The predictive properties concern events over one year (12 diaries), so 
those with incomplete diaries were excluded from this analysis. A risk score 
was calculated by adding individual risk factors to create a continuous risk 
score (range 058). The area under the curve (AUC) was 0.68 and the 
optimal cut5off was at three or more risk factors, correctly classifying 
69.2% of participants (Table 2.10). Although the cut5off (≥2) chosen for 
the entry into the RCT correctly classifies fewer people (65%), it does have 
slightly higher sensitivity (79%), which means that it correctly identified 
more people at high risk that went on to have a fall. But the trade off is the 
reduced specificity (57%), indicating that fewer people who did not have a 
fall were correctly identified as being at low risk. 
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 Area under 
the curve 
(95% CI) 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV  
(95% CI) 
NPV  
(95% CI) 
Returned 
all diaries 
[n=134] 
0.68 
(0.6050.76) 
78.7 
(64.3, 89.3) 
57.5 
(46.4, 68.0) 
50.0 
(38.1, 61.9) 
83.3 
(71.5, 91.7) 
Using participants with complete diaries only (n=133)B 
Cut off 
point for 
risk score 
Sensitivity (%) Specificity (%) Correctly classified (%) 
≥0 100.0 0.0 35.3 
≥1 91.5 37.2 56.4 
≥2 78.7 57.0 64.7 
≥3 66.0 70.9 69.2 
≥4 44.7 82.6 69.2 
≥5 19.2 90.7 65.4 
≥6 12.8 98.8 68.4 
≥7 6.4 100.0 66.9 
≥8 0.0 100.0 64.7 
                                          
 
* note 1 person had data missing on dizziness on standing which excluded 
them from this analysis but not from analysis based on categorised risk 
score, as response to dizziness would not have altered their risk category 
94 
 
A ROC analysis using previous fall as the predictor (sensitivity 46%, 
specificity 85%, PPV 56%, NPV 79%) compared to the risk score is shown 
in Figure 2.4, which shows that previous fall has almost identical ROC 
characteristics compared to the more complicated risk score. Indeed the 
confidence intervals for the areas under the curve show that the two 
models overlap: risk score AUC 0.69 (95% CI 0.6350.75) compared to 
previous fall AUC 0.65 (95% CI 0.6050.71). 
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Those without complete follow up data were excluded from the primary 
analysis described above, because of the risk of introducing bias. However, 
the data from those individuals completing less than 12 diaries was used in 
a sensitivity analysis carried out on an imputed dataset, the results are 
shown in Table 2.11. These data illustrate the effect of including those 
participants without complete follow up data, who were at overall lower 
risk. Even using the multiple imputation model, which attempts to correct 
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for baseline variables, there were fewer falls, with a correspondingly lower 
positive predictive value. This means that the imputed model is still biased 
and the data are not representative of the population with complete follow 
up. So the best estimate available from the cohort study is the primary 
analysis based on those with complete follow up only, even though with 
relatively small numbers the confidence intervals are wide.
96 
$2%!		#!-(;3('!	.#&.!#3(!,	;&/.$#("0	(/.43!-	-$3$	$0$(",3	&#(0("$%	-$3$	
 Prevalence 
of falls 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV  
(95% CI) 
NPV  
(95% CI) 
Area under the 
curve 
(95% CI) 
Returned all 
diaries 
[n=134] 
35.1% 78.7 
(64.3589.3) 
57.5 
(46.4568.0) 
50.0 
(38.1561.9) 
83.3 
(71.5591.7) 
0.68 
(0.6050.76) 
Imputed 
data 
29.7% 68.9 
(66.0571.6) 
59.1 
(57.1561.0) 
41.5 
(39.2543.9) 
81.8 
(80.0583.6) 
0.64 
(0.6250.66) 
Imputed dataset 
Cut off point 
for risk score 
Sensitivity (%) Specificity (%) Correctly classified (%) 
≥0 100.0 0.0 29.7 
≥1 85.4 35.2 50.1 
≥2 68.8 58.9 61.8 
≥3 52.2 74.7 68.0 
≥4 34.3 85.5 70.3 
≥5 20.8 94.3 72.5 
≥6 12.5 98.7 73.1 
≥7 4.2 100.0 71.5 
≥8 0.0 100.0 70.3 
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Clerical error and loss to follow5up resulted in missing data for some of the 
functional outcomes, as detailed below: 
• EuroQoL (301/325) 
• Barthel index of daily living (301/325) 
• Nottingham Extended Activities of Daily Living (304/325) 
• Falls Efficacy Scale (269/325). 
The ADL, FES and QoL scores were not normally distributed and suitable 
transformations could not be found. They were therefore dichotomised at 
or above the median value., depending on the number in each group in 
order to ensure a balanced distribution. 
We compared activities of daily living (ADL), fear of falling (FES) and 
quality of life (QoL) between fallers and non fallers (based on complete 
diaries) and between those at high and low risk of falls (based on all 
participants) Table 2.12. These shown that fallers have substantially 
reduced function, both basic and advanced, increased fear of falling and 
worse quality of life compared to non5fallers.
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Fallers 
Median 
score (IQR) 
Non 
fallers 
Median 
score 
(IQR) 
Odds ratio for median score 
or above comparing fallers 
to non fallers 
(95% CI) 
High risk of 
falls 
Median score 
(IQR) 
Low risk 
of falls 
Median 
score 
(IQR) 
Odds ratio for median 
score or above 
comparing those at high 
and low risk of falls 
(95% CI) 
Barthel 
Median 20 
19 
(18, 20) 
20 
(19, 20) 
0.39 
(0.19, 0.82) 
P=0.013 
19 
(18, 20) 
20 
(20, 20) 
0.18 
(0.11, 0.30) 
P<0.001 
NEADL 
Median 61 
52 
(36, 63) 
63 
(56, 63) 
0.38 
(0.18, 0.79) 
P=0.010 
52.5 
(38.75, 61.25) 
63 
(60, 66) 
0.15 
(0.09, 0.25) 
P<0.001 
FES 
Median 10 
15 
(10, 23.5) 
10 
(10, 12) 
3.42 
(1.52, 7.71) 
P=0.003 
13 
(10, 24.3) 
10 
(10, 10) 
6.60 
(3.8, 11.4) 
P<0.001 
EuroQoL 
Median 6 
8 
(6, 9) 
6 
(5, 7) 
3.60 
(1.68, 7.73) 
P=0.001 
7 
(6, 9) 
6 
(5, 7) 
4.21 
(2.60, 6.86) 
P<0.001 
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Table 2.12 compares activities of daily living, fear of falling and quality of 
life between fallers and non5fallers (based on participants who returned all 
diaries or had a fall recorded in at least one returned diary) and between 
those at high and low risk of falls. The data show that falls risk also 
identified those with reduced function, increased fear of falling and worse 
quality of life. 
Table 2.13 shows the same outcomes, but also includes the imputed 
dataset. The findings of falls and falls risk being associated with adverse 
outcomes holds true in the imputed dataset, albeit with some attenuation 
of the effect size. 
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 Fallers vs. non fallers High vs. low risk 
 
OR complete 
diaries 
(95% CI) 
Odds ratio 
imputed data 
(95% CI) 
OR complete 
diaries 
(95% CI) 
Odds ratio 
imputed data 
(95% CI) 
Barthel 
score 
0.39 
(0.19, 0.82) 
p=0.013 
0.77 
(0.47, 1.27) 
p=0.306 
0.18 
(0.11, 0.30) 
p<0.001 
0.18 
(0.11, 0.30) 
p<0.001 
NEADL 
0.38 
(0.18, 0.79) 
p=0.010 
0.50 
(0.31, 0.82) 
p=0.006 
0.15 
(0.09, 0.25) 
p<0.001 
0.15 
(0.09, 0.24) 
p<0.001 
FES 
3.42 
(1.52, 7.71) 
p=0.003 
1.99 
(1.17, 3.38) 
p=0.011 
6.60 
(3.8, 11.4) 
p<0.001 
8.51 
(5.04, 14.39) 
p<0.001 
EuroQoL 
3.60 
(1.68, 7.73) 
p=0.001 
2.04 
(1.21, 3.45) 
p=0.007 
4.21 
(2.60, 6.86) 
p<0.001 
4.49 
(2.76,   7.31) 
p<0.001 
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We recruited 335 older people into the cohort study; the screening 
population are very similar in terms of baseline characteristics to those who 
declined to participate. 
The modified FRAT, consists of eight simple questions, can be sent out as a 
postal questionnaire (54% response rate), has reasonable face validity and 
good to very good test5retest reliability. The construct validity of the tool is 
demonstrated by the increased number of fallers in the high risk group 
compared to the low risk group (odds ratio 5). 
The predictive properties of the tool are reasonable: sensitivity 79% and 
specificity 58%. The positive predictive value of 50% indicates that for 
every two people identified as being at high risk, one would go onto to 
have a fall in the following year. The 83% negative predictive value means 
that of those screened as being at low risk, approximately on in six will go 
on to have a fall, but five out of six will not have a fall. 
However, the predictive properties of this relatively simple tool were not 
significantly better than just using previous fall alone as the predictor for 
future fall (risk score AUC 0.69 (95% CI 0.6350.75) compared to previous 
fall AUC 0.65 (95% CI 0.6050.71)). The positive predictive value using 
previous fall alone is slightly better than using the screening tool (56% 
versus 50%), but the negative predictive value is lower (79% versus 
83%). Using previous fall as the sole identifier, slightly more than one in 
two people classified at high risk would go onto fall, but one in five of those 
classified at low risk would fall – compared to one in six using the 
screening tool. 
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Fallers had reduced function as measured by the Barthel and the NEADL, 
than non5fallers at twelve months. The magnitude of this effect was similar 
for both extended and basic activities of daily living (odds ratio~0.4, 
p<0.02). Fallers also had a three5fold increased in fear of falling (OR 3.3, 
p=0.003). Linked to the increase in fear of falling and reduced function is 
the worse quality of life in people who had fallen. We used the EuroQoL to 
measure quality of life, which comprise five domains (mobility, self5care, 
daily activities, pain and mood) each with three levels of response (no 
problem – 0, some/moderate difficulty – 1 and unable/extreme difficulty 5 
2). This study showed a three5four fold worsening of self rated quality of 
life in fallers (OR 3.6, p=0.001). 
The finding that quality of life was worse in people who have fallen (median 
8 versus 6 on a 12 point scale) holds for the mobility domain within the 
EuroQoL (median 2 versus 1) in this study. It appears that we have 
affirmed the fall5reduced function5fear of falling5reduced quality of life 
theory in this cohort study. This further supports the construct validity of 
this screening tool, demonstrating the expected association between falls, 
reduced function, fear of falling and reduced quality of life. 
  ,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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The strengths of this study include the prospective design, the monthly 
ascertainment of falls, and the collection of an array of secondary 
outcomes at follow up. 
Those at high risk in the screening cohort were slightly less likely to have 
fallen compared to all those with baseline data. Those at high risk and 
having fallen who agreed to participate were differentially recruited into the 
RCT rather than the screening cohort. This makes the screening cohort 
somewhat unrepresentative. Ideally, the cohort study validating the 
screening tool should have been carried out prior to the RCT (i.e. in series 
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rather than in parallel), but resources (namely time) were insufficient to 
allow this process. It is not possible to be certain in which direction this 
bias may have affected the result, but it is reasonable to hypothesise that 
it led to an underestimate of the true falls prevalence in the high risk group 
in the screening cohort. This would have the effect of reducing the 
sensitivity and the positive predictive value of the screening tool. 
There is clearly an issue around those participants who returned 
incomplete diaries, and the comparisons in Table 2.8 and section 2.7.5.1  
suggest that they were at slightly lower risk of falls than those that 
completed the study. 
We carried out a sensitivity analyses to determine the robustness of the 
results based on the smaller sample of 134 participants completing 12 
months of follow up. This included all participants alive at 12 months; this 
slightly underestimated falls prevalence (30%) (Table 2.11). The complete 
dataset based on 134 participants is small, with correspondingly wide 
confidence intervals around the various estimates. The imputed dataset 
appears to offer biased estimates, and so cannot be used to refine the 
estimate seen in the original dataset. The analysis of those with complete 
follow up is consistent with other similar studies (see below). 
It would have been possible to increase the number of high risk individuals 
used to validate the screening tool by including those assigned to the 
control group of the RCT in the analysis of the predictive properties of the 
screening tool. However, this was not done as the follow5up diaries used in 
ascertaining falls outcomes were different in the two studies and there 
were concerns that the different reporting (more detailed in the RCT) may 
have led to differential reporting and bias. Also, as discussed above, those 
participating in the RCT may be in some way different to those at high risk 
agreeing only to the cohort study, creating further risk of bias. 
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The predictive properties of the screening tool were measured using the 
area under the curve (AUC 0.68 using the 134 participants with complete 
follow up). This compares favourably to other falls screening tools – 0.65 
from Tromp 201, 0.71 from Pluijm 146 and ~0.70 from Nandy 
158. A slightly better score could have been obtained if we had used three 
or more individual risk factors as the cut off (AUC 0.73). 
The finding of reduced basic and extended functional ability in fallers is 
consistent with previous reports of worse function leading to admission to 
long term care in people who have fallen129; however, as we did not 
measure function at baseline, we cannot be sure that this relationship is 
causal. Given that 18% people who fell had more than one fall, and that 
nearly 20% of falls were injurious, it is reasonable to hypothesise that falls 
cause reduced function. There was also a three5fold increase in fear of 
falling in fallers compared to non5fallers, which may also have contributed 
to the reduced function, as has been shown other studies70 71. 
The worse quality of life measured in people who had fallen is consistent 
with previous studies70 71 3255328 which have demonstrated a link between 
fear of falling, functional impairment and a reduction in quality of life in 
people who have fallen. Indeed 80% of women asked would rather be dead 
than experience the loss of independence and quality of life that results 
from a [fall,] bad hip fracture and subsequent admission to a nursing 
home329. The reduced quality of life is thought to be mediated through a 
loss of autonomy330, and fear of falling leading to restricted activity and 
reduced social interaction. 
Falls efficacy is the belief that an individual can master falling and so 
despite having fallen, has the confidence to continue activities; fallers in 
this study has a substantial increase in fear of falling, measured using the 
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Falls Efficacy Scale. Also linked to fear of falling and quality of life are 
individuals’ expectations 5 people who have fallen may have lower 
expectations and are ‘pleasantly surprised’ by their perceived quality of 
life; one paper examined this theory and did not find evidence to support 
this adaptive theory in older fallers331. In a related sub5study carried out in 
parallel to this screening study, it was found that low self5efficacy for falls 
was linked to negative outcome expectation to falls, further casting doubt 
of the adaptive approach (	

).  
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The proportion of people with a fall in the previous 12 months at baseline 
(28%) is in keeping with previous estimates of falls prevalence in UK 
populations (see 1.2). The fall rate during follow up (0.75 falls per person5
year) is higher than estimates of falls rates from UK primary care 
records37, which tend to underestimate falls, but below the lower end of the 
range for international estimates for falls rates in community dwelling older 
people, mainly based on intervention studies (1.151.8 falls per person5
year). This suggests that the cohort studied is reasonably representative, 
at least in comparison to previous studies of fall in community dwelling 
older people. The subsequent fall prevalence of 35% over one year, using 
monthly diaries, is consistent with other studies which have shown that 
more careful ascertainment results in more falls being recorded, typically 
reporting annual falls prevalence using weekly or monthly diaries of around 
33%14 25 26. 
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We have developed a screening tool which is valid, reliable and 
generalisable. It is easy to use in the primary care setting, and can be 
completed by post, with a reasonable response rate (54%). It could be 
equally well completed at a routine primary care visit. The predictive 
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properties of the tool are as good (sensitivity 79% and specificity 58%), if 
not better than previously published falls screening tools (FRAT158 
sensitivity 42%, specificity 92%). The tool performs slightly better than 
just using previous falls to identify those at risk, mainly because of its 
superior negative predictive value – this has important implications in 
terms of the cost5effectiveness and acceptability of the subsequent 
intervention. Falls prevention programmes are expensive, requiring 
multiple team members delivering an intervention over several weeks, so 
need to be targeted at those most likely to benefit if they are to be 
clinically and cost5effective. However, from a practical perspective, using 
previous fall alone is very simple and has similar predictive properties 
compared to the screening tool. Aside from the tool’s ability to identify 
those at risk of future fall, it also identifies a cohort at risk of functional 
decline and reduced quality of life, and so may be useful method of 
targeting older people in the primary care setting for interventions aimed 
at maintaining their independence. Such interventions, generally known as 
comprehensive geriatric assessment, have shown benefit in primary care 
settings for frail older people with a variety of geriatric syndromes, not just 
falls3325334. 
What is not known, at least in the UK setting, is if a multifactorial 
intervention to prevent falls provided to individuals identified as being at 
high risk of falls using this screening tool offers any benefit. 
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In chapter one, the evidence supporting the clinical effectiveness of a 
multifactorial intervention to reduce the rate of falls was presented. The 
case was made for screening for falls in the primary care setting, with the 
aim of identifying individuals who are at risk of falls or who have already 
fallen but have not presented to health services. Screening methodology 
and results showing that a screening tool is effective in identifying such 
high risk individuals was discussed in chapter two. In this chapter, the 
methodology, results and implications of a randomised controlled trial of a 
falls prevention programme applied to the high risk population are 
discussed. 
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A multifactorial intervention such as that used to manage people who have 
fallen, can be considered a complex intervention according to the MRC 
framework335 (note this has been updated since this work was started336). 
When evaluating such complex interventions, it is essential that the 
individual ingredients are clearly defined, so as to allow reproducibility. 
Furthermore, it is important to try and determine the relationship between 
the various components – to unpick the ‘black box’. 
The MRC suggest a series of developmental steps which are required to 
clearly define the nature of a complex intervention335: 
• pre5clinical – exploring the relevant theory 
• phase I – modelling the individual components, developing an 
understanding of their mechanisms and their interdependency 
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• phase II – exploratory trial to describe the constant and variable 
components of the intervention with a  view to defining the protocol 
for a definitive comparison 
• phase III – definitive RCT 
• phase IV – long term implementation – assessing if the intervention 
can be delivered successfully in other settings. 
This process is long and requires multiple separate studies. The plethora of 
positive RCTs on falls prevention detailed in section 1.5 suggested that the 
essential ingredients of falls prevention programmes have been elucidated. 
However, the purpose of this study is to evaluate the complex intervention 
in a different population and setting to that which has previously been 
studied in the United Kingdom (i.e. the screened population, managed in 
the day hospital) – though several international studies have already 
carried out this work in a ‘high risk populations10 12 217 224 225. 
The definition of the complex intervention intended to be delivered in this 
study is detailed in section 3.5, but in brief consisted of a medical review, 
strength and balance training and a home hazards assessment. We 
attempted to assess whether the intended intervention were being 
delivered as planned using behavioural mapping and an audit of activity in 
the falls prevention programme, detailed in appendix 1.1. 
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Given that there have been several previous clinical trials evaluating falls 
prevention programmes, it is important that the results of this trial can be 
interpreted in context – in terms of what this trial can add to the literature. 
A critical appraiser reviewing this trial will examine various aspects of trial 
conduct to determine if the results are a useful addition to the literature. A 
variety of critical appraisal tools have been developed which allow the 
108 
 
appraiser to carry out this process in a systematic manner337, and in 
designing a trial, it is helpful to consider these criteria. 
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Internal validity asks the question ‘do these results represent an unbiased 
estimate of the treatment effect, or have they been influenced in some 
systematic fashion to lead to a false conclusion?’338. Fundamental aspects 
of the internal validity of a randomised controlled trial concern 
randomisation and group balance, participant allocation and follow up, 
blinding, and isolation of the experimental intervention. 
3.2.3.1 Randomisation 
Randomised controlled trials (RCTs) are considered to be the most rigorous 
of clinical trials281 339 because in theory there should be no difference 
between the control and intervention groups except the treatment being 
tested$Randomised controlled trials are designed to avoid sampling bias (a 
form of selection bias), a weakness of case5control and cohort studies, but 
are still open to non5response bias, a different form of selection bias. This 
is why it is important to use intention to treat analysis, which analyses 
individual based on allocation, irrespective of whether or not the 
participants actually received the allocated treatment340. Pre5specified per 
protocol analyses can be carried out to examine outcomes such as adverse 
events. 
Randomisation should ensure that known and unknown confounding factors 
are equally allocated between groups. However, because participants are 
allocated to control or intervention groups randomly, it is possible that 
baseline imbalances between the groups can arise by chance. It is 
recommended that important prognostic variables are recorded for each 
group at baseline341, allowing a comparison to be made between groups, 
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and then if there are any major imbalance, these can be adjusted for at the 
analysis stage. 
However, it is not clear how such imbalances should be evaluated; testing 
for statistical significance between the groups might be used, but the 
question remains, is a statistically significant difference a reflection of a 
failure of randomisation, or is it a chance finding and should the analyses 
be adjusted342? This issue is all the more important when combining trials 
with various baseline imbalance in a meta5analysis343. To overcome this 
uncertainty in handling baseline imbalances, several groups have 
suggested the following strategies342 344 345: 
1. at the planning stage of a study baseline variables of prognostic 
value should be identified on the basis of available evidence.  
2. these should be fitted in an analysis of covariance or equivalent 
technique for other data types.  
3. other variables should not be added to the analysis unless 
information from other sources during the course of the trial 
suggests their inclusion. 
Approaches 1 and 2 are supported by other groups – Pocok 346, Hauck 
347 who suggest adjusting for prognostically important baseline 
variables, whether they are imbalanced or not. Also supporting this 
approach, Hernndez 348 further demonstrated that adjusting for 
baseline covariates improves the power of a clinical trial. 
Some investigators have questioned whether randomised studies are 
always preferable to non5randomised studies. Arguments in favour of non5
randomised studies exist where the effect of the intervention is so 
obviously dramatic (such as defibrillation for ventricular fibrillation), or 
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where the size, duration and cost of a randomised trial outweighs the 
potential benefits of identifying rare adverse events349. 
The ‘gold standard’ RCT is the double5blind placebo controlled drug trial, in 
which the only variance between groups is the intervention under effect 
and the placebo is identical in appearance, taste and smell to the 
intervention. The classic example is a drug trial, in which sugar pills are 
given in place of the intervention medication; other examples include sham 
treatments or psychological placebos (e.g. talking versus counselling). 
Even in these circumstances, it is has been suggested that there is a 
beneficial effect from a placebo, particularly where the outcome is a 
continuous measure rather than a binary outcome350. Moreover, some 
placebos lead to better outcomes than others – a clinical trial comparing a 
pill placebo against a sham treatment placebo found that self5reported pain 
(using a continuous pain scale) was more effective than the pill placebo351. 
Reasons cited for why the placebo effect might confer benefit are 
regression to the mean (e.g. the natural history of hypertension is for it to 
fall after an initial consultation), the effect of time (e.g. operator skill 
improves, natural history of the condition is one of improvement) and 
unidentified parallel interventions352. 
Allocation concealment can be especially difficult when it is not possible to 
blind participants to the intervention, a common feature of many therapy 
intervention trials. There the therapist factors: is it the therapist’s attitude, 
charisma or communication skills, or the therapy technique which they are 
using that is being tested? The participant is not blinded to the fact that 
they are receiving the intervention, and so may be anxious to please the 
investigators, thus introduce reporting bias into their replies to outcome 
measures. 
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3.2.3.1.1 Methods of random allocation 
Random allocation between the arms of a trial aims to ensure that there is 
no sampling bias introduced by the investigators, but should also ensure 
that any bias due to unknown effects is addressed. In a blinded RCT, it is 
imperative that the allocation to the arms of the study is truly concealed, 
so as not to introduce any bias353. This relies upon careful concealment of 
the allocation groups from the investigators, without which treatment 
effects may be artificially elevated354. 
Various techniques have been used to conceal the allocation from the 
investigator, ranging from the use of sealed envelopes (least reliable and 
prone to tampering), through to telephone or web5based randomisation 
sequences. Even the latter are prone to subversion, depending on the 
nature of the allocation sequence. 
The simplest form of randomisation is to toss a coin – heads being one 
group, tails another. A problem with this method is that it is prone to 
tampering or it might be possible for the investigator to guess which group 
the next participants will be allocated, and this in turn could lead to bias. 
A more sophisticated approach is to generate a series of random numbers, 
with even numbers indicating one group and odd numbers the other. 
Because the list is randomly generated, it is less predictable. Stratified 
randomisation allocates participants randomly within blocks according to 
important characteristics, such as age or location. 
Block randomisation (or restriction), can be used to try and keep the 
numbers in each group equal, but allows the investigator to guess the 
allocation of the last participant in that block. To overcome this, random 
permutated block sequences can be used355; with this technique 
(Hadamard Randomization), the allocation sequence is contained within 
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random block sizes, which make it difficult for an observer to guess the 
next allocation. 
Minimisation is a more refined approach and allows multiple potential 
confounding factors to be taken into account; but a problem with 
minimisation is that the group size can be very small356. 
3.2.3.1.2 Alternative randomisation procedures 
In un5blinded RCTs, participants allocated to the control group may not be 
happy, having been made aware during the consent process that a new (as 
yet unproven) treatment is being offered to the intervention group – this 
may lead to poor compliance and/or reporting bias. Recognising this 
dilemma, Zelen proposed an alternative strategy in which participants are 
consented 	 they have been randomised357. In Zelen’s single consent 
process, those allocated to the intervention are told of alterative therapies, 
but those in the control group are not told about the intervention; analysis 
is per the original allocation. In the double consent design, participants are 
offered the initial randomisation arm treatments, but if they decline, they 
are then offered the alternative therapy; again analysis is by the original 
allocation. This technique is designed to help with compliance and 
adherence to follow up, so reducing sampling bias. 
Zelen randomisation is controversial, but has been used in clinical trials 
such as those looking at screening, where it is especially important to avoid 
the ‘Hawthorne effect’, in which the presence of a trial may alter the 
behaviour of those in the control group. The practicalities of carrying out 
such research are challenging, and require follow up ‘at a distance’ such 
that the control group are not aware they are being monitored; this can be 
achieved through record linkage studies or registries358. Not obtaining 
consent from the control group (an ethical requirement) does mean that 
this design is only rarely used. 
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3.2.3.1.3 Public perceptions of randomisation 
Although the general public understand the concept of random allocation, 
they are not always persuaded of its appropriateness in the context of a 
clinical trial, which is partly due to difficulties accepting the notion of 
equipoise359. Equipoise is a key factor in deciding if a randomised trial is 
appropriate – in the investigators mind there should be uncertainty about 
which treatment option is best. The lay public appear to believe that 
doctors should always know what is best – so there should be no equipoise 
in a clinical setting, though this is less of an issue in the context of a 
clinical trial359. This can make recruitment into clinical trials difficult; efforts 
to inform potential participants about the rationale for randomisation 
should focus on improving knowledge and understanding rather than 
clinical aspects of equipoise359. 
3.2.3.1.4 Randomisation – internal validity versus external validity 
In the previous sections, some of the reasons why a randomised design 
might be chosen have been highlighted, namely to reduce bias. Another 
factor which makes RCTs sometimes difficult to interpret more broadly 
(external validity) is the entry process. There may be differing participation 
rates from one centre to another, differing practises from one centre to 
another or one practitioner to another – in other words, elucidating the 
precise components of a given intervention that can be extrapolated to the 
wider setting. The entry criteria for an RCT may be more rigorous and not 
reflect clinical practice, which is where non5randomised studies might have 
an advantage. The concerns that the public hold about randomisation 
(section 3.2.3.1.3) may also mean that those entering the trial may not be 
not representative of the population as a whole. 
The external validity of RCTs can be addressed by having pragmatic entry 
criteria, which as much as possible reflect clinical practice, by using 
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multiple centres (which allows comparison across different sites to see if 
any treatment benefit holds good in different settings) and minimal 
exclusion criteria. 
3.2.3.2 Bias 
Bias is defined as ‘any trend in the collection, analysis, interpretation, 
publication or review of data that can lead to conclusions that are 
systematically different from the truth’281. The two main forms of bias are 
information bias and selection bias360. Publication bias refers to the 
tendency for negative trials not to be published361 362 363 364 365, or for the 
publication to be delayed366; this is more of an issue for systematic reviews 
and meta5analyses than the internal validity of a trial. This is the rationale 
for international trial registries, discussed in section 3.11.1. 
3.2.3.2.1 Information bias 
Information bias is concerned with the misclassification of information 
gathered; this can be sub5divided into random and non5random 
misclassification. Random misclassification can be misclassification of the 
exposure independent of the outcome or vice versa; this form is non5
differential and the effect is to bias the measure of effect towards the null 
hypothesis.  
Non5random (or differential) misclassification can bias associations in either 
direction. An example is recall bias, in which respondents either over5
report or under5report an exposure; this is a particular problem in case5
control studies, where cases and control may report exposure differently 
because of their disease status. Recall bias is best overcome by having 
objectively verifiable outcome or exposure measures (such as medically 
verified falls as compared to self reported falls). Recall bias can be further 
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minimised by prospectively recording outcomes, rather than relying upon 
retrospective recall. 
A second example is observer bias, in which the investigator interprets or 
gathers information differently in different groups. Observer bias can be 
reduced by using standardised outcome assessment measures, ensuring 
observers are rigorously trained, and through blinding. Blinding reduces 
bias that may be introduced by an awareness of the allocation group; trial 
participants can be blinded to the treatment that they are offered (single5
blind trial). 
Double5blinding is possible, where both the participants and the observers 
are unaware of treatment allocation; a typical example would be a double5
blind placebo controlled drug trial. 
Finally, triple blinding is possible, where participants, observers and the 
analysts are blinded to allocation, with allocation only being revealed at the 
end of the analysis. Given the impracticality of blinding participants to 
allocation in this trial, the option available to reduce bias is to have the 
analysis blinded to the allocation group. This was achieved by having the 
allocation group recorded in a numeric code (0 or 1) in the study database, 
rather than by allocation group (intervention or control). 
3.2.3.2.2 Selection bias 
Selection bias can be related to sampling (the initial choice of study 
participants) or loss to follow up; both are major challenges in longitudinal 
studies.  
Sampling bias is a particular problem in case5control studies if the controls 
do not represent the population from which the cases are selected. For 
example, if we compared people who had fallen and attended the day 
hospital to people who had fallen and not attended the day hospital, there 
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would be a high risk of sampling bias. Individuals attending the day 
hospital might be sicker or more frail than those not attending, and so any 
difference between the two groups may be related to the population rather 
than any intervention delivered in the day hospital. Other examples of 
selection bias include case series or cohort studies reporting a positive 
effect of a novel intervention compared to a group not receiving the novel 
intervention – which is in fact related to patient selection. An example 
would be patients selected for a novel surgical procedure, as the surgeon 
might choose the fitter patients, less likely to suffer complications which in 
turn lead to over inflated reported benefit from the intervention. But when 
equal populations are compared in a randomised controlled trial, the 
intervention may have minimal benefit or even cause harm. 
Non5response bias (or loss to follow up) is a major issue, as non5
responders may be different in many ways (e.g. sicker, possibly dead) than 
responders. If non5responders are not included, there is a tendency to 
under5report adverse outcomes. For example, non5responders in this study 
may be individuals who have fallen and been hospitalised. Equally, non5
responders may be very well and not see the point of replying to 
questionnaires. In either case, loss to follow up can systematically alter the 
outcomes of the trial. Different strategies may be employed in the analysis 
stage to test for the effects of non5response bias (section 3.13.2). 
3.2.3.3 Precision 
The second aspect concerning the validity of clinical trials alluded to in 
Guyatt’s statement (section 3.2.3) is precision – or the ‘estimate of 
treatment effect’, a key determinant of which is random error. 
Random error is ‘the divergence, due to chance alone, of an observation on 
a sample from the true population value, leading to a lack of precision in 
the measurement of an association’301. Random error is related to 
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sampling, as individual samples of a population will always vary and it 
possible that the samples selected are not representative of the population 
at large. 
In a type I error (or alpha error), the null hypothesis is rejected when it is 
in fact true – there is no real difference between the study populations. 
This is related to the statistical significance of the outcome, conventionally 
measured as a p5value. Conventionally, a p5value of <0.05 is said to be 
statistically significant, but in reality, the probability of erroneously 
rejecting the null hypothesis is a continuous measure. A p5value of 0.04 
means that the likelihood of obtaining a positive study result when the null 
hypothesis is in fact true is 4 in 100. The level at which one is comfortable 
in accepting the statistical significance will depend on the actual study 
outcome and the context of the trial. It is important to be aware that the 
more statistical tests that are carried out, the greater the possibility of 
finding a statistically significant result by chance alone. This is why the trial 
outcomes should be defined in advance, so that accusations of ‘data5
dredging’ can be countered. 
In a type II error (or beta error), the null hypothesis is accepted when it is 
in fact false. That is to say that the study result is negative, but the truth is 
that the true effect is positive. The likelihood of this form of error is related 
to the power of the study; the probability of a type II error is (15power). 
The power of a study should be calculated in advance, using a statistical 
package (e.g. Stata or nQuery); typical acceptable values for the power of 
a study would include 80%, 90% or 95%. If a trial is under5powered, and 
finds that there is no difference between the groups, it would be incorrect 
to state that the intervention is ineffective; it is the failure to demonstrate 
an effect367. A larger trial may go on to identify the effect. 
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3.2.3.3.1 Sample size (see Table 3.1) 
The eventual sample size of a study will be determined by the precision 
requirements and the power requirements. Precision is a measure of how 
wide the confidence intervals will be; power the chances of correctly 
identifying an effect of the intervention if one really exists. The sample size 
will be determined by the minimal clinically significant difference between 
the two arms of a trial that one would want to be able to detect. 
$2%!		1.!,	&+	#$"-&/	!##&#	
 True situation 
Test result Negative trial Positive trial 
Do not reject null 
hypothesis (not 
significant) 
(True result) 
Probability = 15 α 
Type II error 
Probability = β 
Reject null hypothesis 
(significant) 
Type I error 
Probability = α 
Power 
= 15 β 
 
Aside from statistical considerations, sample size will also be determined by 
feasibility and financial restrictions. It may be that that the power 
calculation requires 100,000 participants, but a trial of this size would be 
logistically difficult to manage (probably resulting in relatively poor quality 
data collection) but also difficult to fund. 
3.2.3.4 Confounding 
Confounding exists where there is an alternative factor associated with the 
outcome which is also associated with the exposure. Confounding is a 
particular problem in non5randomised clinical trials. Whilst it may be 
possible to overcome confounding to some extent by measuring all known 
factors associated with the outcome, there will be factors which are not 
known that may influence the outcome. It is possible to partially correct for 
confounding at the design stage (for example, by stratification) and at the 
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analysis stage by adjusting for confounding variables but only if the 
responsible variables have been measured. 
Restriction can help to reduce confounding; for example, if smoking was 
thought to be a confounding factor in a study, then recruitment could be 
limited to non5smokers; however this strategy reduces the generalisability 
of any findings to a non5smoking population. Alternatively, matching can 
be employed (in case5control studies), such that cases and controls are 
matched according to known confounding factors. The disadvantage of this 
approach is that not all confounding factors may be known, so there may 
be residual imbalance. 
The best method of reducing confounding is randomisation. By randomly 
allocating trial participants into control or intervention groups, any 
confounding factors should be equally distributed between groups and 
imbalance reduced. It is then possible to compare the baseline 
characteristics of the groups, in this trial derived from the screening 
questionnaire, in order to crudely assess if randomisation has been 
successful (see 3.2.3.1). 
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Give the problems of non5randomised designs in the form of confounding 
and bias, a randomised control trial design was chosen as the most 
appropriate method of comparing the intervention with routine practice349. 
This design is particularly strong in its ability to examine benefits and 
hazards of a specific intervention while avoiding allocation bias that may be 
seen in non5randomised controlled studies335. Within randomised designs, 
there are two main options – individual or cluster randomised design. 
Cluster randomised trials are particularly suited to assessing complex 
interventions, which result in organisational5level changes. According to the 
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Medical Research Council (MRC)368, a cluster randomised trial is 
appropriate when: 
• the intervention to be studied is itself delivered to and affects 
groups of people rather than individuals 
• the intervention is targeted at health professionals with the aim of 
studying its impact on patient outcomes 
• the intervention is given to individuals but might affect others within 
that cluster 
• if the intervention involves supplying equipment or staff to an 
administrative unit, then by randomising these units rather than 
individuals only a subset of the units would receive the equipment 
or staff. 
It might have been possible to randomise different practices to either 
intervention or control, thus satisfying the first of these criteria. However, 
the disadvantage of this approach is that different practices may cater for 
different populations, in terms of socio5economic status, age distribution 
and other confounding factors which could lead to group imbalance and 
bias. This can be overcome to some extent by matching practices for 
confounding variables, but matching has limitations (section 3.2.3.4). The 
second and fourth of the MRC criteria do not apply to this trial but the third 
option deserves consideration. Whilst contamination may not take in the 
sense that individuals can only attend the day hospital ‘by invitation’, it is 
possible that increased awareness of falls risk factors in the intervention 
group may be transferred to controls (who with a conventional RCT may be 
living in the same street or even same house as a participant in the 
intervention arm). Against employing a cluster design is the loss of power 
and so need to increase sample size, leading to increased cost and 
complexity. Torgerson369 recommends that an individual randomised design 
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is used unless there are very strong reasons why a cluster design should 
be employed. Noting the arguments above, it was decided to use an 
individual randomised design for this trial. 
Finally, the collection of numerical data in a randomised controlled trial 
allows the results to be more easily combined with other studies. This is 
especially useful for systematic reviews and meta5analyses, which combine 
the results of a series of smaller studies. For valid information to be 
obtained then certain methodologies, or design considerations, have to be 
followed, described in the CONSORT guidelines370, reflected in the reporting 
of the RCT in this study. 
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GP practices that were registered with the Trent Focus for Primary Care 
Research, Collaborative Research Network (CRN), were approached by the 
researchers (DK, SC). The CRN has a Research Practices Board which 
assesses studies on behalf of the member practices. This study was 
submitted to the board and approved in June 2004. The CRN then 
advertised the project to member practices, who then indicated their 
interest in taking part in the study. The CRN Practices expressing an 
interest were visited by the study nurse to explain the study, ensure that 
they would be able to identify the potential participants and answer any 
queries about the study protocol.  These practices were asked to identify 
men and women, 70 years or older registered with their practice. From this 
list, those known to be suffering from a terminal illness were excluded 
using the general practice register or by consulting the general 
practitioners themselves. These individuals are usually well known to the 
practices, but it is not possible to be sure that some were not included in 
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the invitation list drawn up. Similarly, those known to live in a care home 
(nursing or residential) were also excluded. 
Recruitment of general practices was staggered over 12 months so as to 
allow a gradual increase in the number of participants at each day hospital. 
The practices were also contacted towards the end of the study and access 
to participants records requested to ascertain the outcome data. 
Participating practises were paid a small fee to reimburse staff for their 
assistance with the study. 
Only one CRN practice was registered in the Derby area and declined to 
participate in this trial. In order to overcome this barrier, the principal 
investigator at Derby (Dr J Youde) wrote to all practices within the Central 
Derby PCT, inviting them to participate. Two practices were enrolled 
following this invitation and were included in the trial in the same way as 
the CRN practices. 
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Originally, five day hospitals agreed to participate in this study: 
• Sherwood Day Hospital, Nottingham City Hospital 
• Gibson Day Hospital, Nottingham 
• Leengate Day Hospital, Queen’s Medical Centre 
• Derbyshire Royal Infirmary Day Hospital 
• Lincoln County Hospital. 
However, two day hospitals closed prior to the study start date (Gibson and 
Lincoln) due to local service restructuring so had to withdraw. 
Each of the participating day hospitals were briefed by the project manager 
and study nurse on the study and their level of involvement. Regular 
contact was maintained to ensure that the referral processes from the 
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study to the day hospital ran smoothly. Each of the day hospitals agreed to 
help with an observational audit (see 3.12), which was carried out to 
assess the features of the falls prevention programmes delivered in each of 
the day hospitals. 
 0	

Detailed information on the inclusion and exclusion criteria are given in 
section 2.6.3, but are briefly summarised here. Individuals were eligible to 
participate if they were: 
• aged 70 or over 
• registered on the practice list of one of the participating general 
practices 
• scored 2 or more on the screening questionnaire (previous fall or 
two or more other risk factors). 
The exclusion criteria were: 
• patients already attending one of the day hospitals 
• patients under follow up with an existing primary care based falls 
prevention scheme 
• residents in nursing or residential homes 
• patients with terminal illnesses 
• those unwilling or unable to travel to the day hospital, using 
transport as provided 
• patients unwilling or unable to provide fully informed consent 
Individuals who preferred not to participate in the randomised trial were 
offered the possibility of completing monthly diaries only as part of the 
screening cohort (2.5). 
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3.4.3.1 Recruitment interviews 
Recruitment of individuals was carried out by three researchers (SC, RT, 
JE). The general practices were provided with recruitment packs, 
containing a letter of introduction (signed by one of the general 
practitioners at each practice), a screening questionnaire, a patient 
information leaflet and a reply5paid envelope. Each pack was in a sealed 
envelope and the addresses of potential participants were affixed by the 
practice staff, who then arranged for the invitation to be posted. 
On receipt of a completed questionnaire indicating that the individual was 
willing to participate further in the study, one of the three researchers 
responsible for recruitment made telephone contact with the potential 
participant. The telephone conversations followed a standardised format. If 
the individual was willing to participate, verbal consent was obtained over 
the telephone. On a few occasions, a home visit was required to recruit 
individuals (for example, where hearing or vision was an issue). 
Day hospital and primary care falls prevention service records were 
checked to ensure that the potential participant was not currently attending 
the service or under active follow up (exclusion criteria). Active follow up in 
this context was defined as regular visits with either of the services, or on5
going telephone contact between the service and the participant. 
A consent form was then mailed to the individual, who was asked to sign 
and return the form. On receipt of the consent form, those participating in 
the RCT were then randomised to either usual care or the day hospital falls 
prevention programme (see section 3.9 for details). A letter of confirmation 
was sent out to the participant (both groups) along with their first monthly 
diary and a generic falls prevention information pack (Slip, trips and broken 
hips, Department of Health, now out of print). 
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3.4.3.1.1 Cognitive impairment and capacity 
The issue of cognitive impairment in the context of this study is important 
for two main reasons. Firstly, cognitive impairment is a strong predictor of 
future falls (section 1.3.8). Secondly, cognitive impairment raises the issue 
of capacity to consent. 
It is possible to measure cognitive impairment without a face5to5face 
interview; a telephone assessment of cognitive function371 was used in the 
Heart Protection Study as a proxy marker of cognitive impairment372. 
Unfortunately there were insufficient resources in this trial to be able to 
measure cognitive function in all trial participants. However, most 
participants attending the day hospital underwent a mini5mental state 
examination and, assuming there was no failure of randomisation, it is 
reasonable to extrapolate the findings from this arm of the study to the 
controls and hence describe the cognitive function of the trial population. 
The problem with this approach is that individuals with significant cognitive 
impairment may not actually get to the day hospital (because they forgot 
the appointment for example) and so the MMSE score of those attending 
the day hospital may not truly reflect that of the day hospital cohort. 
On a more pragmatic note, the recruitment process for the trial excluded 
individuals with major cognitive impairment, as potential participants 
needed to be able to read, complete and return the screening questionnaire 
as well as give verbal consent over the telephone. This means that the trial 
results will not be generalisable to individuals with significant cognitive 
impairment. 
Aside from measuring cognitive impairment as a possible risk factor for 
falls, it can also be argued that some measure of cognitive impairment 
should be undertaken in order to ascertain the individuals’ capacity to give 
consent to participate in the trial. However, cognitive impairment does not 
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correlate well with capacity to give consent373. People with no cognitive 
impairment may lack the capacity to participate in a clinical trial, whereas 
some people with mild5moderate cognitive impairment may have capacity 
to participate. Capacity requires that an individual can understand, retain 
and manipulate the information being presented to them374. The trial 
recruitment process catered for these requirements, through a step5wise 
consent process – understanding the initial invitation, completing the 
screening questionnaire, telephone discussion about the trial and then a 
final opportunity to reflect before signing and returning the consent form. 
Given the degree of active involvement the intervention arm of the trial 
required, it was felt to be inappropriate to use assent to participate when 
individuals themselves did not have capacity to give consent. 
3.4.3.1.2 Discussing risk 
A potential problem with screening is that individuals are appraised of their 
potential risk of an event, which they had not previously considered. It is 
important that the issue of risk is handled sensitively, so as not to 
engender excessive fear or anxiety, and using language which is easily 
understandable to communicate what can be difficult concepts375. Methods 
used to introduce the concept of risk in this study include the provision of 
the patient information leaflet at the outset, which discusses the risk of 
falling and the telephone contact made on receipt of the completed 
questionnaire. The recruitment discussion handled the concept of risk of 
falling in a matter of fact manner, rather than giving an impression of 
imminent danger. For example, ‘according to the questionnaire that you 
completed, we think that you might be at risk of falling in the future. Do 
you worry about falling… ?’ In fact, many of the individuals contacted were 
already aware of their risk of falling from anecdotal information from their 
friends or relatives. 
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Evidence that came to light during the lifetime of the trial suggested that 
talking to older people about the risk of falling and the dangers of falling is 
not very helpful and tends to dissuade rather than encourage participation 
in falls prevention programmes218. Rather, a more positive approach is 
suggested218, emphasising the benefits of exercise on general health and 
well5being, avoiding a focus on falls 	; we adjusted our recruitment 
interviews accordingly. 
Individuals asking advice about reducing their risk of falling during the 
recruitment discussions were given simple guidance, for example about 
maintaining activity, increasing awareness of home hazards and in the first 
instance contacting their general practitioner of they were concerned about 
their health or medication. They were referred to the falls prevention leaflet 
and for those with internet access, to the study website (now closed). 
There was no attempt to quantify the level of risk for a given individual 
beyond high or low risk. There is no equivalent of the Framingham tables 
for coronary heart disease that can generalise risk of falling for an 
individual. In any event, epidemiological data has limited relevance for a 
given individual, but describes a population and ascribes a risk or likelihood 
of an outcome given certain risk factors. Accepted descriptors of risk were 
not though to be useful in this study, given the high background 
prevalence of falls (Table 3.2). 
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Verbal Frequency Probability 
Very common Over 10% More than 1 in 10 
Common 1510% 1 in 100 to 1 in 10 
Uncommon 0.151% 1 in 1000 to 1 in 100 
Rare 0.0150.1% 1 in 10000 to 1 in 1000 
Very rare Less than 0.01% Less than 1 in 10000 
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For the purposes of this study, it was felt reasonable to leave the 
discussion of risk as stated above. Support for participants was provided 
through ready telephone contact with the study nurse (all participants were 
provided with contact numbers) and access to a website 
(http://www.fallsprevention.org – now defunct). 
 0		

Aside from monthly postal reminders, telephone contact was maintained 
with the participants every three months. Additionally, a quarterly study 
newsletter was dispatched with the diaries and a study website was 
maintained, with the aim of keeping participants interested in the study 
and maximising retention377. Participants were regularly thanked for their 
on5going involvement in the study, when contacted by members of the 
study team and those that were interested will be sent copies of major 
reports resulting from the trial. 
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Randomised controlled trials require that the interventions under 
evaluation are un5ambiguous, well defined and amenable to measurement. 
The individual components of the multifactorial intervention delivered in 
isolation (medical review, strength and balance training and a home 
hazards assessment) are detailed below. 
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The medical assessment included a clinical history (including medications); 
a full physical examination including visual acuity and orthostatic blood 
pressure measurement; laboratory tests where indicated; 125lead ECG and 
where appropriate a neurovascular assessment (carotid sinus massage and 
tilt tests). Treatments varied according to the medical diagnoses made and 
included a medication review, appropriate referral to an optician or 
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ophthalmologist for visual impairment and referral to other specialists 
where necessary. 
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The physiotherapy intervention included an assessment of gait, balance, 
mobility and muscle strength. The original intention was to use the Tinetti 
method206 and measurement of ankle dorsiflexion strength378 as standard, 
but as the different day hospitals had slightly different policies and 
practice, this was not possible. Interventions included gait re5education 
and functional training programme using the principles of Koch379, and a 
muscle strengthening exercise programme based on a modified Dunedin 
protocol32, and where indicated the provision of an appropriate walking aid. 
Again, local policies and practice varied in the specific interventions 
delivered. Feet and footwear were assessed for abnormalities that could 
impair gait and appropriate referrals to a chiropodist or an orthotist were 
made when necessary. The number and timings of follow up visits at the 
day hospital for further assessment and therapy varied according to the 
individualised needs of the participants. 
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The occupational therapy intervention included an interview with the 
participant using a standardised checklist to investigate home hazards380. 
Where necessary, a home visit was also performed. The aim of a home 
visit was to identify any potential hazards that may increase the risk of 
falling, such as poor fitting carpets, poor lighting and access problems. Any 
interventions necessary were recommended and arranged if the participant 
gave permission. 
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The control group received usual care. Despite increased awareness of the 
importance of preventing falls and the interventions available, there was 
relatively little preventative work being carried out at the time the study 
started. People at risk of falls but who had not presented to the health 
service because of a fall related issue, receive little, if any intervention. 
Accordingly, the usual care group did not receive a specific intervention, 
reflecting usual practice. If they came into contact with a falls prevention 
service during the course of the study, this was considered usual practice 
and did not constitute a breach of protocol. This reflects current practice 
throughout most of the United Kingdom2 10 and so adds to the 
generalisability of the trial. 
Individuals in the usual care group received the same patient information 
leaflet and falls prevention leaflet as the intervention group, and were 
asked to complete the diaries on the same monthly basis. No additional 
treatment was offered. 
 43;&/!	!$,4#!,	
Randomised controlled trials demand that the interventions evaluated are 
amenable to measurement and that outcome measures are, where 
possible, standardised, relevant, reliable, valid and sensitive381. Using 
established standardised measures with well defined and comprehensive 
instructions reduces ambiguity and improves consistency382. The use of 
standardised measures will: 
• provide a trial with meaningful results 
• allow them to be communicated more easily 
• allow them to be compared with other trials 
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• allow them to be used in subsequent studies such as meta5analysis 
and systematic reviews. 
Many conventional trials use mortality as the primary outcome measure. 
However, for falls studies, mortality is not the most important outcome. 
Frail older people have limited life expectancy and may die during the 
study, often for reasons unrelated to falls; cardiovascular disease, cancers 
and other important causes of mortality are common in old age. This is 
increasingly being seen in cancer trials as survival improves, there is a 
move away from using mortality as an endpoint, towards using 
intermediate outcomes, such as disease free survival383. 
No single trial can feasibly aim to address the common causes of mortality 
in older people, in contrast to studies involving younger people, where 
there is usually only a single pathology. However, it is clearly important to 
be sure that the intervention in question does not increase mortality, and 
so death is included as a secondary outcome. It is good practice to analyse 
function and mortality, because no intervention would be judged useful if it 
prevented disability but, at the same time, reduced survival384. 
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In an adequately sized trial with effective randomisation, any differences in 
baseline characteristics and possible prognostic factors between the control 
and intervention groups will arise by chance alone. However, it is important 
that there is some record of the baseline characteristics of the trial 
participants to be able to compare the two groups at outset in case of any 
major discrepancies. Baseline characteristics available for all trial 
participants include the following: 
• age/date of birth 
• gender 
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• responses from the screening questionnaire 
• fall in the previous twelve months 
• taking more than four prescribed medications 
• previous stroke 
• Parkinson’s disease 
• inability to stand from a chair without using arms to push up 
(muscle weakness) 
• symptoms of dizziness on standing 
• use of a mobility aid 
• housebound (mobility impairment). 
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Previous primary care based falls studies report falls related outcomes over 
a period of one year9 30 31 34536 224. One year is an appropriate time, as it 
allows time for the intervention to take effect. Broadly, people who fall can 
be divided into two categories; first, recurrent fallers who will have many 
falls over a short period of follow up; second, people who have occasional 
falls, possibly less than once per year. The intervention needs to show an 
impact upon both groups of fallers if it is to be successful and subsequently 
employed in a primary care based prevention strategy. 
Falls rate is a fundamental outcome 5 each fall accumulates risk for 
fracture, admission, loss of confidence and other adverse outcomes. Using 
the rate of falls as the outcome measure introduces the element of time, 
allowing the best use of the data collected (see section 3.14.3); as the 
population being studied is relatively frail and older, it is likely that 
significant numbers of participants will drop out over time – typically 20% 
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in trials on similar populations385 386. This may be due to a variety of 
reasons, including death, move to a care home (study end5points), ill5
health or because they simply do not want to participate any further. This 
is especially likely in the day hospital intervention group, who may find the 
travel to the day hospital tiresome. By using the rate of falls, we are able 
to capture outcomes over the period of an individual’s participation in the 
study. 
Ideally, falls caused by syncopal episodes should also be considered 
separately384. However, without key witness informants to verify the nature 
of the fall, it is difficult to ascertain if a fall involved a loss of 
consciousness. Syncopal falls are frequently associated with amnesia, 
either antegrade or retrograde, such that the informant may not reliably 
recall the true nature of the fall387. Rather than introduce yet more 
reporting error, all falls were considered conjointly, irrespective of the 
aetiology. Published studies record the rate of syncopal falls in community 
dwelling individuals as 3%388 389, but these figures may well be an 
underestimate of the true rate of syncopal falls because of associated 
amnesia. 
By contrast, it was possible to ascertain falls associated with major injury 
and attendance at primary or secondary care services through examining 
health service records. This enabled discrete analysis of injurious and non5
injurious falls. 
The definition of a fall used in this study was the most commonly used 
definition, identified in a recent Cochrane review9 of falls interventions 5 
'unintentionally coming to rest on the ground, floor or other lower level; 
excludes coming to rest against furniture, wall, or other structure'. 
This clarifies that falls due to syncope are to be included as a primary 
outcome measure. The actual definition given to study participants was: 
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For this trial, the most appropriate primary outcome was deemed to be a 
reduction in the rate of falls. It can be argued that falls are only a 
surrogate for more robust outcome measures, such as fractures. But falls 
represent more than just a risk of fracture for older people. Falls can be 
viewed as a syndrome, which encompasses many domains: frailty, multiple 
comorbidities, fractures, fear of falling and functional decline. The 
secondary outcomes used in this trial are designed to capture some of 
these elements. 
3.6.3.1 Medically validated versus self reported falls 
We examined primary and secondary care records for all participants in the 
RCT searching for falls related consultations and medically validated falls. 
3.6.3.2 Proportion of people with single or recurrent falls 
There are advantages to using multiple falls instead of any fall as an 
endpoint. Isolated falls are more likely to be random, ‘one5off’ events, 
whereas recurrent falls are usually associated with underlying neurological 
or musculoskeletal problems and are a stronger predictor of negative 
health outcomes30 295 390. We analysed both arms of the trial looking for 
differences in single versus recurrent (two or more) falls. 
3.6.3.3 Fall5related injuries 
Falls related injuries clarify the consequences of the fall and are useful 
comparators. Falls associated with major injuries were analysed separately 
from non5injurious falls. 
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In order to standardise reporting of injuries in such a way as to ensure 
external comparability, the Severity of Injury Scale391 was used to code 
injuries. This is a relatively simple, internationally recognised injury 
severity score, detailed below: 
• no injury 
• minor (abrasion, contusion) 
• moderate to serious (laceration, tissue tear, haematoma, impaired 
mobility due to injury, fear of subsequent fall and fall injury) 
• serious (fracture, multiple fracture, subdural haematoma, head 
injury). 
3.6.3.4 Time to first fall 
At best falls prevention programmes can be expected to reduce falls rates 
by up to one5third, they do not abolish falls completely. However, they 
may delay the time to the next fall, which may in turn be beneficial to 
patients. Time to first fall was a pre5specified secondary outcome, as 
recommended by the ProFANE task force392; time to second fall was also 
calculated as a 
 analysis. 
When carrying out a survival analysis for time to first fall, censoring should 
consider individuals who do not complete the full follow up period of the 
study. Individuals may fail to complete the full period of follow up for four 
possible reasons: 
• death directly related to a fall 
• death from non5falls related disease 
• migration (out of the study) 
• they join the study too late to complete the full follow up period (not 
applicable in this study). 
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Accordingly only including the period under follow up is important so as not 
to bias the results of the survival analysis. 
3.6.3.5 Mortality 
In many cases, mortality and the primary outcome are correlated or 
‘censoring from mortality’ is informative. This is the case with falls, which 
are associated with a significant 2.65fold increase in mortality rate131. 
Mortality was checked against primary and secondary care records. 
3.6.3.6 Disability or activity limitation 
A measure of functional ability is essential in any trial involving older 
people, as function is a key determinant of quality of life and a useful 
comparator across studies384. The standard measures of disability included 
in this trial are the Barthel index of activities of daily living and the 
Nottingham Extended Activities of Daily Living (NEADL) scale. Both the 
Barthel index and NEADL are well validated measures of functional abilities 
and can be used as postal questionnaires185. The two measures are 
complementary; the Barthel index is a 10 item scale which assesses basic 
function, such as mobility, personal care and continence, with scores 
ranging from 0 (dependant) to 20 (independent). The NEADL assess higher 
function; it comprises 22 activities of daily living self5report items, divided 
into four domains: mobility (six activities), kitchen (five activities), 
domestic (five activities) and leisure (six activities), with scores ranging 
from 0 (dependant) to 66 (independent). 
3.6.3.7 Fear of falling 
Several scales are available for measuring fear of falling, but two that have 
been validated in the United Kingdom include the Falls Efficacy Scale (FES5
UK) and the Activities5specific Balance Confidence scale (ABC5UK). Previous 
studies suggest that the FES had the better postal completion rate (94% 
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versus 86%), and both scales are able to detect differences in falls related 
quality of life measures when compared to non5falling controls393. The FES 
has been validated in the UK as both a face to face and self5completed 
questionnaire. On a more practical note, the FES is more widely used in the 
local services and so staff involved in the trial would be more familiar with 
this measure should the study participants have any queries about the 
scale. The FES consists of ten items with each item being scored from 1 
(most confident) to 10 (least confident). 
3.6.3.8 Quality of life 
Quality of life measures are important for two main reasons. Firstly, they 
acknowledge the impact of falls upon quality of life and secondly, they 
facilitate measurement of cost5utility. The measure used to determine 
quality of life for this study was the EuroQoL55D, which is well validated 
and a useful cross study comparator. The EuroQoL contains five items 
(mobility, self care, participation, pain and mood), each scored from 1 (no 
problems) to 3 (extreme problems). It is a key determinant in the 
economic outcome analyses. The York A1 Tariff scoring algorithm was used 
to convert EuroQoL scores into a utility score394, which is used for economic 
analyses (not discussed here). 
3.6.3.9 Institutionalisation, use of services and cost analysis 
The self5reported institutionalisation data (change of residency – move to a 
care home or sheltered accommodation) were corroborated though 
reference to primary care records. Health service utilisation was collected 
in a similar manner, from both primary and secondary care records. 
Participants also returned monthly information on any assistance that they 
required: 
• help with ADLs (carer, relative, paid/unpaid) 
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• meals delivered (funding) 
• equipment purchased because of falls (e.g. mobility aid) 
• any home adaptations made because of falls and costs. 
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Postal questionnaires were used to collect the outcome data. Postal 
questionnaires have several advantages over face to face assessment324: 
• they reduce the chance of observer bias (misclassification) – a face 
to face interviewer may be aware of the allocation of the individual 
in this single–blind trial and so may record outcomes differentially 
• they are practical to use for large trials 
• they are relatively inexpensive 
• they are relatively unobtrusive for the participant (as compared to 
arranging a follow up interview with an observer). 
However, there is a possibility that some participants are unable to 
complete the questionnaire due to physical limitations, eyesight or inability 
to read English. Participants who were unable to complete and return the 
questionnaires were offered the help of the study nurse who would visit 
them at home. Participants who were sent a questionnaire but who did not 
return it were contacted by the study nurse and offered a second posting 
or a visit at home. When questionnaires were returned with questions 
missing or ambiguous answers given, the independent assessor contacted 
the participant by telephone and asked about individual questions. These 
steps should have prevented recall bias arising from higher response rates 
in those given active treatment, if post alone was used324. 
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3.6.4.1 Primary outcome measure: falls 
Obtaining high5quality reports of falls is resource intensive. Older persons 
may forget falls, and fall ascertainment based on long5term recall is 
incomplete. Cummings 26 followed up 325 community dwelling men 
and women over one year using weekly falls diaries. At one year, 13% of 
participants were unable to recall incident falls and a further 7% recalled 
falls that were not otherwise corroborated. Failure to recall falls was 
associated with a statistically, but not clinically significant one5point 
reduction in the Mini5Mental State Examination. However, there is no 
better method of recording falls available at the present time. 
Most major falls studies have used follow up diaries, supplemented by 
telephone contacts. For community5dwelling older persons, the gold 
standard for tracking falls requires asking participants to mail a follow up 
card weekly or monthly, soliciting non5responders, and characterising each 
event by directly visiting the participants26 395. In this study, it would not 
have been possible to characterise each event through a direct visit. With 
nearly 400 trial participants and with an expected rate of falls of 2/year per 
person36, we could have anticipated around 800 events that would have 
required corroboration. Given the wide geographical spread of participants 
(Nottinghamshire and Derbyshire) and the limited resources (staff and 
financial), it would have been difficult to verify each event 
contemporaneously. However, the study team maintained regular 
telephone contact with study participants to ensure as well as possible the 
accuracy of any reported events, checking information where diary record 
were unclear. 
For this study, falls were recorded by giving each participant a diary and 
reply paid envelope. Participants were asked to record falls in the diary, 
along with the outcome (saw GP, phoned ambulance, sent to hospital, 
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injuries). The diaries were mailed back to the research team at the end of 
every month. Participants who had not returned the diaries within three 
days of the end of the month were contacted via telephone by the study 
nurse to encourage return of the diaries. Those requiring help to complete 
the diaries were visited at home. Previous falls trials using similar 
methodology obtained a 90% response rate, with 20% of participants 
requiring telephone contact and 10% a visit to help complete the diaries 
(	
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monitored until withdrawal from the study, death, admission to care home 
or the end of 12 months follow up, which ever event occurred first. 
3.6.4.2 Secondary outcome measures 
The principal method was self5reporting using the monthly diary. This 
contained a section on falls and the outcomes (carried on as usual, called 
for help, waited for someone to help, called GP, called ambulance, taken to 
hospital, nature of any injury). Additionally, there was a section for 
recording health service utilisation, covering primary care contacts and 
hospital admissions. 
The self5reported falls outcomes were supplemented by recording falls 
related attendances logged in primary or secondary care records. For 
hospital admissions, the speciality relating to the admission and the length 
of stay were obtained. This level of information allowed a more accurate 
ascertainment of events as well as the costs associated. Information on 
falls5related drug treatment (such as bone protection therapy) was 
obtained from the GP records. These data were collected by the project 
manager (SC) and the study nurse (RT) on standardised forms. 
Fall5related injuries data were collected from the diary information, 
supplemented by telephone interview where appropriate. As above, falls5
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related injuries recorded on primary or secondary care records were also 
collated. 
Disability and quality of life were self reported by study participants using 
postal questionnaires at one year. They were contained within the end of 
study booklet. Where participants’ responses were unclear, the study nurse 
contacted the individual by telephone or personal visit to corroborate the 
data. 
Institutionalisation data were available from practice registers when not 
available directly from participants. Those who changed practice as a result 
of changing address were traced through the primary care trusts. 
Mortality was ascertained from primary care records and cross5referenced 
against hospital records. 
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Previous falls prevention studies had a baseline falls rate of 1/year to 
3/year per participant9 30536. A systematic review of falls interventions8 
identified 22 studies which reported falls outcomes using proportions with 
one or more falls, and 27 studies which reported rates of falling. In many 
of the papers reported there seems to be inconsistency between the 
analysis and sample size calculation. For example, the PROFET study36 was 
powered to detect a reduction in fall rate from 2/year to 1.4 per year, with 
a sample size of 352; however the analysis was a logistic regression of at 
least one fall. A paper by Robertson31 used proportions for sample size 
calculations, but negative binomial models for analysis of falls rates. 
In the absence of any clear, definitive guidance we powered the study for a 
reduction in rates of falling. After we had agreed this approach, the 
Prevention of Falls Network Europe published their paper on reporting falls, 
suggesting fall data should be summarised as the number of falls, number 
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of fallers/non5fallers/frequent fallers, fall rate per person5year, and time to 
first fall392. 
The appropriate analysis for rates is Poisson regression analysis, but falls 
rates typically display ‘over5dispersion’.  Over5dispersion occurs when the 
variance is greater than the mean; Poisson analysis is inappropriate in this 
case (as Poisson analysis assumes that the variance is equal to the mean). 
When this is the case, the most appropriate analysis is negative binomial 
regression; this has been suggested as the analysis of choice for falls 
rates396. 
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With an expected rate of falls of 2/year per person36, and an over5
dispersion parameter of 1.5, a clinically important risk reduction of 24% to 
1.5 falls/year can be detected with 80% power and 5% significance (two5
sided) in a trial of 160 participants in each arm, giving a trial size of 320. 
This assumes a Poisson distribution with over dispersion. If the fall rate 
was 1/year per person31, a risk reduction of 33% could be detected with 
this sample size. This sample size calculation was based on the expected 
outcome from the trial based on previous similar interventions12 226. 
This sample size also had 80% power at the 5% significance level to detect 
a reduction of one third in the proportion of people with one or more falls, 
with an expected proportion with one or more falls of 50% at 12 months. 
Allowing for an attrition rate of 20% we planned to recruit a total of 400 
participants. To achieve this, we estimated 3125 subjects needed to be 
screened, of whom 40% might have been at high risk of falls. Of these 
1250, we estimated 20% were likely to be ineligible leaving 1000 potential 
participants of whom it was thought 40% would agree to take part (see 
Figure 3.1). 
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The most appropriate power calculation asks ‘what is the minimum 
clinically significant difference that we want to be able to detect?’ Having 
opted for a 24% risk reduction, this trial was at risk of missing a risk 
reduction less than 24% because of a type II error. For example, we could 
have missed a 15% risk reduction, which would have remained clinically 
significant. A selection of sample size calculations are shown below; these 
do not account for the over5dispersion parameter, so are not precise, but 
do give an indication of the order of magnitude that the sample size would 
need to be in various scenarios.
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Estimated rate in 
control group (falls 
per person5year) 
Estimated rate in 
intervention group (falls 
per person5year) 
Incidence 
rate ratio 
N per 
group 
Total N 
2 1.8 0.9 745 1490 
2 1.53 0.85 322 644 
2 1.224 0.8 176 353 
2 0.918 0.75 110 220 
1.8 1.62 0.9 828 1655 
1.8 1.53 0.85 358 716 
1.8 1.44 0.8 196 392 
1.8 1.35 0.75 122 244 
1.6 1.44 0.9 931 1862 
1.6 1.36 0.85 403 806 
1.6 1.28 0.8 220 440 
1.6 1.2 0.75 137 274 
 
The shaded lines in Table 3.3 indicate the effect size that could be missed 
with a sample size of 320 at various baseline falls rates. A 10520% effect 
size could have been missed as a result of a type II error. 
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The prospective study design is shown in Figure 3.1.
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N=1250 
Excluded or decline (some 
baseline data available) 
N = 600 
Eligible 
Telephone call 
Consent posted 
with baseline data 
collection 
Stratification by 
centre. N = 400 
Control 
N = 200 
Intervention 
N = 200 
Follow up data, n = 360 
Monthly falls diaries 
1 year follow up data – QoL, ADLs, 
service utilisation 
20% 
ineligible 
(Estimate) 
40% accept 
Screening 
questionnaire 
N= 3125 
40% at high risk of falls Follow up monthly (brief diary & end of 
study booklet) for ‘low risk’ or excluded 
who have returned the questionnaire 
20% drop 
out rate 
Low risk; agree to enter 
screening cohort 
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Stratification was used in this trial to facilitate balanced groups of 
participants. Participants were stratified by centre (Nottingham versus 
Derby) only. The block size was of a random size to maximise allocation 
concealment. The randomised list was produced by the study statistician 
(CC) and Trent Institute for Health Services Research; none of the other 
members of the study group had access to the randomisation list. Initially, 
randomisation was carried out by telephone, and then moved to a web 
based system (maintained by the Nottingham Clinical Trials Support Unit – 
CTSU), using the same schedule. 
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As discussed in section 3.2.3.2, it was not possible to blind participants to 
their allocation group, nor the day hospital staff, due to the nature of the 
intervention. It may have been possible to confer some degree of blinding 
in this trial by randomising one group to the evidence based intervention 
(strength and balance training, home hazards assessment and medical 
review), and the other group to a sham treatment delivered in the day 
hospital which did not contain these ‘ingredients’. However the ethics of 
offering such a control are unclear. All analysis was carried out by blinded 
assessors. 
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Ethical Approval was sought and granted by Nottingham 2 Ethics 
Committee (reference 04/Q2404/93). The principles of research 
governance were followed397. Under the then new research governance 
framework, all studies required a formal sponsor. Nottingham City Hospital 
agreed to sponsor this study, in collaboration with other participating 
centres. A study agreement was prepared by the research and 
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development department at Nottingham City Hospital, detailing shared 
governance and indemnity arrangements between the main study centres. 
In order to comply with research governance guidance, participants were 
first contacted by their general practitioner with a letter inviting them to 
complete the screening questionnaire and return to the investigators if they 
were interested in participating in the study. The invitation pack included 
the screening questionnaire and a patient information leaflet. It was made 
clear in the documentation that by returning the screening questionnaire, 
the participants were under no obligation to take part in the study. 
The process for obtaining informed consent is described in section 3.4.3. All 
participants were provided with the contact details and information about 
the study. It was explained that they were free to withdraw from the study 
at anytime without giving a reason and that their normal medical care 
would not be affected. Participants were also reassured that all information 
would be treated as confidential and stored securely.  
All information obtained from participants was coded with a subject number 
to ensure confidentiality. Identifiable personal details and consent forms 
were kept in a locked filing cabinet.  All computer records and data sets 
were password protected. 
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The growth in prospective registration of randomised controlled trials has 
accentuated the need to distinguish between different trials. Trials are 
usually referred to by a series of grant numbers, protocol numbers, trial 
names and acronyms which can make it difficult to determine whether 
reports, publications or entries in trial registers refer to the same trial or 
not. To provide an accurate reflection of the research activity in a particular 
area it is important that each trial is counted only once and that 
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unintended duplication between registers is avoided. The International 
Standard Randomised Control Number (ISRCTN) is a randomly generated, 
85digit number, prefixed by the code ISRCTN that uniquely identifies each 
trial in the ISRCTN Register. 
The ISRCTN should be quoted in all publications relating to the trial, in 
order to: 
• clearly identify the trial and prevent mistaken identity  
• help to detect duplication in current registers of trials, and to avoid 
trial double5counting when assessing a field of research activity  
• enable tracking of the trial from inception to completion, and 
beyond. 
The ISRCTN for this trial, registered with controlled5trials.com 
(http://www.controlled5trials.com/isrctn/) is ISRCTN46584556. 
The trial protocol was submitted to Trials, an on5line journal 
(http://www.trialsjournal.com/content/7/1/5), in January 2006, prior to 
any of the analyses being performed. This was done to avoid the possibility 
of retrospective data analysis, i.e. searching for significant outcomes once 
initial analysis had been undertaken (‘fishing expeditions’). 
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A variety of processes were employed to monitor the interventions 
delivered to participants attending the day hospital, discussed below. 
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Behavioural mapping is a technique for observing and describing 
'environmental influences upon behaviour'398. Behavioural mapping is 
suitable for the observation of the physiotherapy and occupational therapy 
activity since the use of a carefully designed chart is 'quick and easy'398. 
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This technique has been used in a number of studies on stroke 
rehabilitation3995401 to determine the amount of time spent in therapy and 
in other tasks. The results of these studies showed that potentially more 
time could be spent in therapeutic activities399. In an observational study of 
15 stroke patients402, only 13% of the working day was spent in therapy. 
In the comparison of stroke patient's' time use in an intensive rehabilitation 
unit between a Swiss and Belgian setting400 it was found that 45% and 
28% of the day were spent in therapy in Switzerland and Belgium 
respectively. 
A single observer (Ruth Creamer, 4th year medical student, dissertation 
project) carried out a behavioural mapping exercise in one of the day 
hospitals for this study. 
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The number of day hospital visits was obtained by a count of ‘day hospital 
logs’ which were completed for each attendance, by the day hospital staff. 
The logs asked about the amount of input according to discipline, and was 
only available for those in the intervention group (see 4.3). 
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An Access database with password protection was used to store all data. 
For the purposes of analysis, data were transferred to Intercooled Stata 
version 9 using Stat Transfer (2001). Original documentation was stored in 
locked filing cabinets, with identifying information being stored separately. 
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There are two main threats to the integrity of data, random error and 
systematic error403. Certain data checks can help identify such errors. 
Logical checks can identify ‘non5sensical values’ – such as dates of birth in 
the future. Data double entry of a randomly selected proportion of the data 
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can also help to identify errors. Random errors are more difficult to detect, 
but in theory should be evenly distributed between the two arms in a 
randomised trial and therefore not result in bias. However, if the random 
error rate is high, it may reduce the power of the study. 
In order to try and avoid systematic error in data recording, we checked 
random samples of the initial data entry for each person using the 
database. In addition, we carried out audits of random samples of data 
entry. 
Initial data entry accuracy was maximised through the use of the Access 
database. Using ‘forms’ with embedded coding to control the data entry 
reduced the possibility of errors, though miscoding errors were still 
possible. Throughout the database, standard responses were used 
whenever possible. Data accuracy was assessed at different stages 
throughout the project. 
For categorical data, the entries were examined to check that there were 
no implausible values. For continuous variables, range checks were carried 
out for plausibility. Wherever there were discrepancies, data were checked 
against the original records and where these were unclear a consensus was 
attained between two of the study team. Where it was not possible to 
verify data, entries were coded as missing. 
For calculated values, logical checks were performed to assess robustness. 
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Missing values are a problem in randomised controlled trials because the 
sample size can be reduced and if more people drop out from one group 
than the other, bias may be introduced.  There are a variety of accepted 
methods for handling missing data404. 
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Missing values in data are due to different reasons. Participants may not 
have responded because they withdrew consent or they may have died, 
moved away and it may be impossible to trace them or they may be too ill 
at the time of the assessment. Even when questionnaires are returned 
individual items may have been missed. To reduce missing values at the 
study design stage the following actions were taken: 
• the diaries were kept as short as possible and the layout and 
wording were checked for ease of use before the study started by 
day hospital attendees 
• each question was checked for a wide enough range of response 
options 
• assessments were administered by post, but the study nurse was 
available to make telephone contact or visit at home those people 
who needed help 
• the study nurse was available to telephone participants who 
returned the questionnaire with incomplete or inaccurately filled in 
questions 
• copies of the diaries and instructions on completion were stored on 
the study website. 
These measures should have reduced the amount of missing data, but 
some loss is inevitable. As stated previously, Stata handles missing data by 
a process of ‘listwise deletion’ or ‘complete cases only’, that is to say only 
using complete datasets for regression commands. However, this is 
inappropriate for many outcomes as it risks introducing bias. In view of the 
missing data, we carried out Complete Case Analysis and imputed missing 
data. 
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Multiple imputation (MI) was used to estimate values for non5responders at 
each time interval. MI is a Monte Carlo simulation technique where each 
missing data case is replaced by a set of plausible estimates, which are 
drawn from the predictive distribution of the missing data given the 
observed data. In contrast to the more naïve approaches, such as mean 
substitution or last value carried forward, the technique of MI has the 
advantage that it includes a random component to reflect the fact that 
imputed values are estimated rather than treating the imputed values as if 
they are known with certainty405. As such, MI is likely to produce more 
accurate estimates of the standard errors (SE) and variances of the mean 
utility values at each time5point than other methods of imputation. Rubin’s 
rules are used to combine results from multiple imputed datasets to obtain 
the estimates. !		 this was our preferred approach for handling missing 
data because of non5response. 
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Statistical significance was tested at the 5% level; two5sided tests were 
used. Response bias was ascertained by comparing the proportion of 
completed diaries returned in the intervention group to the proportion 
returned in the control group (chi5squared test) and by comparing the 
baseline characteristics of the responders compared to the non5responders. 
All primary and secondary outcomes analyses included stratum as a fixed 
covariate, and the adjusted analyses included all of the baseline variables 
(age, gender and all eight screening items) as fixed covariates, as 
discussed in section 3.2.3.1. 
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3.14.1.1 Assessing population distributions 
Visual inspection of a histogram displaying the data is possibly the best 
method for assessing normality of a distribution. But it is possible to test 
that a population fits the normal distribution using a Shapiro5Wilks test, 
comparing observed observations against those that would be expected if 
the population fitted a normal distribution. Where there is marked 
deviation, then assumptions about the normal distribution are not valid. In 
this case, it may be possible to transform the data; for example if the data 
is positively skewed, a logarithmic transformation may normalise the data 
(by reducing the magnitude of the variance). Many other transformations 
are possible in order to make the data fit a normal distribution (see 
Kirkwood, Medical Statistics, 2nd edition, 13.3). Stata offers a 	 
function which produces a composite pictorial representation of the various 
possible transformations. The gladder function was used to determine the 
‘normality’ of data, supplemented by formal tests, such as the Shapiro5
Wilks test where necessary. 
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Intention to treat analysis is the recommended type of analysis for 
randomised controlled trials335 404 406. Participants were followed up as part 
of the group to which they were first assigned at randomisation, regardless 
of whether the participant continued in the trial, complied with the 
intervention or died. 
Intention to treat analysis guards against any attempts to influence the 
results of the study by excluding aberrant or extreme outcomes. For 
example older, physically impaired people who are more likely to die are 
also more likely to have falls.  If a greater number of people died from one 
group then it may be possible that these people were also the ones who 
found it difficult to attend the day hospital falls prevention programme 
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during the time leading up to their death and this would affect the 
outcomes. Intention to treat analysis addresses this problem by including 
values for all people. The disadvantage of intention to treat analysis is that 
it has the tendency to reduce the treatment effects (as not all individuals in 
the intervention groups will have received the intervention). The converse 
applies – participants randomised to the control arm should be analysed as 
controls, even if they subsequently went on to attend the day hospital, for 
example because they fell and were referred on by their general 
practitioner. This too will tend to reduce the estimate of the treatment 
effect. 
Per5protocol analysis is carried out according to the intervention actually 
received by participants. This is sometimes appropriate, for example in 
drug trials, where it is important to know about adverse affects related to 
the drug being tested. 
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For falls incidence rates Poisson regression was used, or if there was over 
dispersion, then negative binomial regression was preferred, as discussed 
in section 3.7. 
3.14.3.1 Model checking 
Statistical models are useful as they provide estimates of an effect which 
may be generalisable. However for the results of a model to be valid, 
certain assumptions are made about the data. In order to test these 
assumptions, various checks were carried out when using various 
regression models, to ensure that the model assumptions had not been 
violated (Table 3.4).
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Model type Model check Process Expected result 
Influence Cook’s distance (measures the aggregate change in the estimated coefficients when each 
observation is left out of the estimation) 
<(4/n) where n is the number of 
participants407 
Leverage  <(2p/n), where p is the number of 
independent variables  
Goodness of 
fit 
Deviance residuals – a measure of goodness of fit in a generalised linear model 
(approximately normally distributed if the model is correct and may be plotted against the 
fitted values or against a covariate to inspect the model's fit) 
+/5 2 standard deviations407 
Goodness of 
fit 
Pearson’s χ2 goodness of fit test Non5significant value indicates 
reasonable fit 
Collinearity Covariate correlation matrix A large positive or negative 
correlation may indicate collinearity 
Collinearity Add in the square of a continuous variable (age) Likelihood ratio test 
Logistic, 
Poisson 
and 
negative 
binomial 
regression 
Goodness of 
fit 
Pregibon’s beta (dbeta) – similar to Cook’s distance No clear guidance! 0.06 is too 
low408 and 0.2 is high409 
Proportional 
hazards 
 
Kaplan5Meier curves Lines should be parallel and not 
cross 
Proportional 
hazards 
Schoenfeld residuals 5 plot residuals against time Significance test 
Linearity Martingale residuals 5 plot vs. continuous covariates to detect non5linearity Visual inspection 
Goodness of 
fit 
Deviance residuals – plot against id to identify outliers Visual inspection 
Cox’s 
Proportion
al Hazards 
Collinearity Add in the square of a continuous variable (age) Likelihood ratio test 
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The pre5planned secondary analyses comparing treatment arms are 
detailed below. 
3.14.4.1 The proportion of participants with one or more falls 
For the number of participants with one or more fall, odds ratios and 95% 
confidence intervals were estimated using logistic regression, using 
stratum as a fixed covariate and an adjusted analysis using the baseline 
parameters (age, gender, screening risk factors). 
3.14.4.2 Time to first fall 
The time to the first fall was estimated using survival analysis (Kaplan5
Meier curves) and comparisons made between groups using Cox 
proportional hazards regression with stratum as a fixed covariate and an 
adjusted analysis using the baseline parameters (age, gender, screening 
risk factors). 
3.14.4.3 The proportion of people with injurious falls 
For injurious falls, odds ratios and 95% confidence intervals were 
estimated using logistic regression, using stratum as a fixed covariate and 
an adjusted analysis using the baseline parameters (age, gender, screening 
risk factors). 
3.14.4.4 The proportion of people institutionalised at 12 months 
For institutionalisation, odds ratios and 95% confidence intervals were 
estimated using logistic regression, using stratum as a fixed covariate and 
an adjusted analysis using the baseline parameters (age, gender, screening 
risk factors). 
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3.14.4.5 Impact on disability, quality of life, fear of falls, and use of health 
services 
These outcomes are all continuous variables (e.g. disability measured on 
the Barthel scale from 0520) and were described using means (if normally 
distributed) or medians (if not normally distributed). Where assumptions 
for undertaking linear regression were not met, data was transformed and 
analysed using linear regression, or dichotomised at the median and 
analysed using logistic regression. 
3.14.4.6 Falls5related mortality 
For mortality, odds ratios and 95% confidence intervals were estimated 
using logistic regression, using stratum as a fixed covariate and an 
adjusted analysis using the baseline parameters (age, gender, screening 
risk factors). 
3.14.4.7 Pre5specified sub5group analyses 
Subgroup analysis were carried out using age (70–85, 85+) and falls 
history in the last year (0–1, ≥2). The statistical significance of differences 
between subgroups was tested using tests for interaction in the regression 
models. 
Not pre5specified, but nevertheless of interest, a per5protocol analysis and 
a per day hospital analysis was conducted using the same approach.
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3.15.1.1 Error rates in data entry 
A random sample of 10% of screening forms and diaries was double 
entered to check for accuracy. The error rate was 33/7073 (0.47%, 95% 
CI 0.4650.48%),) for baseline data items. For falls diaries the error rate 
was 21/2173 (0.97%, 95% CI 0.9650.98%), and for the functional 
outcomes 12/4900 (0.24%, 95% CI 0.2350.25%),). All errors were 
corrected in the Access database. 
The error rate for falls records was less than 1% 5 which means that any 
difference between the two groups of 1% or less may be due to data entry 
error, but this level of difference is unlikely to be clinically important. 
3.15.1.2 Logical checks 
The randomisation list was obtained from the Clinical Trials Support Unit 
(CTSU), this contained several data items: stratum (Derby=0, 
Nottingham=1), unique identifier (corresponding to Access database 
unique identifier), participants’ initials, randomisation date, person 
requesting randomisation, randomisation number, and allocation (1 or 0). 
364 participants were randomised according to the database, which 
corresponded to the number in the randomisation list when linked in an 
Access query, with no discrepancies. The randomisation list and internal 
database record of allocation were identical. A variety of other cross checks 
were carried out as detailed in appendix 4.4. 
GP and hospital records were checked for evidence of any attendance at a 
Falls Prevention Programme (FPP). An isolated referral to physiotherapy, 
hospital doctor or occupational therapist was not coded as FPP unless 
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explicitly stated as falls prevention therapy and more than one professional 
involved; a referral to the intermediate care team referral was considered 
as a FPP. 
 0
Recruitment into the randomised controlled trial was challenging; the 
original estimates suggested 3125 individuals would need to be screened to 
achieve the desired sample size; in fact, over 6000 individuals were 
screened. Of those not excluded by their general practice, 2846/5312 
(54%) provided some information, with 52% of those responding classified 
as being at high risk of future fall. The overall recruitment rate into the RCT 
was 364/6133 (6%) (Figure 3.2). Of those not excluded during recruitment 
who were at high risk, 364/1481 (25%) agreed to participate in the RCT; 
181 in the control arm and 183 in the intervention arm. One individual in 
the intervention arm was excluded after randomisation, as they were 
subsequently discovered to have attended a day hospital falls prevention 
programme in the year prior to randomisation. 
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*Reasons for exclusion included residence in a care home (2) or recent 
attendance at a falls programme (10). 
≥70 
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 with GP 
6133 
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5312 eligible 
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2466 
 
Baseline data 
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1481 high 
risk 
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risk 
5 unable to 
classify, not 
contactable 
Declined 
RCT 
1105 
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by  
study 
nurse 12* 
 
Declined 
1192 
Screening 
cohort 
168 
RCT 
364 
No further 
involvement 
938 
Agreed to 
screening 
cohort 
167 
Screening 
cohort 
n=335 
 
High risk 
167 
Low risk 
168 
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Participant flow within the RCT is shown in Figure 3.3. Participants were 
equally randomised between intervention (n=183) and control (n=181) 
arms. 
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Assessed for eligibility 
N = 6133 
Excluded n = 5769 
Not meeting inclusion criteria (n = 
844) 
Refused to participate (n = 4590) 
Declined but took part in screening 
arm (n=335) 
Randomised 
N = 364 
Control (n=181) 
Received allocated intervention (n = 
174) 
Did not receive allocated 
intervention (n = 7) 
7 participants were referred to a falls 
prevention programme by GP 
Intervention (n=183) 
Received allocated intervention (n = 
131) 
Did not receive allocated 
intervention (n = 52) 
1 died prior to FPP 
7 too sick to attend 
43 declined FPP 
1 excluded as previous attendance 
at FPP 
 
Lost to follow up (n = 9) 
9 withdrew (no data) 
Discontinued (n = 2) 
2 withdrew (some data) 
 
Primary outcome 
Analysed (n = 172) 
Excluded from analysis (n = 9) 
9 withdrew (no data) 
(2 withdrew but some data & eligible for 
primary outcome) 
Secondary outcomes 
Analysed (n = 140) 
11 withdrew before final FU 
Missing functional data on 30 
Primary outcome 
Analysed (n = 172) 
Excluded from analysis (n = 11) 
1 excluded 
10 withdrew (no data) 
Secondary outcomes 
Analysed (n = 137) 
1 excluded as previous FPP 
16 withdrew before final FU 
Missing functional data on 29 
Lost to follow up (n = 11) 
10 withdrew (no data) 
1 excluded as previous attendance 
at FPP 
Discontinued (n = 6) 
6 withdrew (some data) 
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Loss to follow up was similar in both arms of the trial: 11/183 (6%) in the 
intervention arm, compared to 9/183 (5%) in the control arm. In both 
arms losses to follow up were explained by withdrawals, because 
individuals felt the trial was too burdensome (intervention – 9, control 5 8) 
or because of ill5health (intervention – 1, control 5 1), with one person in 
the intervention arm being excluded after randomisation as they were 
found to have already attended a falls prevention programme in the 
previous year. These individuals did not provide any follow up data 
regarding falls or functional outcomes, though their home circumstances 
and mortality status at 12 months were known. Losses due to death within 
the follow up period were the same in both arms (control 5 9/181 (5%), 
intervention 5 9/183 (5%)). More participants discontinued the study in the 
intervention arm: 6/183 (3%) versus 2/181 (1%) in the control arm. 
Again, this was because of the burden imposed by the trial or because of 
ill5health; however, those that discontinued the trial did provide some 
follow up data on falls and so are included in the primary outcome analysis. 
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Participants were equally randomised between the two allocation arms and 
within each of the strata (Table 3.5), although there were five errors in 
coding stratum, for example individuals resident in Derby stratum were 
assigned to Nottingham stratum. 
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 Randomisation stratum  
Randomisation 
group 
Derby Nottingham Total 
Control 61 120 181 
Intervention 62 121 183 
Totals 123 241 364 
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Table 3.6 shows the baseline characteristics of all participants, and then 
split by allocation. The population recruited to the RCT are similar to those 
who declined to participate in any aspect of the study in terms of age and 
gender (Table 2.7), but are at higher falls risk overall – as intended. There 
was no missing baseline data in those recruited into the RCT. 
There are relatively small, but potentially important differences in baseline 
characteristics comparing the control group to the intervention group, with 
the intervention group having a slightly ‘sicker’ profile, although the risk 
score (sum of the individual risk factors), was the same in both groups. All 
of the baseline covariates highlighted in bold were included in the adjusted 
analysis. Stratum was a fixed covariate throughout. 
As specified in the protocol and discussed in section 3.2.3.1, we carried out 
analyses adjusted for the baseline imbalances – in subsequent sections, 
adjusted analyses refers to adjusting for age, gender and the screening 
items, crude analysis refers to the inclusion of stratum only as a fixed 
covariate. 
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Characteristic  All 
N=364 
Control 
N=181 
Intervention 
N=183 
Centre/stratum Nottingham 241 (66%) 120 (66%) 121 (66%) 
 Derby 123 (34%) 61 (34%) 62 (34%) 
Age (years) Mean (SD) 78.7 (5.6) 78.4 (5.6) 79.1 (5.7) 
 Median (IQR) 77.8 (74.2582.8) 77.6 (73.5582.9) 78.3 (75.0582.9) 
 Range 705101 70592 705101 
Female Frequency (%) 218 (60%) 112 (62%) 106 (58%) 
At least one fall in previous 12 months Frequency (%) 210 (58%) 102 (56%) 108 (59%) 
Taking more than 4 medications Frequency (%) 192 (53%) 89 (49%) 103 (56%) 
History of stroke Frequency (%) 53 (15%) 20 (11%) 33 (18%) 
Parkinson’s disease Frequency (%) 6 (2%) 2 (1%) 4 (2%) 
Inability to stand from a chair without using arms to push 
up 
Frequency (%) 240 (66%) 115 (64%) 125 (68%) 
Symptoms of dizziness on standing Frequency (%) 218 (60%) 115 (64%) 103 (56%) 
Use of a mobility aid Frequency (%) 182 (50%) 86 (48%) 96 (52%) 
Housebound/not housebound (mobility impairment) Frequency (%) 83 (23%) 39 (22%) 44 (24%) 
Mini5mental state examination 
(median (IQR) 
 Not available  29 (28530) 
Range 15530 
n=101 
8/101 (8%) had 
an MMSE ≤24/30 
Risk score (sum of screening risk factors) Median (IQR) 3 (254) 3 (254) 3 (254) 
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The behavioural mapping exercise was carried out at one site only (QMC), 
as unfortunately additional staffing and funding could not be obtained to 
complete the process in the other sites. 
The results of the behavioural mapping study have been reported 
elsewhere410, but are summarised here in brief. 
‘23 patients (median age 81.5, 37.5% male) were observed over a total of 
35 patient5days at QMC day hospital. 68% of time was spent in rest, 10% 
in physiotherapy, 2% in occupational therapy. 49% of patient time was 
spent alone, 33% with other patients; the remainder of time with health 
care professionals. 13% of time was spent in therapy, which was mainly 
relevant to falls prevention. 
The proportion of time spent in therapy in a day hospital is small, but 
consistent with previous mapping studies. We have developed a useful tool 
to describe activity in the day hospital, but further validation work is 
required.’ 
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Four percent (7/181) of the controls group actually attended a day hospital 
falls prevention programme (FPP), referred by their GP as part of usual 
care; 131/183 (72%) of the intervention group attended. 
The median number of recorded attendances at the FPP was 2 (058) in the 
intervention group. There was significant variation between day hospitals – 
QMC 2 (0510), NCHT 6 (158) and DRI 1 (054), p=0.025 (Figure 3.4). 
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The reasons for non5attendance were not logged systematically, but we did 
collate comments recorded on the monthly diaries relevant to this issue. 
The main reasons for non5attendance relate to negative views of treatment 
(‘when attending the Leengate Clinic on 23rd I suffered a pulled muscle. 
The injury is responding to complete rest and dressing with Ibuleve, but I 
shall not be able to participate in physiotherapy until I have recovered. To 
avoid the risk of further injury I shall not attend any more sessions at the 
clinic. All your papers are enclosed’ and not feeling the need to be in the 
study (‘really I feel a big fraud... maybe there are more deserving people 
than I’, ‘ … as I haven’t had any falls this month. This is not unusual for me 
in fact it’s normal. Sorry to have wasted your time. It’s over a year since I 
had a fall. However there’s no pattern to it, it just occasionally happens.’ 
Some participants did not perceive the therapy to be useful to them 
(‘Withdrawn from Day hospital 5 did not feel it was beneficial to him, feels 
too fit to attend. Will continue with diaries.’ 
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The contribution of individual disciplines to each individuals care in the falls 
prevention programme was obtained from the day hospital logs. These 
were completed voluntarily by the day hospital staff, with limited accuracy 
(no formal training or test of reliability), and often with substantial 
amounts of missing data (up to one5third missing). It is not possible to be 
sure if the missing data indicates not seen, or just missing. Nevertheless, 
the day hospital logs provide some insight into the processes taking place 
in the different units, as detailed in Table 3.7. Clearly, these data only 
apply to those individuals who actually did attend the day hospital. 
The data in Table 2.7 indicate that there are important differences between 
the three falls prevention programmes, suggesting that the interventions 
being delivered are not uniform across the three units.
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QMC 
Median (IQR) 
NCHT 
Median (IQR) 
DRI 
Median (IQR) 
Significance test 
(median test) 
Attendance rate 
(turned up at least once) 
45/74 (61%) 38/45 (84%) 48/67 (72%)  
Number of medical reviews per participant 8 (5511) 7 (258) 2 (156) P=0.001 
Nature of medical assessment 
Junior staff overseen 
by consultant 
Junior staff 
overseen by 
consultant 
All patients 
assessed initially 
by consultant, 
varying input 
thereafter 
 
Number of occupational therapy reviews 8 (4.5511) 7 (1.7558) 2 (155.75) P=0.001 
Duration of occupational therapy input (minutes) 45 (3057) 92.5 (77.55122.5) 60 (48.75583.75) P=0.012 
Number of physiotherapy reviews 8 (5511) 7 (258) 2 (155.75) P<0.001 
Duration of physiotherapy reviews (minutes) 255 (131.255367.5) 310 (2305435) 65 (605315) P=0.001 
Falls incidence rate 
(per person5year) 
1.77 (1.4452.14) 1.83 (1.4252.32) 1.56 (1.2651.92)  
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Falls were ascertained through the monthly diaries, 172 participants in 
each group completed at least some falls diaries and so were eligible for 
primary outcome analysis. In total 3749 monthly falls diaries were 
returned, 1908 in the control group and 1841 in the intervention group. 
The median number of diaries returned was 12 (IQR 12512) in both groups. 
There was no significant difference between the two arms in the median 
number of diaries returned (Mann5Whitney p5value 0.61). 
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Control 
(n=181) 
Intervention 
(n=183) 
Number of diaries returned 1908 1841 
Median (IQR) number of diaries returned 12 (12512) 12 (12512) 
Number returning 12 diaries 138 (76%) 136 (74%) 
Number returning 11 diaries 8 (4%) 3 (2%) 
Number returning 10 diaries 3 (2%) 4 (2%) 
Number returning 9 diaries 3 (2%) 4 (2%) 
Number returning 8 diaries 2 (1%) 1 (1%) 
Number returning 7 diaries 4 (2%) 6 (3%) 
Number returning 6 diaries 7 (4%) 2 (1%) 
Number returning 5 diaries 2 (1%) 1 (1%) 
Number returning 4 diaries 1 (1%) 2 (1%) 
Number returning 3 diaries 1 (1%) 3 (2%) 
Number returning 2 diaries 1 (1%) 6 (3%) 
Number returning 1 diaries 2 (1%) 4 (2%) 
Number returning 0 diaries 9 (5%) 11 (6%) 
 
In total, 677 falls were reported over 304.55 person5years; the overall falls 
rate was 2.2 (95% CI 2.152.4) falls per person5year. The proportion of 
non5fallers and recurrent fallers is shown in Table 3.9. 
170 
$2%!	6	#&.&#3(&"	&+	+$%%!#,	21	$%%&;$3(&"	
Number of falls Control group 
n=172 
Intervention group 
n=172 
None 82 (48%) 86 (50%) 
1 fall only 37 (22%) 41 (24%) 
2 or more falls 53 (31%) 45 (26%) 
 
There were 417 falls over 156.7 person5years (2.7 falls per person5year) in 
the control group compared to 260 falls over 151.2 person5years (1.7 falls 
per person5year) in the intervention group. Individual falls rates (number 
of falls per person/time under follow up) are shown in Figure 3.5, the 
extreme outlier in the control group was id=389, who had 107 falls over 11 
months of follow up. 
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The crude incidence rate ratio adjusted for stratum, using Poisson 
regression to compare the intervention group against the control group was 
0.65 (95% CI 0.5550.74), p<0.0001. However, the goodness of fit test was 
id=389 
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highly significant (p<0.0001), indicating that the Poisson model was a poor 
fit for the data. The crude analysis excluding the outlier id=389 gave an 
incidence rate ratio of 0.86 (95% CI 0.7351.01), p=0.075 but Pearson’s 
goodness of fit test remained highly significant (p<0.0001), indicating that 
these data, even with the outlier removed, do not fit a Poisson model. 
Using a negative binomial regression model, the crude incidence rate ratio 
was 0.64 (95% CI 0.4350.95) p=0.025. The deviance residual scores are 
shown in Figure 3.6. These scores should normally lie within +/5 2 standard 
deviations407, which is the case of most participants except the participant 
with id 389, who had 107 falls over 12 months of follow up. Further 
regression diagnostic tests shown in appendix 4.5.1 all indicated a 
relatively poor model fit for this participant, who still had high leverage and 
influence. 
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id=389 
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A sensitivity analysis was carried out excluding id 389; other investigators 
have excluded extreme outliers when analysing fall rates411. The rate of 
falls in the control group excluding id 389 was 2.0 compared to 2.7 falls 
per person5year when id 389 was included. The overall falls rate fell from 
2.2 (95% CI 2.152.4) including id 389, to 1.9 (95% CI 1.852.1) without id 
389. The resultant incidence rate ratio (IRR) comparing control and 
intervention groups was 0.86 (95% CI 0.5951.25), p=0.424. This time the 
Generalised Linear Model (GLM) diagnostics showed a better fit (Cook’s 
<0.2, leverage <0.15 and dbeta <2.5) for all participants, and although 
these values are still relatively high, no individual stood out other than id 
389. Introducing age5squared showed no evidence of non5linearity, 
likelihood ratio test p=0.987. 
The negative binomial regression to be the most appropriate analysis for 
the data, and excluding id 389 appears reasonable – the extreme rate of 
falls in this individual are best shown in Figure 3.6. All analyses concerning 
rates described below exclude id 389. 
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Given that adjusting for baseline imbalances had been pre5specified in the 
study protocol412 and all of the baseline covariates are prognostically 
important for falls (see 3.2.3.1), an adjusted analysis was carried out using 
all of the baseline covariates. The adjusted analysis included all of the 
screening items, age and gender, as well as stratum. 
Using the adjusted negative binomial regression model, the IRR was 0.73 
(95% CI 0.5151.03), p=0.071. The regression diagnostics did not suggest 
that the assumptions for the model had been violated (Cook’s <0.14, and 
leverage <0.24). Introducing ‘age squared’ as a parameter gave a 
likelihood ratio test of p=0.681, indicating no evidence of a non5linear 
relationship with age, which was therefore retained as a (centred) 
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continuous variable. Table 3.10 summarises the key analyses for the 
primary outcome. 
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 Unadjusted Adjusted 
Results with participant id=389 retained 
Poisson regression 0.65 (95% CI 0.555
0.74), p<0.0001 
Negative binomial 
regression 
0.69 (95% CI 0.465
1.02), p<0.001 
 
Results with participant id=389 excluded 
Poisson regression 0.86 (95% CI 0.735
1.01), p=0.075 
 
Negative binomial 
regression 
0.86 (95% CI 0.735
1.01), p=0.075 
0.73 (95% CI 0.515
1.03), p=0.071 
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Two sub5group analyses were pre5specified, by age category (70584, 85+) 
and by previous fall status and two additional unplanned subgroup 
analyses were performed (gender and stratum) 5 Table 3.11. These 
analyses look for a differential effect within each parameter – for example, 
examining if the effect of the intervention is different depending on 
whether or not the individual has had a previous fall. If there was evidence 
of a differential effect, indicated by a large or small incidence rate ratio for 
the interaction parameter (effect in previous fallers divided by effect in 
those without previous fall), and a significant p5value result in the 
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likelihood ratio test for the interaction, then it would have been appropriate 
to report the results by sub5groups. 
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Sub5group analysis Incidence rate ratio for the 
interaction (95% CI) 
Likelihood ratio 
test p5value 
Age category*allocation 
(70584 vs. 85+) 
1.3 (0.553.4) 0.572 
Previous fall*allocation 
(previous fall vs. no previous fall) 
0.7 (0.451.5) 0.384 
Gender*allocation 
(male vs. female) 
0.8 (0.451.6) 0.574 
Stratum*allocation 
(Derby vs., Nottingham) 
1.7 (0.853.5) 0.144 
 
None of these analyses show significant evidence of a differential effect 
according sub5group. 
3.16.5.1 Per5protocol analysis (post5hoc) 
Attendance at, and engagement with a FPP, whether delivered by primary 
care or in the day hospital, was arbitrarily designated as more than one 
attendance at the day hospital FPP or evidence from primary care records 
of multidisciplinary input into falls management. Irrespective of RCT 
allocation, 134/344 (39%) individuals attended some form of FPP. The rate 
of falls in those attending a FPP was 2.1 (95% CI 1.952.4) fall per person5
year, compared to 2.3 (95% CI 2.152.5) in those not attending a FPP. The 
incidence rate ratio for falls by attendance at a FPP was 0.39 (95% CI 
0.1151.40), which is a potentially clinically important effect size, but the 
likelihood ratio test was p=0.134, so it is not statistically significant. 
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The pre5specified and 
 secondary analyses are presented in Table 
3.12. With respect to the model checking for these analyses, Parkinson’s 
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disease exerted significant leverage, but a sensitivity analysis excluding 
those with high leverage values, did not substantially alter the result. For 
uncommon events, such as death during follow up and admission to a care 
home, the model was a poor fit for those who had the event, but otherwise 
robust. The Cox proportional hazards model tests showed crossover over 
time and some collinearity with baseline characteristics, making the model 
unreliable; this was not a pre5specified analysis. 
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Outcome Descriptive data Crude analysis Adjusted 
analysis 
 Control Intervention Effect size 
(95% CI), 
significance 
Effect size 
(95% CI), p5
value 
Proportion of 
people falling over 
12 months (OR) 
73/138 
(53%) 
69/136 
(51%) 
0.90 
(0.5651.46) 
p=0.672 
0.91 
(0.5451.53) 
p=0.725 
The proportion of 
participants with 
two or more falls 
(OR) 
38/138 
(28%) 
38/136 
(28%) 
1.01 
(0.5951.72) 
p=0.969 
0.98 
(0.5151.76) 
p=0.933 
The proportion of 
people with self5
reported injurious 
falls (OR) 
55/138 
(40%) 
56/136 
(41%) 
1.05 
(0.6451.70) 
p=0.856 
1.08 
(0.6451.82) 
p=0.778 
The proportion of 
people 
institutionalised at 
12 months (OR) 
 
1/170 
(<1%) 
3/166 
(<1%) 
3.1 
(0.3530.2) 
P=0.328 
4.8 
(0.3573.1) 
P=0.260 
Mortality at 12 
months (OR) 
9/181 
(5%) 
9/182 
(5%) 
1.0 
(0.452.6) 
P=0.994 
0.8 
(0.352.4) 
P=0.705 
Mortality rates in 
person –years 
(IRR) 
(post5hoc) 
0.05 
(95% CI 
0.0350.10) 
0.05 
(95% CI 
0.0350.10) 
0.89 
(0.3452.30) 
p=0.804 
0.7 
(0.352.0) 
p=0.543 
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None of the secondary outcomes described in Table 3.12 showed any 
strong evidence of a differential effect in a per protocol analysis based on 
attendance at a fall prevention programme. 
3.16.6.1 Proportion of people with medically verified injurious falls 
Primary care recorded falls data were abstracted from primary care 
records, injuries are coded according to the Severity of Injury Scale, and 
are shown in Table 3.13. Data are only available for those individuals who 
have a consultation with their GP documented. 
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Abbreviated injury rating Controls n=22 Intervention n=18 
No injury 9 (41%) 6 (33%) 
Minor (abrasion, contusion) 10 (45%) 9 (50%)  
Moderate (laceration, tissue tear, 
haematoma, impaired mobility due to 
injury, fear of subsequent fall and fall 
injury) 
2 (9%) 3 (17%) 
Serious (fracture, multiple fracture, 
subdural haematoma, head injury) 
1 (5%) 0 (0%) 
Total 22          18 
Pearson chi squared test for trend (3 degrees of freedom) p=0.690. 
There was no significant difference between the two groups when primary 
care verified injurious fall was dichotomised (no injury vs. injury) in the 
crude analysis (OR 1.4 (95% CI 0.455.3), p=0.601), or in the adjusted 
analysis (OR 2.6 (95%CI 0.3522.1), p=0.387).  
Secondary care recorded falls data were abstracted from secondary care 
records, and injuries were coded according to the Severity of Injury Score. 
Again, data are only available for those individuals who have a documented 
fall5related hospital attendance. 
24/135 (18%) in the intervention group had a verified ED attendance 
compared to 24/137 (18%) in the control group; the figures for 
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	 ED attendances were 13/24 (55%) for both groups – 11 of which 
were associated with an injury in both (Table 3.14). 
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 Controls n=24 Intervention n=24 
None 13 (54%) 13 (54%) 
Minor 4 (17%) 5 (21%)  
Moderate 3 (13%) 5 (21%) 
Serious 4 (17%) 1 (4%) 
Pearson chi squared test for trend (3 degrees of freedom) p=0.492. 
Nor were there any significant differences in the ED visits with an injurious 
fall when ED verified injurious falls were dichotomised (no injury vs. 
injury): in the crude analysis the odds ratio was 1.0 (95% CI 0.353.1), 
p=0.991, and in the adjusted analysis the odds ratio was 1.3 (95% CI 0.25
8.0), p=0.760. 
3.16.6.2 Time to first fall 
The median time to first fall in days was 271 in the control group, 
compared to 292 in the intervention group. The crude hazard ratio was 0.9 
(95% CI 0.751.3), p=0.625; the adjusted hazard ratio was 0.9 (95% CI 
0.751.3), p=0.622 (Figure 3.7). 
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3.16.6.3 Second fall outcomes (not pre5specified) 
38/73 (52%) of controls who had one fall had at least one more fall versus 
38/69 (55%) of those in the intervention group had a second fall, crude 
odds ratio 1.1 (95% CI 0.652.2), p=0.717, adjusted odds ratio 0.9 (95% 
CI 0.452.0), p=0.826. 
The median time to second fall after the first fall was 55 days in the control 
group compared to 87 days in the intervention group (Figure 3.8). The 
crude hazard ratio for time to second fall was 0.9 (95% CI 0.551.2), 
p=0.248. The adjusted hazard ratio was 0.7 (95% CI 0.551.1), p=0.103. 
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3.16.6.4 Impact on disability, quality of life and fear of falls 
There data missing on functional outcomes for 38 controls and 46 in the 
intervention group. In view of the missing data, a multiple imputation 
model was run including all of the baseline covariates. 10 datasets were 
created using the multiple imputation command (ICE) in Stata, with 
missing data being generated with a random component, but which 
incorporates the known baseline parameters. 
Personal ADLs were measured using the Barthel score, with a possible 
range of scores from 0 (extremely dependant) to 20 (independent). The 
Barthel scores were negatively skewed and no transformations rendered 
the score near normal. The Barthel scores were dichotomised at the 
median (19/20). The median (IQR) scores for both groups were identical – 
19 (17520). The results for the original and imputed datasets are detailed 
in Table 3.15. 
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Extended activities of daily living (outdoor mobility, domestic tasks, social 
interaction etc) were measured using the Nottingham Extended Activities of 
Daily Living score, with a possible range of 0 (severely restricted) to 66 
(independent). Again the distribution was very skewed, so the results were 
dichotomised at the group median (56 out of 66). Table 3.15 shows the 
adjusted and imputed estimates. 
Fear of falling was assessed using the Falls Efficacy Scale, this is a ten item 
scale asking about the level of fear of falling in a variety of daily activities; 
each item is graded from 1510, with ten indicating the most fear (least 
confidence) and the maximum score possible is 100. The FES data was 
similarly skewed and so was dichotomised at the group median (17/100) – 
see Table 3.15. 
Quality of life was measured using the five item EuroQoL, scored 1, 2 or 3 
with higher values indicting worse quality of life. Skewed data again 
demanded non5parametric analysis around the group median of 8 (659) – 
see Table 3.15.
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Outcome 
 
Control 
N=172 
[number of missing values] 
Intervention 
N=172 
[number of missing 
values] 
Adjusted odds 
ratio (95% CI), 
significance 
Imputed 5 
control 
N=1720 
Imputed 5 
intervention 
N=1720 
Imputed data 
adjusted odds 
ratio (95% CI) 
 
Barthel score 
Median (IQR) 
 
19 (17520) 
[29] 
19 (17520) 
[35] 
1.4 (0.852.4) 
p=0.184 
19 (17520) 19 (18520) 1.38 (0.8052.36) 
p=0.248 
NEADL score 
Median (IQR) 
56 (43.75561) 
[34] 
53 (43562) 
[45] 
1.0 (0.551.8) 
p=0.884 
54 (43561) 51 (40.7561) 0.82 (0.4551.52) 
p=0.532 
FES score 
Median (IQR) 
18 (10541) 
[29] 
16 (10538) 
[37] 
0.8 (0.451.3) 
p=0.312 
19 (10541.4) 17 (10539) 0.75 (0.4351.31) 
p=0.312 
EuroQoL 
(median (IQR) 
8 (659) 
[38] 
7 (658) 
[27] 
0.5 (0.350.9) 
p=0.027 
8 (659) 7.5 (659) 0.74 (0.4151.35) 
p=0.334 
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These original data show no significant differences between the two arms 
of the RCT in terms of Barthel, NEADL and FES scores, but a slightly benefit 
in the EuroQoL score (OR 0.350.9). However, the advantage in terms of 
quality of life was not seen in the sensitivity analysis based on the imputed 
dataset. 
3.16.6.5 Health service resource use 
Participants were asked to record any visits to their general practitioner 
(GP) in their monthly diary returns, along with the duration of the visit. 
These reports were not constrained to falls alone, but reflected all care 
needs. As with many of the secondary outcomes, the distribution was 
heavily skewed and could not be adequately transformed into a normal 
approximation, and data were dichotomised about the group median (see 
Table 3.16). 
We also collected verified GP attendances from primary care records. The 
self reported visits and verified GP visits were only moderately well 
correlated (r=0.62); an analysis of variance revealed r2 to be 0.66, 
adjusted r2 0.62, p<0.0001. This is perhaps best shown in Figure 3.9, a 
Bland5Altman plot of the difference of paired variables versus their 
average; the mean difference was 51.34 visits (95% CI 51.86 to 50.82), 
suggesting that GP records underestimate the true burden of falls. 
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Table 3.16 shows health service use over follow up, not limited to falls 
related activity alone but including all contacts with the health service 
documented on primary or secondary care administration systems. 
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Medians (Interquartile range) Number (%) above the 
median  
Outcome 
All Control Intervention Control Intervention 
Crude odds 
ratio 
(95% CI), 
significance 
Adjusted 
odds ratio 
(95% CI), 
significance 
Self5reported visits to the GP 
over 12 months n=238 
5 
(358) 
5 (358) 5 (357) 72/151 
(48%) 
63/135 
(47%) 
1.1 (0.751.8) 
p=0.703 
1.2 (0.752.0) 
p=0.524 
Verified GP attendances over 12 
months n=270 
5 
(359) 
6 
(358) 
5 (359) 69/137 
(50%) 
60/133 
(45%) 
0.8 (0.551.3) 
p=0.389 
0.8 (0.551.3) 
p=0.381 
Verified non5ED hospital visits 
over 12 months or death n=334* 
0 
(050), range 055 
0 
(050) 
0 
(050) 
36/169 
(21%) 
39/165 
(24%) 
1.1 (0.752.0) 
p=0.607 
1.1 (0.651.8) 
p=0.805 
Verified ED visit over 12 months 
or death n=334 
Number not recorded 32/169 
(19%) 
40/165 
(24%) 
1.3 (0.852.3) 
p=0.288 
1.3 (0.752.2) 
p=0.413 
Verified falls5related hospital 
visit** over 12 months or death 
n=75 
Number not recorded 6/36 
(17%) 
7/39 
(18%) 
1.1 (0.353.8) 
p=0.852 
1.0 (0.254.8) 
p=0.997 
Verified fracture over 12 months 
follow5up or until death n=364 
0 
(050), range 051 
0 
(050) 
0 
(051) 
3/181 
(2%) 
6/183 
(3%) 
2.0 (0.558.0) 
p=0.329 
1.4 (0.356.7) 
p=0.618 
*Excludes visit to the day hospital as part of the falls prevention programme 
**The correlation between self5reported with verified ED visits was poor (r=0.10) – verified visits only reported
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The self5reported cumulative duration of visits to the GP was 56 (IQR 305
100) minutes for controls and 55 (IQR 30590) minutes for those in the 
intervention group, with no significant differences between the groups 
(Mann5Whitney p=0.644). 
Self reported visits to the district nurse (DN) were captured using the 
monthly diaries – either visits to the surgery or home visits, with a median 
of 4 (IQR 257) visits over one year, irrespective of allocation, and no 
significant differences between the groups even after adjusting for baseline 
imbalances – adjusted odds ratio (splitting at the median) 0.7 (95% CI 
0.451.2), p=0.211. 
The cumulative duration of DN visits was similar between the groups: 
median 35 minutes (IQR 15585) in the controls versus 30 minutes (IQR 155
70) in the intervention group (Mann5Whitney p=0.690). The crude odds 
ratio (splitting at the median) was 1.0 (95% CI 0.651.0), p=0.958, and the 
adjusted odds ratio 0.9 (95% CI 0.551.6), p=0.832. 
3.16.6.6 Social services resource use 
Self reported social services resource use was collected from the monthly 
diaries. The data for this domain was poorly completed, with replies from 
around 15% of RCT participants. 9/25 (36%) individuals in the intervention 
group stated that they received meals on wheels, compared to 11/30 
(37%) in the control group. Pearson’s chi (1 d.f) p=0.959; adjusted odds 
ratio 0.5 (95% CI 0.152.4), p=0.406. 
Participants were asked if they received any regular support in performing 
their daily activities; this was the case for 41 in the intervention group as 
opposed to 46 in the control group, but missing responses make the 
denominator uncertain and render the data unhelpful. Similarly, 60 in the 
control group as opposed to 66 in the intervention group had made some 
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form of home adaptation; the median number of adaptations in the control 
group was 1 (IQR 152) compared to 2 (IQR 153) in the intervention group, 
(Mann5Whitney p=0.319). Finally, 96 in the intervention group compared 
to 98 in the intervention group had purchased some form of assistive 
technology, at a median total cost of £14 and £10.75 respectively, Mann5
Whitney p=0.690. 
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Three hundred and sixty5four community5dwelling older people at high risk 
of falling were randomised into a pragmatic, multicentre trial evaluating 
falls prevention programmes in three different day hospital in the East 
Midlands. Twenty five percent of those eligible consented to participate, 
representing 6% of the population aged 70+ registered with participating 
general practices. 
One hundred and eighty5one were allocated to the control group and 183 
to the intervention, of whom seven and 131 respectively attended a falls 
prevention programme. Losses to follow up were similar in both groups 
(5%), less than originally anticipated. Complete follow up data was 
available for 138/181 (76%) in the control group and 136/183 (74%) in 
the intervention group. There were slight imbalances in baseline 
characteristics between the two groups, and subsequent analyses were 
adjusted for prognostically important baseline variables. Most (92%) of 
those attending the day hospital were cognitively intact. 
The primary outcome of the trial was the rate of falls; the unadjusted 
incidence rate ratio using negative binomial regression was 0.64 (0.435
0.95), p=0.025, in favour of the intervention. 
Regression diagnostics identified a significant outlier in the data, whether 
by deviance residuals, Cook’s distance, leverage or dbeta values; the 
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individual had an extreme number of falls (107 over 12 months). A 
sensitivity analysis excluding this individual showed a much better fit for 
the negative binomial regression model, but the benefit in favour of the 
intervention was reduced – IRR 0.86 (0.5951.25), p=0.424. An adjusted 
analysis including the baseline variables known to affect falls outcomes and 
excluding the outlier gave an adjusted IRR of 0.73 (0.5151.03), p=0.071, 
and this is the most appropriate summary measure of effect to describe 
this trial result. 
A variety of sub5group analyses (age, gender, previous fall status, stratum 
or per protocol) failed to demonstrate a significant difference in the effect 
of the intervention by any particular sub5group. 
There were no significant differences between the groups using the 
intention to treat analysis in terms of the proportion of fallers, recurrent 
fallers, medically verified falls, injurious falls, time to first fall or time to 
second fall. There was a suggestion of benefit in delaying the time to a 
second fall (55 days control vs. 87 days intervention), associated with a 
clinically important reduction in the hazards ratio of 0.7 (95% CI 0.551.1) 
in the adjusted model, but this was not statistically significant (p=0.103). 
In a wide array of secondary outcomes, there were no significant 
differences between the groups, including institutionalisation, mortality, 
basic or extended activities of daily living, and fear of falling. Although 
there was evidence of benefit using the EuroQoL (odds ratio 0.5 (0.350.9), 
p=0.027), this was not demonstrated in a sensitivity analysis using an 
imputed dataset to compensate for missing data – adjusted odds ratio 0.7 
(0.4151.35), p=0.334. 
There were no significant differences between the groups in terms of health 
and social care resource use – self reported and validated GP visits, self5
reported visits to the district nurse, self–reported and validated hospital 
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attendances, or self5reported use or purchase of meals on wheels, home 
adaptations or other assistive technology. 
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Although the initial analysis appears to show a statistically significant and 
clinically important trial result, the appropriate analysis shows no 
conclusive evidence of benefit. The findings are consistent with a 49% 
reduction in the rate of falls, or a 3% increase – adjusted IRR 0.73 (0.515
1.03), p=0.071. The best estimate is for a 27% reduction in the rate of 
falls. Such a reduction is clinically important, but the probability of finding 
this level of effect when the null hypothesis is in fact true (that there is no 
difference between those randomised to the intervention and those in the 
control group) is 7/100 (p=0.07). 
There are several possible explanations as to why this trial that pointed at 
a clinically important reduction in the rate of falls should have been unable 
to do so with a high level of confidence – inadequate power and chance, 
bias, insensitive outcomes, reverse causation or an inadequate 
intervention. 
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The p5value relating to the null hypothesis – that there was no difference 
between the two groups in this trial was 0.07; it is conventional to infer the 
presence of genuine differences between groups to require this probability 
to be either less than 5% or 1% in order to reject the null hypothesis of no 
difference. The trial was planned to detect a clinically important risk 
reduction of 24% assuming a baseline fall rate of 2 per person5year, 320 
person5years of follow up and 80% power. The assumptions for the sample 
size calculations were reasonably accurate as the study recruited 304 
person5years and fall rates were 2.2 (control) and 1.9 (intervention). The 
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slight disparity in the person5years of follow up calculated in the original 
power calculation and that seen in the trial (320 vs. 304 person5years), 
may well account for the lack of power to reject the null hypothesis. This 
study was designed using 80% power, and although this is commonly used 
in trial planning, it means that there was a one in five chance of dismissing 
a real effect of a 24% reduction in the rate of falls if one existed (type II 
error). 
Two other recent falls prevention trials have shown no evidence of benefit, 
because of a lack of power. Hendriks "-. studied a high risk population 
attending the emergency department with a fall. They powered their trial 
to show a 20% difference in the proportion of fallers (52% versus 32%, 
alpha 0.05, beta 90%) with 164 participants in each arm. 258 participants 
were eligible for the primary outcome (proportion of falls at one year), and 
the odds ratio was 0.86 (0.5051.49), p=0.59. They concluded that the 
intervention was ineffective, but in fact could have missed even a 30% 
reduction in falls, again because of a type II error. 
Elley 229 carried out a RCT to look at the effectiveness of a nurse 
specialist coordinating a falls prevention programme for high risk 
community dwelling older people. They also powered their trial to show a 
20% difference on the proportion of fallers (52% versus 32%, alpha 0.05, 
beta 90%) with 105 participants in each arm. 312 participants were eligible 
for the primary outcome (rate of falls over one year), and the incidence 
rate ratio was 0.96 (0.7051.34), using Poisson analysis. They concluded 
that the intervention was ineffective, but in fact could have missed a 
clinically important 15% reduction in falls rates because of a type II error. 
The population attributable fraction (=p(RR51) / [p(RR51)+1], see section 
2.4.2) reflects the attributable risk multiplied by the proportion of the 
population exposed (35% prevalence measured prospectively in the 
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screening cohort): 0.35*(0.7351)/[0.35*(0.7351)+1]=10%. This suggests 
that 10% of all falls in people aged 70 or older could be prevented using 
the modified FRAT to identify people at risk and providing a multifactorial 
falls prevention programme if the estimate of effect seen in this study is 
correct. This compares to an estimated 9% reduction in serious fall5related 
injuries anticipated at the population level in the US55 and Austrialia272 and 
could have considerable public health impact. In 2005–06, the acute care 
of 68,416 patients with hip fracture in England cost the NHS an estimated 
£781 million413. Assuming that 80% of hip fractures are related to falls 
(probably an underestimate), then a 10% reduction in the number of falls 
could result in 5473 fewer hip fractures per annum (10%x80%x68416). 
This represents 5473 individuals who would avoid a fracture, up to 82095 
(5473 x15) hospital bed days saved, or a £62 million saving 
(£781M*5473/68416). Whilst the cost of this would need to be balanced 
against the cost of a falls prevention programme, it illustrates the potential 
impact of a 10% reduction in falls, and how important the 27% estimated 
reduction in falls seen in this trial could be. 
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Participants were aware of their allocation, and thus differential reporting 
cannot be excluded as a cause of bias. For example, those in receipt of falls 
services might be more likely to recall and hence notify falls, whereas 
those receiving less input might be less likely to recall falls; this might have 
attenuated the effect. But a series of validated analyses (medically verified 
falls, hospital admissions etc) also failed to show any difference between 
the groups in terms of their reporting of these outcomes, which makes 
reporting bias unlikely. 
There were imbalances in baseline covariates which may have been a 
source of bias, with the intervention group being slightly sicker than the 
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control group, but adjusted analyses did not substantially alter the crude 
outcomes. 
Monthly diary data were entered by a research nurse blinded to the 
allocation, but it is not possible to exclude some form of manipulation or 
tampering which may have systematically affected the results. However, 
the double entry checks did not reveal any obvious evidence of systematic 
bias, with error rates of less than 1% recorded. 
Design bias might have been a possibility – the usual care group could 
have accessed falls prevention programmes, thus attenuating the effect of 
systematically implementing a falls prevention programme; however, given 
that only 7/181 in the control group accessed any form of falls prevention 
programme, this is unlikely, though may have slightly reduced the 
intervention effect. 
It is possible that those screened into the study were in some way 
fundamentally different from people who would otherwise have been 
referred routinely to a falls prevention programme, either because of 
differing falls rates, or because of their characteristics (Table 2.7) – such as 
willingness to participate. Certainly the age and gender of those in the 
screening arm and the RCT were similar to those that declined to 
participate in the trial, though clearly their falls risk factor profile was 
different, as could have been their motivation to attend. Those at high risk 
agreeing to participate in the RCT may be different in some unknown way 
compared to those at high risk who only agreed to participate in the 
screening cohort. As discussed in section 2.8.2, this may have led to an 
overall higher risk group in the RCT compared to the screening cohort. 
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The use of a randomised controlled trial design should have prevented 
unknown confounding factors from exerting a significant effect upon the 
trial outcome, but it is possible that some confounding occurred which has 
not been measured, and so cannot be accounted for. 
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The outcomes used in this trial (falls, functional outcomes, fear of falling 
and quality of life) have been used in a wide variety of similar trials and 
have been able to demonstrate a difference between groups, whether this 
be in self reported falls, fear of falling or function. Insensitive outcomes are 
not a good explanation for the lack of effect seen in this trial. 
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A possible explanation is reverse causation – namely that the intervention 
increased falls, possibly mediated through an increase in activity. Against 
this is the absence of any difference between the two groups in terms of 
functional outcomes, in particular mobility related outcomes in both the 
Barthel and mobility sub5section of the NEADL make this theory 
implausible. Additionally, both groups reported similar scores for fear of 
falling. 
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That the intervention tested was insufficiently potent to affect falls related 
outcomes in this population is a further possible explanation. Although the 

sub5group analysis limited to those who attended the falls 
prevention programme showed a large effect size – incidence rate ratio 
0.39 (95% CI 0.1151.40), p=0.149 this was not statistically significant 
(likelihood ratio test p=0.185). Adherence to the allocated intervention was 
limited, with only 37% of those allocated to the intervention attending six 
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or more sessions of the falls prevention programme. Previous trials 
showing an effect from falls prevention programmes had adherence rates, 
measured by compliance with follow5up, of around 80% (section 1.5.1). 
This suggests that lack of adherence to the evidence based intervention in 
this trial may be an explanatory factor in the failure to demonstrate an 
effect from the intervention. Reasons for non5attendance included time and 
travel arrangements, and participants not perceiving themselves to benefit 
from the falls prevention programme. 
When individuals attended the FPP more than one visit, on the whole they 
received appropriate interventions (~60 minutes occupational therapy, 
~300 minutes physiotherapy and a series of medical reviews), though the 
‘dose’ of these interventions was probably sub5optimal. More recent 
evidence suggests that at least 50 hours of exercise are required to see 
clinically important reductions in falls rates414 which may be best achieved 
by community5based peer5led exercise programmes415. The inadequate 
intervention in this study compared to what has previously been described 
in ‘positive’ studies may well have contributed to the lack of effect. 
The absence of a clearly defined, uniform intervention in the three day 
hospitals is a weakness of this study, but it still remains a valid 
examination of falls prevention programmes as commonly configured in 
England and Wales, as discussed further in 3.18.9.  
Appendix 4.6 details a meta5analysis comparing efficacy (explanatory) 
trials to effectiveness (pragmatic) falls prevention trials. Whilst imperfect in 
terms of methodology, the meta5analysis lends support to the theory that 
there is a discrepancy between efficacy trials and their delivery in clinical 
practice (trials of effectiveness). 
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This trial in isolation does not demonstrate beyond reasonable doubt that a 
multifactorial falls prevention programme delivered in day hospitals to 
predominantly cognitively intact older people living in the primary care 
setting identified as being at high risk of falls using a postal screening 
questionnaire, is beneficial. A smaller, yet clinically important benefit 
cannot be excluded, but would need a larger, adequately powered trial: a 
clinically meaningful 15% reduction in falls would need a trial with 644 
participants with alpha set at 0.05 and 15beta at 0.80. Likely explanations 
for the lack of effect include inadequate power, cross over in the control 
arm, poor compliance and a sub5optimal intervention in the intervention 
arm. 
The totality of evidence from other trials suggests that falls prevention 
interventions, sufficiently intensive and properly delivered, can reduce falls 
rates10 12 217 224 225. The results from this trial are consistent with the results 
from other published trials, as shown in the meta5analysis in appendix 4.6, 
although there was significant heterogeneity (fixed effect estimate I2 
statistic 69%, p<0.0001). The best estimate of effect size in this trial 
(27%) is similar to that seen in other trials, although in the particular 
circumstances of this trial the findings are compatible with there being no 
difference, and so the null hypothesis cannot be confidently rejected. 
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The bulk of the published evidence would have led one to expect this trial 
to have shown a benefit; most RCTs, meta5analyses and systematic 
reviews have all pointed to the benefits of a structured falls prevention 
programme in high risk populations10 12 217 224 225, although not specifically 
in a day hospital setting. More recent evidence has focussed on more 
pragmatic interventions229, which have found no evidence of benefit, with 
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the authors highlighting the issue of compliance being one of the main 
detractors. The findings of this trial are compatible with the evidence 
presented in the meta5analysis by Gates ""/; which found that fall 
prevention services may reduce falls by up to 20%, but the findings were 
also compatible with a slight increase in falls (0.91 (95% confidence 
interval 0.82 to 1.02).
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The falls rates seen in this study were broadly in keeping with what might 
be expected in England; 2 per person5year in a high risk population 
compared to 1.151.8 falls per person5year28 29 in all community dwelling 
older people. Falls clinics, broadly equivalent to the day hospital based falls 
prevention programme evaluated in this RCT, are commonplace across 
England and Wales416. It has been estimated that there are 298 falls clinics 
throughout England and Wales (SDO report, 2007416), 96% of which are 
based in community hospitals or acute hospitals. Most of these falls clinics 
(228/231, 99%) offer a multifactorial intervention similar to that described 
in this RCT. This suggests that the results of this RCT are generalisable to 
falls services throughout England and Wales. 
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This is the only RCT to date examining falls prevention services as 
commonly configured in England and Wales; the results of this trial in 
isolation do not conclusively support falls prevention services delivered in a 
day hospital setting to a screened population of older people identified as 
being at high risk of a future fall. A clinically meaningful reduction in falls 
cannot be excluded as a type II error may account for the findings. This 
trial also highlights the issue of compliance, with only 37% of those 
randomised to the intervention receiving six or more sessions of falls 
prevention therapy. It also highlights the importance of adhering to the 
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evidence based ‘recipe’ for falls prevention – had a more intensive 
intervention been provided then this trial may have been more conclusive. 
The introduction of the screening element is an important difference 
compared to usual falls prevention programmes, which tend to be more 
reactive, and so patients attending are more self5selecting – and so 
adherence may be better. This is supported by differential recruitment into 
the RCT rather than the screening arm of individuals with a previous fall. 
There are important implications for falls services – if they are to achieve 
the reductions in falls seen in efficacy trials, services should strive to 
reproduce the evidence based interventions in practice. This will involve 
findings innovative methods to encourage participants to continue 
attendance for the full programme of strength and balance training, and 
‘marketing’ the programmes in such a way that participants will not be 
dissuaded from attending. The work from Yardley 218 and Horne 417 
is informative in this regard, demonstrating the importance of emphasising 
the positive aspects of falls prevention services (healthy ageing, improving 
quality of life), as opposed to the negative (you will continue to fall if you 
don’t come). 
Some authors have suggested that clinical trials in areas where there is a 
high pre5trial probability of finding a positive outcome might be stopped 
early, before the conventional limits of significance have been achieved in 
order not to violate the principle of individual as opposed to collective 
equipoise418. In the context of this trial, it can therefore be argued that it 
could have been stopped early (before convention statistical significance 
was reached), but no provision for this was made in the study protocol. 
That these trial findings are in keeping with previous similar trials as shown 
in the meta5analysis provides further reassurance that there is benefit from 
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a falls prevention programme provided to populations at high risk of falls 
more generally (RR 0.86, 95% CI 0.7650.98))10. 
The argument for interpreting this trial supports the efficacy of falls 
prevention interventions is supported by the meta5analysis data, Bayes 
theorem and Stein’s paradox419. Bayes theorem would interpret the trial in 
the context of the 		 findings (most falls prevention trials are 
positive), and so perhaps have a lower threshold for declaring a positive 
effect. Stein’s theory expands on the regression towards the mean theory, 
namely that the best estimate of ‘truth’ is the combination of estimates. 
Using these paradigms, one could argue that the most plausible 
interpretation in the general context of high risk populations for this trial is 
that there was a 27% reduction in falls in favour of the intervention. But 
nevertheless, with regards to the specific research question this trial set 
out to answer, the findings do not support the role of falls prevention 
services delivered in the day hospital to a screened population. 
There are also implications for the research agenda. One area which needs 
to be addressed in more detail is around encouraging participation, 
compliance and adherence. This is a programme of qualitative work, 
looking at how individuals deemed to be risk of future falls perceive 
themselves, what sorts of interventions they will find acceptable, where the 
interventions should be located and how the interventions can be sustained 
in the longer term? It also needs to address health professionals’ 
perceptions of patient risk and the rigour with which evidence based 
interventions are applied. The implication is that although there are 
multiple RCTs of falls preventions, that some of the critical developmental 
work, as described in the MRC framework for developing complex 
interventions335, at least concerning day hospital delivered programmes, 
has not been fully elucidated. Once the falls prevention programme has 
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been refined, and piloted for acceptability, there may then be a role for a 
larger, adequately powered RCT addressing the effectiveness and cost5
effectiveness of falls prevention programmes in a screened population. It is 
important to assess the feasibility and biological plausibility of interventions 
before proceeding to interpret RCTs or even meta5analyses420. 
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The primary aim of this study was to determine if screening for individuals 
at high risk of falls and offering a day hospital based falls prevention 
programmes to those at high risk was beneficial. 
Wilson & Jungner’s285 screening criteria provide a suitable framework to 
revisit this question in light of the evidence presented: 
• The condition should be an important public health problem 
Falls are a common problem for older people, with 24% of people aged 
over 65 years falling at least once every year. Falls are the leading cause of 
trauma in older people and a prime cause of fracture; they are also a 
major cause of mortality in older people. Falls have a similar impact on 
hospital services to other major conditions such as stroke and myocardial 
infarction (section 1.7). 
• There should be an accepted treatment 
Multifactorial interventions delivered to previous fallers and others at high 
risk have been effective in reducing falls rates by around 25%. Whilst this 
trial is in keeping with the evidence that falls prevention programme are 
effective, it was unable to show any effect from such a programme 
delivered in a day hospital to a high risk population. 
• Facilities for diagnosis and treatment should be available/ there 
should be a suitable test 
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We have validated a modified version of the FRAT which has reasonable 
predictive properties: sensitivity 78.7% and specificity 57.5%. The positive 
predictive value of 50% indicates that for every two people identified as 
being at high risk, one would go onto to have a fall in the following year. 
The 83% negative predictive value means that of those screened as being 
at low risk, approximately one in six will go on to have a fall. 
• There should be a recognisable latent or early asymptomatic 
stage/The natural history of the condition should be understood 
There is a latent period in which individuals are at risk of falls, but have not 
fallen, as discussed in section 1.4. Of the 364 identified as being at high 
risk and include din the trial, 42 had not previously fallen, and there was 
no evidence of benefit in those who had fallen over those who had not prior 
to randomisation. 
• The test should be acceptable to the population 
The modified FRAT was reasonably acceptable to community dwelling older 
people – 54% completed and returned the form. 
• There should be an agreed policy on whom to treat as patients 
The identification of high risk individual is encouraged by NICE, though a 
formal screening programme has not been recommended 
• The cost of case5finding should be economically balanced in relation 
to the possible expenditure as a whole 
This is a crucial component of this work, and analysis is in progress 
• Case5finding should be a continuing process 
The modified FRAT is easy to apply in primary care and could be relatively 
easily incorporated into routine practice, supported by incentive strategies. 
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Current practice of referring people who are at high risk of falls or who 
have already fallen for a multifactorial falls prevention programme is 
patchy – in this study only 7/181 (4%) of those in the control arm. Having 
considered the screening criteria above, there now appears reasonable 
justification to suggest a more proactive approach to preventing falls in 
older people. 
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Further work on the acceptability and implementation of multifactorial falls 
prevention interventions is required; once suitable approaches have been 
found, a further adequately powered RCT may be considered to determine 
the effectiveness and cost5effectiveness of a systematic screening 
programme to identify older people at risk of falls, and offer a multifactorial 
intervention. However, considering the totality of the evidence presented in 
this thesis, it is not unreasonable to focus additional research efforts on 
implementation and acceptability alone rather than adding to the evidence 
base for falls prevention programmes, which would be costly and difficult to 
justify. 
Although this trial in isolation does not provide sufficient evidence to health 
care commissioners to recommend screening and intervention for falls, in 
combination with the totality of the evidence it would not be unreasonable 
to do so. But before embarking on widespread screening, the likely cost of 
such a programme needs to be estimated. At the very least a more 
rigorous approach to case5finding should be encouraged.
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Databases searched: Ovid MEDLINE(R) 1996 to June Week 4 2008; 
EMBASE 1996 to 2008 Week 27; titles were scanned for relevance, then 
abstracts and full papers examined if relevant. Key references from full 
papers were hand searched. 
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  MEDLINE EMBASE 
1 Accidental Falls/ (Falling/ in EMBASE) 6818 8574 
2 Prevalence/ 87841 121789 
3 Incidence/ 84490 84983 
4 2 or 3 164246 196330 
5 Aged/ 812946 690869 
6 1 and 4 and 5 458 569 
7 
limit 6 to (English language and humans and (clinical 
trial, all or "review")) 
78 47 
8 Retained 17 1 
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# Searches MEDLINE EMBASE 
1 Accidental Falls/ (Falling/ in EMBASE) 6831 8592 
2 institutionalization/ or long5term care/ 8436 40205 
3 Aged/ 813955 691890 
4 1 and 2 and 3 80 141 
5 from 4 keep … 13 8 
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# Searches MEDLINE EMBASE 
1 
(old or older* or senior* or elder* or geriatric* or 
middle?age*).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word] 
418539 408214 
2 fear of falling.mp. 254 258 
3 fall* efficacy scale.mp. 51 51 
4 2 or 3 275 277 
5 1 and 4 215 210 
6 limit 5 to yr="2003+" 21 20 
7 from 6 keep… 15 15 
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# Searches MEDLINE EMBASE 
1 Accidental Falls/ 6853 8592 
2 Depression/ 24093 85966 
 Add ‘Aged’ in EMBASE 691890 
3 1 and 2 (3) 63 353 
4 Selected 14 10 
 ,
	
	
 Searches MEDLINE EMBASE 
1 Falling/ 6853 8592 
2 MORTALITY/ 10059 128600 
3 cohort analysis/ 5 47086 
4 1 and 2 (and 3) 10 20 
5 from 4 keep 9, 20 2 2 
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 Searches MEDLINE EMBASE 
1 Accidental Falls/ 6853 8592 
2 Caregivers/ 9987 12512 
3 carer strain.mp. 32 31 
4 carer burden.mp. 59 59 
5 carer stress.mp. 28 33 
6 2 or 3 or 4 or 5 10027 12556 
7 Aged/ 815645 691890 
8 1 and 6 and 7 14 60 
 From 8 keep… 3 0 
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This search uses the search strategy detailed in the NICE guidelines from 
2004, focussing on studies from 2004 onwards. 
 Searches MEDLINE EMBASE 
1 Accidental Falls/; Falling in EMBASE 6922 8707 
2 Cohort Studies/; Cohort analysis in EMBASE 72021 47839 
3 
(Risk* or predict* or screen* or 
probability*).mp. [mp=title, original title, 
abstract, name of substance word, subject 
heading word] 
1118147 1155411 
4 Aged/ 820536 699279 
5 limit 3 to "review articles" 179497 171976 
6 1 and 2 and 3 and 4 130 140 
7 1 and 4 and 5 377 238 
8 6 or 7 502 372 
9 limit 8 to yr="2002 5 2008" 337 284 
 From 9 keep… 31 19 
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This is a sensitive rather than specific search; retained studies were those 
that included evidence based falls risk factors combined in a screening tool, 
with prospective follow up and results reported as 
sensitivity/specificity/area under the curve. 
 Searches MEDLINE EMBASE 
1 Risk Assessment/ 82404 152694 
2 *Recurrence Risk/ 5 284 
3 PREDICTION/ 66580 115940 
4 "prediction and forecasting"/ 5 1244 
5 *Falls Risk Assessment Tool/ 9 1 
6 Risk Factor/ 257700 194062 
7 1 or 2 or 3 or 4 or 5 or 6 377516 409941 
8 Prospective Study/ 166603 68568 
9 Cohort Analysis/ 72413 47839 
10 Follow Up/ 5 233211 
11 8 or 10 or 9 5 318638 
12 Human/ 4610101 3814687 
13 Aged/ 823705 699279 
14 *Falling/ 6953 2309 
15 11 and 7 and 13 and 12 and 14 32 183 
16 From 15 keep 3 37 
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This search builds upon the review detailed in the NICE guidelines from 
2004. It uses a simplified search strategy, focussing on randomised 
studies, systematic reviews and meta5analyses from 2003 onwards. Only 
work on falls prevention in community dwelling older people was selected. 
 Searches MEDLINE EMBASE 
1 Accidental Falls/ (Falling in EMBASE) 6962 8732 
2 Aged/ 825311 700684 
3 1 and 2 3998 3969 
4 limit 3 to (English language and humans and 
yr="2003" and (meta analysis or randomized 
controlled trial or "review")) 
In EMBASE: limit 3 to (human and English 
language and "treatment (2 or more terms 
high specificity)" and yr="2003 5 2008" and 
"Clinical Trial" [Subjects] ) 
193 196 
5 From 4 keep 53 Nil new 
' ,
		
	
 Searches MEDLINE EMBASE 
1 Day Care/ or day hospital.mp. 639 2792 
2 Ambulatory Care/ 4579 5062 
3 Ambulatory Care Facilities/ 2213 8160 
4 1 or 3 or 2 7301 15799 
5 Aged/ 347226 700684 
6 Accidental Falls/ 3455 8732 
7 6 and 4 and 5 14 74 
8 From 7 keep… 0 0 
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The variables in Table 4.1 were examined for missing or extreme or 
implausible results, and any errors corrected. All discrepancies were 
corrected in the Access database where appropriate. 
$2%!		$3$	;#&,,	;:!;?,	
Item 1 Item 2 Notes 
Date of consent Date randomised  
Stratum Postcode/town 5 errors; allocation by 
stratum was imbalanced with 
4 individuals who should 
have been in the Nottingham 
stratum according to 
postcodes being allocated to 
the Derby stratum and one in 
the reverse direction 
Allocation Exclusions id 2191 attended DH but only 
found out after randomisation 
so excluded from the analysis 
Cross check DH logs GP records 
Hospital records 
 
Date of entry Date of care home 
admission 
Date of death 
Date final diary 
Withdrawn & no diaries – 
date of exit = date diary 1 
sent +1 day 
Deaths  
 
Hospital records 
AE records 
GP records 
 
Fall Date of fall 
Fall number 
Injury 
Fall detail 
Fall1 vs fall2 dates 
Missing dates equally 
distributed between groups; 
the mid5point date for the 
diary month corresponding to 
that fall was assigned. 
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A limited meta5analysis was carried out to determine the relative benefit if 
efficacy trials as compared to effectiveness trials. Trials were drawn from 
the most recent meta5analyses from Campbell12 and Gates226 as well as 
including trials published since 2003 logged in Medline. 
Search terms included: randomised controlled trial, accidental falls, aged, 
limited to English language & humans 
Inclusion criteria were: falls over 12 months reported as primary outcome, 
community dwelling population (including retirement villages), uni or 
multifactorial intervention, sample size more than 100 in each arm, 
number of events in control and intervention groups or measure of relative 
risk with confidence intervals reported. 
Each paper was assessed to determine if it was an efficacy/explanatory 
trial or an effectiveness/pragmatic trial. In this context, 
pragmatic/effectiveness trials were defined as evaluations of established 
clinical services, and explanatory/efficacy trials as trials of clearly defined 
protocol driven interventions. However, few trials report sufficient detail to 
enable complete clarity in distinguishing the two. This means that the 
distinction is somewhat subjective; this could have been improved by 
having a second reviewer classifying each trial, with discussion where there 
was disagreement. Summary data from the selected trials is shown in 
Table 4.2.
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Author/year Classification n Intervention  Relative risk 95% CIs 
Campbell 2005 Efficacy 391 Multifactorial 0.59 0.42 0.83 
Bischoff5Ferrari 2006 Efficacy 445 Unifactorial 0.77 0.51 1.15 
Cumming 2007 Efficacy 616 Unifactorial 1.57 1.2 2.05 
Lord 2003 Efficacy 551 Unifactorial 0.78 0.62 0.99 
Wolf 2003 Efficacy 291 Unifactorial 0.75 0.52 1.08 
Cumming 1999 Efficacy 530 Unifactorial 0.64 0.5 0.83 
Stevens 2001 Efficacy 1737 Unifactorial 1.02 0.83 1.27 
Campbell 1997 Efficacy 233 Multifactorial 0.6 0.47 0.78 
Clemson 2004 Efficacy 310 Multifactorial 0.69 0.5 0.96 
Davison 2005 Efficacy 313 Multifactorial 0.64 0.46 0.9 
Freiberger 2007 Efficacy 217 Multifactorial 0.77 0.6 0.97 
Lord 2005 Efficacy 597 Multifactorial 0.9 0.69 1.17 
Shumway5Cook 2007 Efficacy 453 Multifactorial 0.75 0.52 1.09 
Tinetti 1994 Efficacy 301 Multifactorial 0.69 0.52 0.9 
Robertson 2001 Efficacy 240 Multifactorial 0.54 0.32 0.9 
Conroy 2008 Pragmatic 344 Multifactorial 0.73 0.51 1.03 
Elley 2008 Pragmatic 312 Multifactorial 0.96 0.7 1.34 
Mahoney 2007 Pragmatic 349 Multifactorial 0.81 0.57 1.17 
213 
The meta5analysis using the fixed5effect estimate had an I2 statistic of 
69.1%, p<0.0001 indicating significant heterogeneity between the studies. 
Accordingly, a random5effects meta5analysis was carried out (Figure 4.5). 
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NOTE: Weights are from random effects analysis
Overall  (I-squared = 50.8%, p = 0.007)
Mahoney 2007
Clemson 2004
Wolf 2003
ID
Stevens 2001
Lord 2003
Cumming 2007
Campbell 2005
Conroy 2008
Tinetti 1994
Davison 2005
Cumming 1999
Campbell 1997
Lord 2005
Robertson 2001
Shumway-Cook 2007
Bischoff-Ferrari 2006
Study
Freiberger 2007
Elley 2008
0.76 (0.68, 0.83)
0.81 (0.57, 1.17)
0.69 (0.50, 0.96)
0.75 (0.52, 1.08)
ES (95% CI)
1.02 (0.83, 1.27)
0.78 (0.62, 0.99)
1.57 (1.20, 2.05)
0.59 (0.42, 0.83)
0.73 (0.51, 1.03)
0.69 (0.52, 0.90)
0.64 (0.46, 0.90)
0.64 (0.50, 0.83)
0.60 (0.47, 0.78)
0.90 (0.69, 1.17)
0.54 (0.32, 0.90)
0.75 (0.52, 1.09)
0.77 (0.51, 1.15)
0.77 (0.60, 0.97)
0.96 (0.70, 1.34)
100.00
4.29
5.79
4.67
Weight
6.05
7.02
2.63
6.45
5.09
6.88
6.05
7.63
7.95
5.54
4.48
4.57
3.95
%
7.02
3.95
  0-2.05 2.05
 
This meta5analysis, including data from our trial indicates a combined 
relative risk reduction of 0.76 (0.6850.83) in favour of falls prevention 
strategies delivered to high risk individuals. 
A further meta5analysis was carried out separating pragmatic from 
explanatory trials (Figure 4.6). This shows a similar relative risk reduction 
of 0.76 (0.6850.83) for the explanatory trials, but a reduced effect in 
pragmatic trials – effect size 0.82 (0.6550.99). 
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NOTE: Weights are from random effects analysis
.
.
Overall  (I-squared = 50.8%, p = 0.007)
Elley 2008
Davison 2005
Stevens 2001
Subtotal  (I-squared = 0.0%, p = 0.549)
Lord 2003
Conroy 2008
Study
Lord 2005
Wolf 2003
Bischoff-Ferrari 2006
Efficacy
Robertson 2001
Campbell 1997
Cumming 1999
Clemson 2004
Shumway-Cook 2007
Subtotal  (I-squared = 56.8%, p = 0.004)
Campbell 2005
Mahoney 2007
Tinetti 1994
ID
Cumming 2007
Pragmatic
Freiberger 2007
0.76 (0.68, 0.83)
0.96 (0.70, 1.34)
0.64 (0.46, 0.90)
1.02 (0.83, 1.27)
0.82 (0.65, 0.99)
0.78 (0.62, 0.99)
0.73 (0.51, 1.03)
0.90 (0.69, 1.17)
0.75 (0.52, 1.08)
0.77 (0.51, 1.15)
0.54 (0.32, 0.90)
0.60 (0.47, 0.78)
0.64 (0.50, 0.83)
0.69 (0.50, 0.96)
0.75 (0.52, 1.09)
0.75 (0.66, 0.84)
0.59 (0.42, 0.83)
0.81 (0.57, 1.17)
0.69 (0.52, 0.90)
ES (95% CI)
1.57 (1.20, 2.05)
0.77 (0.60, 0.97)
100.00
3.95
6.05
6.05
13.33
7.02
5.09
%
5.54
4.67
3.95
4.48
7.95
7.63
5.79
4.57
86.67
6.45
4.29
6.88
Weight
2.63
7.02
  0-2.05 2.05
 
The funnel plot (Figure 4.7) shows a reasonable spread of results, 
suggesting that publication bias is not a major factor. 
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Whilst imperfect in terms of methodology, these findings lend support to 
the theory that there is a discrepancy between efficacy trials and their 
delivery in clinical practice (trials of effectiveness). 
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